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Transmissible spongiform encephalopathies (TSEs) are a group of fatal
neurodegenerative diseases. The causative agent for these diseases is unknown. After
peripheral inoculation, accumulation and replication of the agent has been found to
occur in lymphoid tissues prior to spreading to the CNS and brain where pathology is
caused. Within lymphoid tissues, follicular dendritic cells (FDCs) are critical for the
accumulation of the TSE agent. Elowever, specifically which lymphoid tissues
neuroinvasion occurs from is unclear. The aims of this thesis were to determine the
importance of draining lymphoid tissue in pathogenesis of the ME7 strain of scrapie
agent after inoculation via the oral, scarification or intra-peritoneal (i.p.) routes. The
formation of most lymphoid tissue is critically dependent on lymphotoxin (LT) a|3
signalling through LT|3R during gestation. Mice in which this signalling has been
interrupted, either through in ntero treatment with LTPR-Ig or by genetic deficiency
of LTa or LTf3, lack various lymphoid tissues. LTa~/~ mice and LTP_/" mice also lack
FDCs so these were reconstituted with wild-type (WT) bone marrow, thus restoring
FDCs without inducing the formation of missing lymphoid tissues. After oral
inoculation Peyer's patches (PPs) within the intestine were found to be crucial for
pathogenesis as mice lacking PPs did not develop disease. Isolated lymphoid
follicles (ILFs) which resemble PPs have recently been described in the murine small
intestine and are thought to compensate for PP-deficiency. ILFs were investigated
here and found to contain FDCs and, as a result support neuroinvasion of the scrapie
agent in the absence of PPs. Mice lacking inguinal lymph nodes (ILNs) displayed
decreased susceptibility to scrapie disease after inoculation via scarification of the
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skin of the thigh. This demonstrated that the ILNs are important, but neuroinvasion
could occur from other tissues in some cases. The cranial mediastinal lymph nodes
(CMLNs) drain the peritoneal cavity. Investigations in this thesis revealed both
LTamice and LTp_/~ mice lack these nodes. LTa_/" mice were less susceptible and
had delayed onset of disease compared to WT mice whereas LTp~/_ mice were as
susceptible and developed disease in the same timeframe as WT mice after i.p.
inoculation. This demonstrated that the CMLN is dispensable for neuroinvasion via
the i.p. route, but raised the possibility that lymphoid tissue present in LTP"/_ mice
and absent from LTa"/_ mice was important in supporting neuroinvasion. In all three
routes the lack of draining lymphoid tissue had an effect on the pathogenesis of
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1.1. Transmissible spongiform encephalopathies
1.1.1 TSE diseases
Transmissible spongiform encephalopathies (TSEs) or "prion" diseases are a group
of invariably fatal, neurodegenerative diseases which affect both humans and
domestic and wild animals. They have also been described as slow viruses, subacute
spongiform encephalopathies and transmissible dementias (Collinge, 2001).
The oldest known TSE disease is scrapie, a disease of sheep and goats which was
first recognised about 300 years ago (McGowan, 1922). This disease is named for
the clinical signs it produces in affected animals (tremours to the head and neck,
scratching, rubbing, and gait abnormailities; McGowan, 1922) and is also known as
"la tremblante" (French for trembling), "traberkrankheit" (German for trotting
disease) or "rida" (Icelandic for ataxia or tremour) in other countries (Detwiler et al.,
2000). Scrapie is endemic in most sheep producing counties worldwide, with the
exception of Australia which has not reported any cases of scrapie disease in its
national flock. Scrapie was originally thought to be a genetic disease (McGowan,
1922), but an outbreak of scrapie due to a vaccine composed of scrapie-contaminated
spleen and brain tissue first showed that the disease was infectious (Gordon, 1946).
An early experiment demonstrated that scrapie could be transmitted between sheep
and goats (Cuille & Chelle, 1936), subsequently the similarities in the epidemiology,
pathology and clinical signs between scrapie in sheep and TSEs of other species were
noted (Hadlow, 1959). The route of transmission of scrapie is unclear, but may
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involve both horizontal (sheep to sheep; Brotherston et al., 1968) and vertical (ewe to
lamb) transmission (Foster et al., 1996).
TSEs in other species have been described - such as chronic wasting disease (CWD)
a TSE which affects mule deer (Odocoileus hemionus hemionus) and elk (Cervus
elephus nelsoni; Williams & Young, 1980) transmissible mink encephalopathy
(TME) that affects farmed mink (Hartsough & Berger, 1965) and familial fatal
insomnia (FFI; Medori et al., 1992), Gerstmann Straussler Scheinker syndrome
(GSS; Gerstmann et al., 1936) and Creutzfeldt-Jakob disease (CJD; Creutzfeldt,
1920; Jakob, 1921a, 1921b) that affect humans. Table 1.1 describes the
nomenclature and aetiology ofmany TSE diseases.
In the early 1980s an outbreak of TSE disease in cattle (which were not previously
known to be natural hosts of TSE disease) led to the first description of bovine
spongiform encephalopathy (BSE; Wells et al., 1987). This outbreak is thought to
have arisen by TSE contaminated protein derived from rendered carcasses of
ruminants being used to supplement the diet of intensively farmed cattle (Anderson
et al., 1996; Wilesmith et al., 1991). The original source of the contaminant and the
conditions which allowed the emergence of BSE remain unclear (Collee & Bradley,
1997a, 1997b). The wide use of cattle products in feedstuffs resulted in subsequent
outbreaks of feline spongiform encephalopathy (FSE) in domestic and exotic cats
(Wells et al., 1987; Wyatt et al., 1991), and TSE diseases in other exotic animals
such as kudu and oryx (Jeffrey & Wells, 1988; Kirkwood et al., 1990; Wells et al.,
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of the human Creutzfeldt-Jakob disease (vCJD) has been shown to be caused by the
same agent as the BSE epidemic (Bruce et al., 1997; Hill et al., 1997) and therefore
is presumed to have arisen and spread by the consumption of BSE contaminated beef
and other cattle derived products. Figures to the 6th November 2006 show there have
been 158 deaths from vCJD in the UK and a further 6 patients living with the clinical
signs of vCJD (figures from http://www.cjd.ed.ac.uk/figures.htm). The BSE
epidemic and the subsequent transmission of the BSE agent across the species barrier
to humans has led to vast scientific and medical interest in these diseases with a view
to developing both diagnostic strategies to identify them and therapeutic strategies to
control them.
1.1.2 The nature of the causative TSE agent
The nature of the causative TSE agent is unclear and is a hotly debated topic among
TSE researchers. At present there are at least three main theories as to the precise
nature of the causative agent.
Historically, TSEs were thought to be slow viruses due to the long incubation time
between exposure to the infectious agent and the onset of clinical signs of disease
(Collinge, 2001). The "virus hypothesis" proposes that the TSE agent is a virus as
TSEs are transmissible, display strain specific variation and initially virus particles
were thought to have been identified (Cho, 1976; Cho & Greig, 1975). However,
this hypothesis now seems unlikely as treatments that would inactivate viral
replication such as exposure to ultraviolet light, ionising radiation, dry heat or
chemical treatments do not affect the pathogenesis of TSEs. Additionally, TSE
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disease specific nucleic acid has never been identified (Alper et al., 1966; Brown et
al., 1986; Kimberlin et al., 1983; Somerville et al., 1997a; Taylor et al., 1996a).
It has been suggested that it is thermodynamically possible for a protein to be the
only component of an infectious agent; consequently it was proposed that TSE agent
could consist solely of a protein (Griffiths, 1967). Subsequently, a relatively
proteinase resistant host protein was found to co-purify with infectivity leading to the
proposal of what is known as the "prion hypothesis" (Bolton et al., 1982; Prusiner,
1982). The term "prion" was coined from proteinaceous infectious particle and the
prion hypothesis is, therefore, the idea that the relatively proteinase resistant,
detergent insoluble, misfolded form of the prion protein (termed PrPSc; Meyer et al.,
1986) is the major, or sole component of the infectious agent (Prusiner, 1982). TSE
disease is propagated by PrPSL converting the normal cellular form of the prion
protein (PrPc) into PrPSc. This hypothesis explains why disease specific nucleic acid
has never been identified, and why viral inactivation treatments do not affect TSE
pathogenesis. This hypothesis is further supported by evidence suggesting that
prions created in vitro can be infectious when used in vivo (Legname et al., 2004)
and that PrPSc can convert PrPc to PrPSc in vitro (Kocisko et al., 1994). Elowever,
the prion hypothesis does not explain the existence of TSE strains. It has been
proposed that strains are due to different conformations of PrPSc (Prusiner, 1991) or
different glycosylation patterns (Ermonval et al., 2003). However, different
conformations or glycosylation patterns have not been shown to be the cause of
disease (Soto & Castilla, 2004). The demonstration of TSE infectivity in the absence
of the misfolded form of the prion protein (Barron et al., 2001; Lasmezas et al.,
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1997) and presence of PrPSc in the absence of TSE infectivity are also not readily
explained by the prion hypothesis (Prusiner et al., 1990).
This has led to the proposal of the "virino hypothesis". This is the suggestion that
the TSE agent consists of an informational component (such as nucleic acid) that
interacts with host PrPc (Dickinson & Outram, 1988). The conversion of PrPc to
PrPSc may prevent the degradation of the informational component (Farquhar et al.,
1998). As this agent would not have to encode the synthesis of viral coat proteins a
piece of nucleic acid involved in this process could be very small. Thus this
hypothesis explains the presence of TSE strains while allowing for the absence of
detectable nucleic acid. This hypothesis could also overcome the difficulty of strains
as the informational component may have the ability to confer strain specific
characteristics.
1.1.3 The cellular form of the prion protein
Whatever the nature of the TSE agent it is clear that the prion protein is central to
TSE disease as the misfolded form co-purifies with infectivity in all cases of natural
disease and mice genetically deficient in PrP are resistant to disease (Bueler et al.,
1993; Manson et al., 1994a; Sakaguchi et al., 1995). This has led to considerable
interest in the structure and function of PrPc. PrPc is encoded a single gene in the
genome of rodents, ruminants and man (Oesch et al., 1985; Westaway & Prusiner,
1986). This gene is denoted Prnp in mice, the equivalent gene is denoted PRNP in
humans and PrP in other species. PrPc is a sialoglycoprotein made up of
approximately 210 amino acid residues and has several distinct domains that may be
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related to function, including a minimum of four copper binding octapeptide repeats,
a glycophosphatidylinositol (GPI) anchor and an N-terminal signal peptide. There are
two sites on the PrP molecule to which a carbohydrate may be added during
synthesis. These are asparagine residues at positions 181 and 197. The differential
glycosylation of these site results in three forms of PrPc - unglycosylated,
monoglycosylated (where a sugar molecule is added at either one of these sites) or
diglycosylated (where a sugar molecule is added at both sites; Oesch et al., 1985).
PrP is expressed at the highest level in the tissues of the central and peripheral
nervous systems (Kretzschmar et al., 1986; Oesch et al., 1985). Lower levels of
expression of PrP are found in other peripheral tissues including lymphoid tissues
(Caughey et al., 1988; Dodelet & Cashman, 1998; Mabbott et al., 1997). The
biological function of this molecule is unknown. Three independent PrP"A mice lines
have been generated (Bueler et al., 1992; Manson et al., 1994a; Sakaguchi et al.,
1995). These develop normally and appear healthy, however, subtle abnormalities
have been reported in these mice such as disturbances in circadian rhythms (Tobler et
al., 1996) and impaired T lymphocyte responses (Kubosaki et al., 2003; Lewicki et
al., 2003; Mabbott et al., 1997). Experiments have suggested that PrPc may have a
role in preventing apoptosis of both human and murine neuronal cell lines (Bounhar
et al., 2001; Kim et al., 2004; Kuwhara et al., 1999; Roucou et al., 2004). This
hypothesis is further supported by the finding that after cross-linking PrPc with a PrP
specific antibody in vivo and thus preventing PrPc from functioning normally mass
apoptosis of neurones was observed (Solforosi et al., 2004). Other evidence has
suggested that function of PrP may be to prevent neuronal death due to copper
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toxicity as PrPc can bind copper (Brown, 2004; Brown et al., 1997a; Brown et al.,
1997b; Millhauser, 2004). Markers of oxidative stress are found at increased levels
in the brains of PrP"7" mice (Wong et al., 2001) and mice infected with scrapie
display poor responses to oxidative stress (Milhavet et al., 2000) suggesting that
PrP may play a role in the prevention of damage to neurones due to oxidative stress
c
by acting as a superoxide dismutase (Brown et al., 1999a). PrP may also have a
function in signal transduction by affecting the activity of the tyrosine kinase Fyn
(Mouillet-Richard et al., 2000).
Although the function of PrPc is unknown, the conversion of PrPc to PrPSc seems to
be vital for the establishment of TSE disease as in the absence of PrPc disease does
not develop (Bueler et al., 1993; Manson et al., 1994a; Sakaguchi et al., 1995) and
PrPSc co-purifies with infectivity in natural cases of TSE disease (Bolton et al., 1982;
Meyer et al., 1986). When PrP+/+ neurones were grafted into the brains of PrP"7"
mice disease specific pathology was observed only in the grafted tissue suggesting
that the expression of PrPc is vital for the generation of pathology (Brandner et al.,
1996). Experiments have also showed that heterozygous PrP+/" mice take longer to
develop disease than PrP+/+ counterparts (Manson et al., 1994b) again demonstrating
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the importance of PrP for the development of TSE disease.
The survival time of mice inoculated with scrapie is influenced by polymorphisms in
the gene encoding PrPc. Initially these were described as a separate gene termed
Sine for scrapie incubation period (Dickinson et al., 1968), which has two alleles, s7
and p7, for short and prolonged incubation periods respectively (Dickinson &
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MacKay, 1961; Dickinson & Meikle, 1971; Dickinson et al., 1968). Later research
revealed that these correlated to polymorphisms at codons 108 and 189 of the Prnp
gene with Leu-108 and Thr-189 corresponding to Sincs7 and Phe-108 and Val-189
corresponding to Sine?7 (Moore et al., 1998). These alleles are now termed Prnpa
and Prnpb respectively. More recently a third allele (Prnpc) has been identified
where Phe-108 and Thr-189 also influences the incubation period of scrapie in mice
(Lloyd et al., 2004).
Polymorphisms in the gene encoding PrPc have also been observed to have an effect
on the pathogenesis of natural TSEs. For example, in sheep, polymorphisms at
codons 136, 154 and 171 in the ovine PrP gene have been shown to influence
susceptibility to natural scrapie. Depending on the allelic combination and the breed
of sheep these polymorphisms can lead to susceptibility or resistance to disease. For
example in the Suffolk breed sheep homozygous for polymorphisms Ala-136, Arg-
154 and Gin-171 (ARQ/ARQ genotype) are highly susceptible, whereas sheep with
the genotype ARR/ARR are resistant. In Cheviot sheep the ARQ/ARQ genotype is
associated with resistance while VRQ/VRQ sheep are highly susceptible (Goldmann
et al., 1991; Goldmann et al., 1994; Hunter, 1998).
Similarly, polymorphisms at codon 129 in the PRNP gene of humans influence
susceptibility to vCJD - all clinical vCJD cases have been found to be methionine
homozygotes at this codon (Ironside, 2000). Additionally, mutations in the PRNP
gene, such as P102L, D178N and E200K are each closely associated with the
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development of GSS, FFI and fCJD respectively (Hsaio et al., 1991; Hsaio et al.,
1989; Medori et al., 1992).
1.1.4 Distinguishing the cellular form from the disease specific form of the prion
protein
PrPSc has some properties which allow it to be distinguished from PrPc such as
proteinase resistance and insolubility when treated with detergents. When PrPSc is
treated with proteinase K (PK) the 33-35 kDa protein is truncated to leave a 20-30
kDa proteinase resistant core. When PrPc is treated similarly it is fully hydrolysed.
Thus when PK treated tissue homogenates are analysed by immunoblotting PrP will
be detected only in infected samples (Oesch et al., 1985). Immunoblotting of either
PrPc or PrPSc results in a three band pattern, the three bands representing the
unglycosylated, monoglycosylated and diglycosylated forms of the protein (in order
of increasing molecular mass; Oesch et al., 1985).
The relative resistance of PrPSc to PK also allows PrPSc to be distinguished from PrPc
on tissue sections. Tissue sections can be fixed to nitrocellulose, treated with PK
followed by immunostaining with PrP specific antibodies. Thus only PrPSc will be
left on the nitrocellulose for detection (Schulz-Schaeffer et al., 2000). The absence
of a commercially available antibody to distinguish between PrPc and PrPSc makes
conventional immunostaining and other techniques that do not allow for PK
digestion difficult. PrPSc specific antibodies have recently been generated which
may make analysis of future TSE pathogenesis experiments easier to interpret
(Paramithiotis et al., 2003). In this thesis, disease specific accumulations of the PrP
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have been visualised using conventional immunostaining with the monoclonal
antiserum 1B3 as a series of studies have revealed these accumulations to occur only
in the tissues of TSE affected animals and to correlate closely with the presence of
the TSE agent and the detection of disease specific PrP is enhanced by using
periodate-lysine-paraformaldehyde (PLP) fixative and pre-treatment with formic acid
(see section 2.4.2; Beekes & McBride, 2000; Brown et al., 1999b; Mabbott et al.,
2000a; Mabbott et al., 2003; McBride et al., 1992; McBride et al., 2001). In this
case, where PK resistance has not been confirmed, these accumulations are referred
to as PrPd to distinguish them from PK resistant PrPSc. The use of conventional
immunostaining has the advantage that counterstaining of the tissue may be done
allowing for the anatomical location of PrPd accumulations to be ascertained. This
cannot be done where treatment has digested the tissue away.
PrPSc can also be distinguished from PrPc based on its misfolded conformation.
Infrared and circular dichroism experiments showed that PrPc consists of
approximately 43 % a-helix and 3 % P-sheets whereas PrPSc consists of 34 % a-helix
and 43 % P-sheet (Pan et al., 1993). Large amounts of material are required to do
this kind of analysis making it impossible for this to be carried out on tissues from
individual mice.
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1.1.5 Neuropathological characterisation of TSE strains in rodent models
At present around twenty strains of scrapie have been identified by passage in lines
of inbred mice. TSE strains are distinguished according to the disease incubation
period and the vacuolar pathology in the brain. When a serially passaged scrapie
strain is injected at a high dose directly into the brains of a group ofmice of the same
line the incubation periods are highly reproducible such that the standard error is less
than 2 % of the mean (Dickinson & Meikle, 1971; Dickinson et al., 1968). However,
two different strains of the scrapie agent in the same line of mice will result in two
distinct incubation periods as will the same scrapie agent in two different lines of
mice. Thus measuring the disease incubation period can be used to distinguish
scrapie strains. Similarly, the pattern of vacuolation in the brain can also be used to
distinguish scrapie strains. Brain areas are identified and scored according to the
severity and distribution of the vacuolation. These values can be plotted on a graph
to generate what is termed a "lesion profile" (Fig 1.1). Mice from the same line
infected with the same strain of scrapie agent will repeatedly result in similar lesion
profiles, whereas the same strain of agent injected into a different line of mice will
result in a different lesion profile. Similarly, two different strains of the agent
injected into the same line ofmice will result in two distinct lesion profiles (Fig 1.1;
Fraser & Dickinson, 1973).
Glycoform analysis can also be used to distinguish TSE strains. This uses the
intensity and migration of the PrP glycoform banding pattern obtained using
immunoblotting. Different strains have different ratios of the three glycosylation
states of PrP. These migrate at different speeds when subjected to gel
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1 2 3 4 5 6 7 8 9 1* 2* 3*
Scoring Area Of Brain
Figure 1.1- Vacuolar pathology of scrapie strains ME7 and 79A. Vacuolation in
the brain was scored on a scale of 0-5 in the following grey matter (1-9) or white
matter (l*-3*) areas: 1, dorsal medulla; 2, cerebellar cortex; 3, superior colliculus; 4,
hypothalamus; 5, thalamus; 6, hippocampus; 7, septum; 8, retrosplenial and adjacent
motor cortex; 9, cingulate and adjacent motor cortex; 1*, inferior and middle
cerebellar peduncles; 2*, decussation of the superior peduncles; 3*, cerebral
peduncles. Each point represents mean vacuolation score.
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electrophoresis allowing strains to be distinguished (Collinge et al., 1996; Parchi et
al., 1995; Somerville, 1999; Somerville et al., 1997b).
TSE disease can be confirmed by the presence of four hallmarks of TSE disease in
the brain of an affected individual (Fig 1.2). In a TSE affected brain glial cells will
be activated resulting in an increase in size and number of astrocytes (Bruce et al.,
1994; Deidrich et al., 1991) and microglial cells (Williams et al., 1997). Loss of
neurones will also be evident (Fraser, 2002). These features occur in every case of
TSE disease, but may also occur in the brains of individuals affected by other
neurological diseases. Characteristic vacuolar pathology (Fraser & Dickinson, 1973)
and PrPSc deposition (DeArmond et al., 1985) will also be observed in the brain of a
TSE affected individual and are specific to TSE diseases.
1.2 TSEs and the immune system
1.2.1 The role of lymphoid tissues
Although the pathology caused by TSE diseases is largely confined to central
nervous system (CNS) tissues, very few natural cases of acquired TSE disease
involve transmission directly to the CNS itself. Many natural TSE diseases are
thought to be transmitted via the oral route, for example BSE in cattle (Wilesmith et
al., 1991), vCJD in humans (Bruce et al., 1997; Hill et al., 1997), scrapie in sheep
and goats (Andreoletti et al., 2000; Heggebo et al., 2003; Heggebo et al., 2000;
Keulen et al., 1999), CWD in mule deer and elk (Williams & Young, 1980) and
TME in mink (Hartsough & Berger, 1965). Other routes include iatrogenic
transmission such as blood transfusion (Llewelyn et al., 2004; Peden et al., 2004) or
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Figure 1.2- Classical hallmarks of TSE disease within the brain.
a) characteristic vacuolar pathology after staining with haemotoxylin and eosin,
b) deposition of disease specific prion protein (PrPd) shown using PrP-specific
monoclonal antiserum 6H4 (brown) and c) activation of glial cells shown using
Glial fibrillary acidic protein (GFAP) -specific monoclonal antiserum (red). All
sections counterstained with haematoxylin to distinguish cell nuclei. Original
magnification X200.
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or implantation of infected tissues (Duffy et al., 1974). Thus, study of the peripheral
pathogenesis of TSE disease may allow for the development of therapeutic
interventions to prevent the spread of the TSE agent to the CNS where invariably
fatal, and, at present, pharmacologically irreversible damage is done to the tissues.
Challenge with a TSE agent does not generate a specific immune response as seen
following infection with most other infectious agents (McFarlin et al., 1971). There
is no discernible humoural immune response as an absence PrP specific antibody
generation has been reported (Chandler, 1959; Clarke & Haig, 1966; Marsh et al.,
1970; Pattison et al., 1964; Porter et al., 1973). Similarly, genetic deficiency of Fc
receptors has no effect on TSE pathogenesis (Klein et al., 2001). There is also no cell
mediated immune response to the TSE agent (Kingsbury et al., 1981). The lack of
an immune response is not due to the TSE agent itself being immunosuppressive as
responses to other antigenic challenges appear to be normal in scrapie infected mice
(Clarke, 1968; Gardiner & Marucci, 1969; Garfin et al., 1978). The lack of a TSE
specific immune response is likely due to the fact that a major or sole component of
the infectious TSE agent is very similar to PrPSc, derived from the host protein PrPc
which is expressed on many tissues (Manson et al., 1992; Oesch et al., 1985). Thus
the host is immunologically tolerant to the TSE agent (Gregoire et al., 2005).
However, there is a role for the immune system in TSE pathogenesis. The early
detection of the TSE agent in lymphoid tissues, prior to detection in the CNS or onset
of clinical signs of disease in many natural and experimental TSEs suggests that
lymphoid tissues do play a role in the peripheral pathogenesis of disease (Andreoletti
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et al., 2000; Hadlow et al., 1987; Heggebo et al., 2003; Heggebo et al., 2002;
Heggebo et al., 2000; Hilton et al., 1998; Keulen et al., 1996; Keulen et al., 1999;
Mabbott et al., 2003; Mohan et al., 2005a; Sigurdson et al., 1999). Early studies
showed that splenectomy prior to intra-peritoneal (i.p.) inoculation of the scrapie
agent delayed the onset of clinical disease thus demonstrating that the early
accumulation of the TSE agent in lymphoid tissues is important for the efficient
development of disease, although the spleen is not the only place neuroinvasion
occurs from (Clarke & Haig, 1971; Fraser & Dickinson, 1970, , 1978). Splenectomy
studies using sub-cutaneous, intra-gastric or intra-ocular routes of inoculation have
demonstrated an inconsistent or no role for the spleen, again suggesting that
neuroinvasion can take place from other tissues in the absence of the spleen (Fraser
et al., 1992; Fraser, 1996; Kimberlin & Walker, 1989). Studies have also shown that
the induction of lymphocytic foci by chronic inflammation allows the accumulation
of the TSE agent in organs in which this would not otherwise occur (Heikenwalder et
al., 2005; Seeger et al., 2005). The contribution of various cells and molecules within
lymphoid tissues to the peripheral pathogenesis of TSEs has since been investigated.
1.2.2 The role of lymphocytes
The role of lymphocytes in TSE pathogenesis has been studied by deleting various
subsets of lymphocytes and investigating the effect on disease susceptibility. Early
studies in mice showed that thymectomy, which causes a general depletion of T-
lymphocytes, prior to experimental peripheral infection with scrapie had no effect on
the development of disease (Fraser & Dickinson, 1978; McFarlin et al., 1971). Later
studies found mice deficient in specific T lymphocyte subsets (e.g. CD4, CD8,
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TCRcx) to be as susceptible to scrapie disease as wild-type mice (Klein et al., 1997).
A further study has shown that mice with a combined absence of both CD4+ and
CD8+ T lymphocytes at the time of inoculation had delayed onset of disease
(Lewicki et al., 2003). However, this effect was found after both peripheral
inoculation (i.p.) and direct inoculation of the CNS (intra-cranial inoculation)
suggesting that T lymphocytes were enhancing the pathogenesis of disease in the
CNS rather than in the periphery. Taken together these data demonstrate T
lymphocytes do not contribute to the peripheral pathogenesis of TSEs.
Experiments investigating the role of B lymphocytes, however, showed these cells do
play a role in the peripheral pathogenesis of TSEs. In contrast to wild-type mice,
mice deficient in B lymphocytes do not accumulate infectivity in the spleen or
develop neurological disease (Klein et al., 1997). Severe combined
immunodeficiency (SCID) mice that have no B or T lymphocytes are also relatively
resistant to peripheral scrapie challenge (Fraser et al., 1996; Lazmesas et al., 1996;
Taylor et al., 1996b). B lymphocytes can be reconstituted in SCID mice by grafting
with wild-type bone marrow. Using bone marrow grafts from either PrP+/+ mice or
PrPv~ mice into SCID mice it has been demonstrated that bone marrow derived
lymphocytes need not express PrPc for disease to occur (Brown et al., 1999b). The
PrP status of the recipient mouse itself, not the graft which provides the B
lymphocytes, was important in determining whether disease resulted. This is
corroborated by the findings of another study which used a transgenic mouse strain
expressing high levels of PrP on B lymphocytes only (Montrasio et al., 2001).
These transgenic mice did not replicate scrapie in their spleens. As host cells must
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express PrPc to replicate TSE agents (Bueler et al., 1993; Manson et al., 1994b;
Sakaguchi et al., 1995) these data suggest that a non bone marrow derived host cell
expressing PrPc is important in the peripheral pathogenesis of TSEs. B lymphocytes
give vital signals to many other cell types through the use of cytokines (Chaplin &
Fu, 1998; Kosco-Vilbois et al., 1997) therefore the absence of B lymphocytes can
result in the absence of other cell types as a consequence. Together these results
imply that although B lymphocytes play a role, their effect is possibly indirect. An
earlier y-irradiation study in which a sub-lethal whole body dose was given to mice
prior to scrapie infection showed these mice were still susceptible to the disease,
even though actively dividing lymphocytes had been temporarily depleted (Fraser &
Farquhar, 1987). Taken together these data suggest that a non-bone marrow derived,
PrPc expressing, y-irradiation resistant cell that relies on the presence of B
lymphocytes is critical for TSE pathogenesis in lymphoid tissues.
1.2.3 The role of follicular dendritic cells
Follicular dendritic cells (FDCs) reside in lymphoid follicles and retain antigen on
their surface for long periods of time. FDCs have intimate associations with B
lymphocytes and are thought to play a crucial role in the selection of antigen binding
B lymphocytes during an immune response and the maintenance of B lymphocyte
memory (Berg et al., 1995). These cells have been considered to play a role in the
pathogenesis of TSE disease due to the fact that they appear to express high levels of
PrPc in uninfected mice (Brown et al., 1999b; McBride et al., 1992). Accumulation
of high levels of PrPd have been observed on FDCs from experimentally infected
mice (Fig 1.3; Brown et al., 1999b; Mabbott et al., 2000b; McBride et al., 1992),
33
Figure 1.3- Disease specific prion protein (PrPd) accumulation on follicular
dendritic cells in mouse spleen tissue. PrPd was detected using PrP-specific
antiserum 1B3 (red). Section was counterstained with haematoxylin (blue) to
distinguish cell nuclei. Original magnification X200.
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natural sheep scrapie (Andreoletti et al., 2000; Heggebo et al., 2002; Heggebo et al.,
2000; Keulen et al., 1999), experimental CWD (Sigurdson et al., 1999) and patients
with vCJD (Hilton et al., 1998). Also, FDCs are mitotically inactive cells and
therefore relatively resistant to y- irradiation (Heinen et al., 1995). FDCs are
dependent upon signals from B lymphocytes to induce their maturation and remain in
a fully differentiated state (Berg et al., 1995). A recent study has also shown that the
onset of susceptibility to peripherally inoculated scrapie in neonatal mice coincides
with the development and maturation of FDCs as the mice age (Ierna et al., 2006).
These characteristics strengthened the argument for the involvement of FDCs in TSE
pathogenesis. However, not all TSE models may depend on FDCs for their
pathogenesis. Some studies have shown that in the absence of FDCs disease
susceptibility is decreased (Horiuchi et al., 2006; Mabbott et al., 2000a; Mabbott et
al., 2002; Mabbott et al., 2000b; Mabbott et al., 2003; Montrasio et al., 2000; Prinz
et al., 2003b) others that susceptibility is not affected by the absence of FDCs (Klein
et al., 1997; Manuelidis et al., 2000).
FDCs need constant stimulation from B lymphocytes via interactions with cytokines
to maintain their fully differentiated state. Tumour necrosis factor -a (TNFa) is one
such cytokine, consequently in the absence of stimulation via TNFa FDCs do not
develop (MacKay & Browning, 1998; Matsumoto et al., 1996; Pasparakis et al.,
1996). B lymphocytes secrete TNFa, which binds to TNF receptor 1 (TNFR1) on the
FDC or its precursor cell, allowing the signal to pass on to the inside of the FDC
(Beutler & Huffel, 1994). Disrupting this signalling pathway leads to a lack of
terminally differentiated FDCs (MacKay & Browning, 1998; Matsumoto et al., 1996;
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Pasparakis et al., 1996) but mature lymphocytes are present providing an opportunity
to investigate the potential role specifically of FDCs in TSE pathogenesis. After
peripheral inoculation of TNFa"/_ mice with the ME7 scrapie strain, PrPSc and
infectivity do not accumulate in the spleen and susceptibility is reduced (Mabbott et
al., 2000b). The TNFa signalling pathway can also be disrupted by treatment with a
TNFR1 homologue. This treatment causes FDCs to de-differentiate temporarily
(Mabbott et al., 2002). When mice were treated with this reagent prior to peripheral
scrapie inoculation the incubation period increased and scrapie accumulation in the
spleen decreased. This would suggest that scrapie replication was unable to take
place during this period in the spleen due to the de-differentiation of the FDCs, again
suggesting an important role for FDCs in TSE pathogenesis. Another study,
however, did not support this role for FDCs (Klein et al., 1997). This study used
mice genetically deficient in TNFR1 (TNFR1" mice). It would be expected that as
these mice lack differentiated FDCs they would not succumb to disease. However,
the results showed that after peripheral inoculation with the RML scrapie strain there
was no appreciable difference between the TNFRl7" mice and their wild-type
counterparts in disease susceptibility. This could be explained by the fact that this
study involved the use of a different scrapie strain to that of the first two studies
(Mabbott et al., 2002; Mabbott et al., 2000b) which raises the possibility that
different strains of scrapie may exhibit different host cell tropisms. It is also
possible that, as the latter study used a higher dose of scrapie than the others did, the
immune system was by passed and infection proceeded immediately to the CNS with
no replication stage necessary. This theory was also put forward by investigators
comparing wild-type bone marrow reconstituted SCID mice with SCID mice to
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account for the 33% of SCID mice which did develop disease (Lazmesas et al.,
1996). TNFa also has other functions, one of which is the activation of
macrophages. A subsequent study (Prinz et al., 2002) put forward the theory that in
TNFa"7" or TNFR1"7" mice the lack of FDCs was perhaps compensated for by
replication in dormant macrophages. Strong accumulations of PrPSc were detected in
macrophages in lymph nodes from scrapie infected TNFR1"7" mice (see section
1.2.5).
Lymphotoxin exists in two forms - a secreted homotrimer of lymphotoxin -a (LTa3)
which is a ligand of TNFR1 and TNFR2, and a membrane bound heterotrimer
LTaiP2 which signals through LT(3 receptor (LT(3R; (Pfeffer, 2003). LTa^ is
another cytokine required for the terminal differentiation of FDCs and is expressed
by B lymphocytes. This protein can bind LTpR on FDCs or their precursor cells
providing a further signal for FDC differentiation (Endres et al., 1999). In the
absence of either LTaiP2 or LTpR FDCs do not differentiate (Koni et al., 1997;
Matsumoto et al., 1996). If FDCs are important for TSE pathogenesis one would
expect that interruptions to the LTpR signalling pathway would affect TSE
susceptibility in similar ways described above for the TNFa pathway. Studies
involving the use of a homologue of the LTPR (LTPR-Ig) to block the LTpR
signalling pathway found that this treatment caused the FDCs to de-differentiate
temporarily (MacKay & Browning, 1998). Treatment with LTpR-Ig prior to
peripheral scrapie inoculation blocked the accumulation of PrPSc in the spleen,
extended the incubation period (Mabbott et al., 2000a; Mohan et al., 2005a;
Montrasio et al., 2000) and reduced disease susceptibility and even prevented the
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onset of disease in mice which had no functional FDCs at the time of oral inoculation
(Mabbott et al., 2003). Another study (Prinz et al., 2002), using RML scrapie and
mice genetically deficient in various components of the LT pathway found that in all
cases, resistance was conferred suggesting that replication of scrapie was unable to
occur due to the lack of FDCs or other LT-dependent cells caused by disruption of
LT signalling. One study, however, using LTp knockout mice and a mouse passaged
CJD agent found no difference between wild type and knockout mice (Manuelidis et
al., 2000) implying no role for FDCs in TSE pathogenesis. This again raises the issue
of different strains of TSE exhibiting different host cell tropisms.
1.2.4 Role of complement
Complement is a series of proteins of the innate immune system that complement
(hence the name) the activities antibody. Various characteristic molecular patterns
on pathogens, or antibody:antigen complexes can activate the complement cascade.
This results in the opsonisation of pathogens, the lysis of infected cells or the
induction of an inflammatory response (Walport, 2001). The binding of opsonised
antigen to FDCs is thought to enhance the development of immunological memory
(Berg et al., 1995; Walport, 2001). It has been proposed that the attachment of the
TSE agent to FDCs via interactions with complement is another crucial part of the
pathogenesis of TSE diseases (Klein et al., 2001; Mabbott et al., 2001).
One stage of the complement cascade results in C3 being deposited on the surface of
pathogens from which one possible outcome is the attachment of the antigen to FDCs
through the binding of C3 with complement receptor CR1 (Berg et al., 1995;
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Walport, 2001). When there is no C3 present at the time of scrapie agent
inoculation, either through genetic deficiency or temporary depletion by treatment
with cobra venom factor, accumulation of the scrapie agent in the spleen was
reduced and that the incubation period was lengthened (Klein et al., 2001; Mabbott et
al., 2001). Mice deficient in the Cr2 gene which lack the complement receptors
CR2/CR1 (CD21/CD35) also show delayed onset of clinical scrapie disease (Klein et
al., 2001). As C3d (a C3 breakdown product) is the ligand for CR2/CR1 these data
suggest that the attachment of the scrapie agent to FDCs via interactions with
complement component C3 and complement receptors CR2/CR1 is important for the
development of scrapie disease.
The deposition of C3 of the surface of a pathogen can be mediated by a chain of
events beginning with the activation ofClq and involving C2 (classical pathway), or
a separate chain of events involving Factor B and the spontaneous hydrolysis of C3
(alternative pathway; Walport, 2001). Studies have also investigated the effect of
genetic deficiency of Clq (Clq"7" mice) or both factor B and C2 ( H2-Bf/C2_/" mice)
on scrapie pathogenesis. Clq may bind to antibody that has bound antigen and these
complexes can adhere to CR1 (Tas et al., 1999) or Clq receptor (Norsworthy et al.,
1999) on the FDC directly, thus attaching the antigen. Clq, C2 and Factor B can
also bind indirectly to FDCs by activating the complement cascade, which results in
the deposition of C3 on the antigen surface, and subsequent attachment to the FDC as
described above (Berg et al., 1995; Walport, 2001). Interestingly, Clq has been
shown to bind directly to a structurally altered form of PrP (Blanquet-Grossard et al.,
2005). An increase in incubation time and reduction in scrapie accumulation in the
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spleen was noted when Clq7" mice or F12-Bf/C27" mice were inoculated with the
scrapie agent (Klein et al., 2001; Mabbott et al., 2001). These results suggest that
the classical pathway is most likely involved in the attachment of scrapie to FDCs.
The effects on scrapie pathogenesis in Clq7" mice are more profound than in mice
deficient in complement components downstream of Clq which suggests that the
scrapie agent may also be attached directly to FDCs via interactions with Clq. This
is further supported by evidence that FDCs themselves can synthesise Clq
(Schwaeble et al., 1995).
An alternative explanation of the role ofClq comes from a study which showed that
the expression of PrPc by FDCs was increased during infection with vesicular
stomatitis virus (Lotscher et al., 2003). In Clq7" mice this upregulation did not
happen which suggests PrPc expression may be regulated by Clq. Thus in the
absence of Clq the peripheral pathogenesis of scrapie may be impaired due to lower
expression of PrPc by FDCs. This also adds weight to the hypothesis that
inflammation at the time of TSE inoculation can enhance the pathogenesis of TSEs
(Ffeikenwalder et al., 2005; Seeger et al., 2005).
The deposition of C3b on the surface of a pathogen can lead to the lysis of that
pathogen- by the formation of the membrane attack complex (MAC) which consists
of complement components C5-C9 (Walport, 2001). There may be a role for
complement components and the MAC in neurodegeneration as complement
components have been detected in the brains of humans affected by vCJD, fCJD,
sCJD and GSS (Ishii et al., 1984; Kovacs et al., 2004) and rodents affected by
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scrapie or BSE (Dandoy-Dron et al., 2000; Riemer et al., 2000). However, increased
expression of clusterin - a negative regulator of the MAC has also been detected in
the brains of natural and experimental cases of TSEs (McHattie et al., 1999; Sasaki
et al., 2006) and no differences are observed in the neuropathology induced when
mice deficient in various complement components (Clq, C2, C3 and C5) are
inoculated with scrapie (Klein et al., 2001; Mabbott & Bruce, 2004; Mabbott et al.,
2001) which would suggest that whatever the effect of the activation of complement
is in a TSE affected brain, neurodegeneration itself is not mediated by complement.
1.2.5 The role ofmacrophages
Another cell type that resides in the germinal centres of lymphoid tissues and is
possibly radioresistant is the tingible body macrophage. These cells play a role in the
destruction of foreign protein and host cell debris (Smith et al., 1991;
Swartzendruber & Congdon, 1963) so it is possible that they will take up the TSE
agent as part of their normal activities. Studies have shown the accumulation of the
scrapie agent in macrophages in spleens of scrapie infected mice (Jeffrey et al.,
2000), Peyer's patches (PPs) of scrapie infected hamsters (Beekes & McBride,
2000), lymph nodes of scrapie infected sheep (Herrmann et al., 2003) and tonsils of
CWD infected mule deer (Sigurdson et al., 2002). Also, as mentioned earlier, it has
been suggested that accumulation or replication of scrapie might occur in
macrophages that are not activated - for example, in lymph nodes of TNFRl7" (Prinz
et al., 2002). This study found that PrP colocalised with markers for macrophages in
mice lacking functional genes for molecules of the TNFR1 signalling pathway.
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However, the significance of this accumulation is not clear. A body of evidence
points to macrophages playing a preventative role in the peripheral pathogenesis of
TSEs. It is possible to deplete macrophages by treatment with clodronate (Beringue
et al., 2000). When such experiments were carried out it was found that far from
preventing disease as would be expected if macrophages were aiding scrapie
pathogenesis, this treatment actually enhanced pathogenesis thereby suggesting that
macrophages in the spleen play a preventative role in a natural situation (Beringue et
al., 2000; Maignen et al., 2005). This idea is consistent with data from in vitro
studies which found that scrapie infectivity decreased over time when incubated with
macrophages (Carp & Callaghan, 1981,, 1982). However, clodronate also transiently
depletes FDCs and B lymphocytes in the spleen thus the effect of clodronate
treatment on scrapie pathogenesis could be attributed to the absence of other cell
types. Further in vivo work is clearly required to ascertain the precise role of
macrophages in TSE pathogenesis.
1.2.6 Transport of the TSE agent to the lymphoid tissue from the site of
inoculation
From the work discussed so far it is possible to conclude that lymphoid tissues and
various components of the immune system are involved in the peripheral
pathogenesis TSE disease. The way in which the TSE agent reaches the lymphoid
tissues from the site of inoculation is not clear but may involve dendritic cells (DCs),
M cells (when infection occurs via the gastro-intestinal tract) or a cell free pathway.
DCs have a completely different origin and function so should not be confused with
FDCs mentioned earlier. DCs are bone marrow derived and function to sample their
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local environment in the periphery, capture antigen, migrate to lymphoid organs and
present the antigen to T lymphocytes to initiate an immune response against the
antigen (Banchereau & Steinman, 1998). It is quite plausible, therefore, that DCs
might take up the TSE agent at the point of entry in the course of their natural
activity. In vitro work has shown immature DCs respond chemotactically to a
fragment of PrP (Kaneider et al., 2003) and can acquire and retain TSE agents in
native form (Eluang & MacPherson, 2004; Mohan et al., 2005c). These studies
suggest DCs would make ideal candidates for the transport of the TSE agent from the
site of inoculation. However, DCs do not generally migrate to the B lymphocyte
follicles of lymphoid tissues where FDCs are found (Shortman & Lui, 2002),
although there is a subset of DCs which do (Berney et al., 1999; Yu et al., 2002). In
vivo work has shown that in lymph draining from the intestine, PrPd was associated
with a small percentage of DCs, but not present in other cells (Huang et al., 2002).
These PrPd-positive DCs were found not to be infectious, however, this could be due
to the numbers of PrPd- positive cells being too small to transmit disease in a
bioassay. PrPSc was not detected in any DC population after cannulation of the
draining afferent lymphatics of the site of inoculation in an in vivo study in sheep
(Gossner et al., 2006) suggesting that DCs have no role in the transport of the agent.
The migration of Langerhans cells from the skin to the draining lymph node is
impaired in CD40L_/" mice (Moodycliffe et al., 2000). When these mice were
challenged with scrapie via scarification of the skin of the thigh, disease progression
was not impaired suggesting that Langerhans cells are not important for transport of
the scrapie agent from the site of inoculation (Mohan et al., 2005b). However, this
does not exclude a role for other populations of migratory DCs in the skin such as
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dermal dendritic cells (Lenz et al., 1993) which can provide a Langerhans cell-
independent pathway of presentation of antigen from the skin (Kurimoto et al., 1994;
Streilein, 1989), or Langerhans cells migrating under steady state conditions rather
than cells actively stimulated to migrate (Yoshino et al., 2003). DCs have been
shown to open tight junctions in the intestinal epithelium and sample the contents of
the intestinal lumen (Rescigno et al., 2001), suggesting that DCs could be involved
in the direct uptake of the TSE agent from the intestine. DCs remain, therefore, a
prime candidate for the transport of the TSE agent from the site of inoculation to the
local lymphoid tissues but further studies are required to confirm this. DCs may also
play a role in protection against TSE diseases as studies have shown that they can
degrade the TSE agent over time (Mohan et al., 2005c; Rybner-Barnier et al., 2006).
Many natural TSEs are likely to be acquired via the oral route. M-cells are
specialised cells in the intestinal epithelium which sample antigens from the
intestinal lumen and translocate them across the epithelium for uptake by antigen
presenting cells such as DCs (Neutra et al., 1996). Using an in vitro M-cell model it
has been shown that M-cells are capable of taking up the scrapie agent which
suggests they may transfer TSE agents across the intestinal epithelium (Heppner et
al., 2001), although in vivo confirmation of this is required. Stomach enzymes may
partially degrade PrPd to its 27-30 kDa PK resistant core (Jeffrey et al., 2006; Mishra
et al., 2004). In vitro evidence suggests it is possible that these fragments may be
able to cross the intestinal epithelium through being taken up by enterocytes (Mishra
et al., 2004; Morel et al., 2005). This idea is supported by studies showing that the
laminin receptor present on enterocytes can act as a receptor for PrPSc (Gauczynski et
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al., 2006; Morel et al., 2005). The transit of the TSE agent across an intestinal
epithelial model also appears to be dependent on ferritin, an intriguing finding as
ferritin is found in high quantities in meat (Mishra et al., 2004).
1.2.7 Transport of the TSE agent from the lymphoid tissue to the CNS
The spread of TSE agents from the sites of replication in lymphoid tissue to the CNS
is thought to occur via the peripheral nervous system. Early investigations in mice
found that after peripheral challenge replication of scrapie in the CNS consistently
began in the thoracic region of the spinal cord with replication in the brain and other
parts of the spinal cord occurring significantly later (Kimberlin & Walker, 1980).
This suggested that neuronal rather than haematological spread was occurring as this
ordered sequence of events would not be expected if the agent was spreading via the
bloodstream. In experimentally infected rodents PrPd has been found in peripheral
nerves prior to detection in the CNS (Baldauf et al., 1997; Beekes et al., 1996;
Beekes & McBride, 2000; Beekes et al., 1998; McBride & Beekes, 1999; McBride et
al., 2001). The involvement of the enteric nervous system in natural TSE disease has
been shown by the accumulation of PrPd in these nerves in cases sheep scrapie
(Heggebo et al., 2003), humans with vCJD (Haik et al., 2003) and deer affected by
CWD (Sigurdson et al., 2001). Further evidence of the involvement of peripheral
nerves has come from a study showing that FDCs abnormally close to the nerves in
the spleen ofCXCR5" mice speeds up disease progression (Prinz et al., 2003a).
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1.3 Development of secondary lymphoid tissue
From the work discussed so far it can be seen that although knowledge of the
peripheral pathogenesis of TSEs is accumulating many questions remain
unanswered. One such question is; from which lymphoid tissues does neuroinvasion
occur? Does neuroinvasion occur solely from the lymphoid tissues draining the site
of inoculation in which the initial accumulation of the TSE agent has been observed
(Andreoletti et al., 2000; Hadlow et al., 1987; Heggebo et al., 2003; Heggebo et al.,
2002; Heggebo et al., 2000; Hilton et al., 1998; Keulen et al., 1996; Keulen et al.,
1999; Mabbott et al., 2003; Mohan et al., 2005a; Sigurdson et al., 1999) or does
neuroinvasion occur from many tissues such that the absence of the draining
lymphoid tissue can be compensated for by others? These issues are addressed in
this thesis. The approach taken here is to utilise mice that lack various lymphoid
tissues due to the disruption of signals involved in the organogenesis of lymphoid
tissues.
In mice, the development of secondary lymphoid organs does not occur by a uniform
process - different lymphoid organs develop using different molecular pathways and
occur at different times during gestation. For example, experiments using LTpR-Ig to
block LTpR signalling during embryonic development showed that treatment at
distinct times blocked the formation of distinct lymphoid organs (Rennert et al.,
1996). The formation of the spleen was not affected by this treatment although the
microarchitecture was altered. This allows for the creation of mice that lack specific
lymphoid tissues (e.g. Peyer's patches and lymph nodes) but retain the spleen.
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1.3.1 Development of Peyer's patches
The first time it is possible to visualise the formation of the Peyer's patches (PPs) in
the mouse is on the antimesenteric side of the intestine at about 15 days of gestation.
At this stage the early PP appears as a cluster of vascular cell adhesion molecule
(VCAM) -1 and intercellular adhesion molecule (ICAM) -1 expressing stromal cells
of mesenchymal origin and lymphoid tissue initiating cells (LTICs) of lymphoid
origin that are CD4+CD3" and express IL7Ra and a4p7 integrin (Adachi et al., 1997;
Finke et al., 2002; Mebius et al., 1996). This cluster is known as the PP anlage (Fig
1.4, Step 5). The development of LTICs is thought to be dependent on the
transcription factors, Ikaros (Georgopoulos et al., 1994; Wang et al., 1996) and Id2
(Yokota et al., 1999) and the nuclear hormone receptor retinoid-related orphan
receptor-y (Kurebayashi et al., 2000; Sun et al., 2000). In mice genetically deficient
in these molecules lymph nodes (LNs) and PPs do not develop and LTICs are not
detected in the rudimentary lymphoid tissue anlage. This also demonstrates that the
formation of PPs and all LNs is crucially dependent on LTICs.
The first interaction for the formation of PP anlagen may be between a4p7 integrin on
the LTIC and mucosal addressin cell adhesion molecule (MAdCAM) -1 on venous
endothelial cells overlying the foetal intestine (Fig 1.4, Step 1). MAdCAM-1 has
been found to be expressed on these endothelial cells from day 13.5 of gestation
(Hashi et al., 2001) and LTICs are known to express a4p7 integrin (Mebius et al.,




MAdCAM-1 is expressed by endothelial cells
overlying the foetal intestine prior to Peyers patch
(PP) formation. CD3-CD4+ lymphoid tissue
initiating cells (LTICs) may begin to aggregate at
the site of PP formation by binding MAdCAM-1
through a4p7 integrin.
Interleukin 7 receptor- a ligand (IL-7RaL) from an
unknown source binds to IL-7Ra on the LTIC
causing an upregulation of the expression of
lymphotoxin (LT) ct^ on the LTIC cell surface.
LTa,p2 on the LTIC binds to LT(3 receptor (LT(3R)
on surrounding stromal cells, inducing the stromal
cells to express vascular cell adhesion molecule -
1 (VCAM-1) and intercellular adhesion molecule-1
(ICAM-1) on the cell surface and to secrete
CXC113
CXCL13 is a chemoattractant for LTICs, drawing
them into the site of PP formation. CXCL13 also
binds CXCR5 on LTICs inducing them to express
c^ integrin which can then bind VCAM-1 on the
stromal cell - a further method of localising LTICs
to the PP formation site.
a4p! integrin binding to VCAM-1 results in the
formation of the PP anlage - a cluster of stromal
cells and LTICs.
Fig 1.4- Steps in the formation of Peyer's patch anlage.
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later on. In any case this interaction is not vital as experiments that blocked this
interaction from 10 days gestation failed to completely prevent the accumulation of
LTICs (Mebius et al., 1996) and normal numbers of PPs are found in P7 integrin""
mice (Wagner et al., 1996).
What is certain is a ligand that binds to IL-7Ra (IL-7RaL) from an unknown source
binding to IL-7Ra on LTICs is a vital step in the formation of the PP anlage as mice
lacking the receptor have no PPs (Adachi et al., 1998; Yoshida et al., 1999). This
ligand is not IL-7 itself since IL-7"A mice were found to have PPs (Nishikawa et al.,
2003). This is in contrast to other studies that did not detect the macroscopic
development of PPs in IL-7~A mice (Freeden-Jeffry et al., 1995; Laky et al., 2000)
macroscopically. However, it can be argued that, as IL-7"/_ mice are also severely
lymphopenic, macroscopic analysis would not be sensitive enough to find PP
structures when few lymphocytes are present. IL-7Ra combines with IL-2Ry (yc) to
form the IL-7R (Kondo et al., 1994), which implies that IL-7 cannot bind to IL-7Ra
itself and is, therefore, unlikely to be the ligand which associates with IL-7Ra during
the formation of PP anlagen. The ligand that binds IL-7Ra during the generation of
PP anlagen is also unlikely to be the other known IL-7Ra ligand, thymic stromal
lymphopoietin (TSLP), as the signal transduction pathway for TSLP has been very
well characterised and does not involve the signalling molecules that induce the
expression of molecules involved in PP anlage formation (Park et al., 2000). This
implies there is a third, as yet unidentified, ligand for IL-7Ra that is employed in the
formation of PPs. It was found that blocking the action of this unknown ligand using
an antibody to IL-7Ra prevented the expression of LTajp2 by the LTICs. In vitro
49
LTICs could be induced to express LTaip2 using rIL-7 - an expression that could
also be suppressed by preincubation with the same antibody mentioned above
(Honda et al., 2001). This suggests that the role of IL-7RaL in PP formation is to
induce the expression of LT011P2 in LTICs (Fig 1.4, Step 2).
It is well documented that mice lacking either LTa or LTp or treated with an agent to
block the interaction of LTaip2 with its receptor LTpR completely lack PPs (Banks
et al., 1995; Honda et al., 2001; Koni et al., 1997; Rennert et al., 1996; Togni et al.,
1994; Yoshida et al., 1999), thus demonstrating a vital role for these molecules. In
utero treatment with a LTpR agonist in LTav" mice results in the formation of lymph
nodes in the progeny, further demonstrating the importance of LTpR signalling for
the formation of lymphoid tissues (Rennert et al., 1998). It has also been shown that
stromal cells express LTPR (Honda et al., 2001), the receptor for the LT011P2
heterotrimer. Thus LTIC-derived LT011P2 interacts with LTpR expressed by the
stromal cells, to induce important downstream effects. Signalling through LTpR is
known to trigger two separate nuclear factor kB (NF-kB) pathways of signal
transduction. The first involves the activation of inhibitor of kB kinase P (IKKP) and
the subsequent formation of p50:RelA heterodimer - a transcription factor involved
in the transcription of VCAM-1 and the protein plOO (Dejardin et al., 2002). The
second involves the activation of NF-kB inducing kinase (NIK) that activates the
inhibitor of kB kinase-a (IKKa). Together NIK and IKKa degrade plOO to p52 that
forms a heterodimer with RelB to become a transcription factor involved in the
transcription of chemokines including CXCL13 (Dejardin et al., 2002; Yilmaz et al.,
2003). It is known that stromal cells express VCAM-1 on their surface and secrete
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chemokine CXCL13, both of which are critical for PP formation, in a IL-7Ra-
dependent manner (Honda et al., 2001). Together these data strongly suggest that the
role of LT011P2 in PP formation is to induce the expression of VCAM-1 and CXCL13
by the stromal cells (Fig 1.4, Step 3).
The next step is to determine the role these molecules may play in the formation of
PPs. CXCL13 (also known as B lymphocyte chemoattractant, BLC) plays a role in
the homing and positioning of B cells in lymphoid tissue in an adult. In an embryo it
appears to act strongly as a chemoattractant for LTICs (Honda et al., 2001). LTICs
have also been found to express the receptor (CXCR5) for CXCL13. Signalling
through this receptor induces the activation of 014P1 integrin on the LTIC which then
allows the binding of 014P1 integrin to the VCAM-1 on the stromal cell (Fig 1.4, Step
4). The interaction of (X4P1 integrin and VCAM-1 has been found to be essential for
the clustering of LTICs and stromal cells (mentioned above as the first visible sign of
PP formation; Fig 1.4, Step 5; Finke et al., 2002).
These data fit together to present a coherent pathway for the formation of PP anlagen
(Fig 1.4). However, there appear to be some conflicts as to whether the required
molecules are actually expressed at the necessary times according to the proposed
pathway. For example, it is commonly agreed that the first appearance of the PP
anlagen is at about 15.5 days of gestation, which would imply that the pathway
discussed above takes place before this time. This is supported by IL-7Ra being
found to be critical from about 14 days gestation (Yoshida et al., 1999) in
experiments using IL-7Ra- specific antibody injections at various times. However,
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immunostaining experiments could not detect IL-7Ra expression before day 15.5
(Adachi et al., 1997), and also CXCL13 was not detectable before day 17.5 (Honda
et al., 2001). This may be due, however, to the level of sensitivity of the
immunostaining being insufficient to detect the output ofjust a few cells in the early
stages of PP anlage formation. There also appears to be conflict as to the role of
TNFa and TNFR1 in the formation of PPs. Some studies show a reduced number of
PPs in either TNFa7" (Korner et al., 1997; Pasparakis et al., 1997) or TNFR17"
(Pasparakis et al., 1997) and some studies showing no PPs at all in these mice
(Kuprash et al., 2005; Neumann et al., 1996). The development of PPs appears to be
affected to some extent by the absence of either TNFa or TNFR1 in all the studies
mentioned, suggesting that TNFa and TNFR1 do play a role in PP development
although precisely what that role is remains to be determined. There does not appear
to be any evidence as to whether LTICs and/or stromal cells in the PP anlagen
express either of these molecules.
We now need to consider how the homogeneous PP anlage forms into the highly
organised PP - a process termed compartmentalisation. Whole mount
immunostaining has shown the migration of LTICs to the edge of the PP anlage to
form the centre of the follicle beginning on day 18 gestation and finishing about day
2 after birth (Hashi et al., 2001). This study also showed that, in the same time
frame, the stromal cells also migrate and are arranged around the outside of the
clusters of LTICs. An influx of mature lymphocytes was also noted around
gestational day 18, and it was initially thought that this could be the trigger for the
migration of the anlage cells. This proved not to be the case as SCID mice that lack
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mature lymphocytes were found to show compartmentalisation of PP anlagen (Hashi
et al., 2001). The molecular mechanisms that are involved in compartmentalisation
are not well understood.
Cells with the same phenotype as LTICs (CD3"CD4+) and similar gene expression
profiles have been found in the spleen and lymph nodes of adult mice (Kim et al.,
2003; Kim et al., 2006). These cells are found within the B lymphocyte follicles and
at the interface between the follicles and adjoining T lymphocyte areas (Kim et al.,
2003). They also express high levels of T lymphocyte co-stimulatory molecules
OX40 ligand (OX40L) and CD30 ligand (CD30L; Kim et al., 2005; Kim et al.,
2006). This has led to the suggestion that LTICs in adult lymphoid tissues play a
role in supporting T lymphocyte help for B lymphocytes both during affinity
maturation and the induction of memory antibody responses (Gaspal et al., 2005).
Thus, having been involved in the development of an organ, LTICs then go on to
support one of the crucial functions of that organ.
1.3.2 Development of peripheral lymph nodes
Although the general principles behind the formation of all lymphoid tissues are the
same (generation of anlagen by the interaction of LTICs with stromal cells, then
compartmentalisation and influx of mature lymphoid cells) the molecular
mechanisms bringing about these events are slightly different for different types of
lymphoid tissues.
53
The first event in the development of lymph nodes is the budding of endothelial cells
from major veins to form lymph sacs. Connective tissue protrudes into these sacs,
pushing them outwards, eventually allowing the sacs to form the subcapsular sinus of
the lymph node. Lymph vessels sprout from the lymph sacs into the surrounding
tissues where they eventually meet and attach to lymph vessels sprouting from other
lymph node anlagen, thus leading to the development of the complete lymphatic
vasculature (Wigle & Oliver, 1999). The main difference between PP and lymph
node (LN) formation is that there is another essential molecule, TNF-related
activation induced cytokine (TRANCE, also known as RANKL, OPGL, ODF or
TNFSF11). Mice deficient in TRANCE (TRANCE"7" mice) do not develop lymph
nodes, although the PPs are intact (Kim et al., 2000). TRANCE"7" mice showed
decreased numbers of LTICs and no LN anlage formation although some LTICs
were still present suggesting that TRANCE is not involved in their differentiation.
This defect could be restored by transgenic TRANCE expression in TRANCE"7" mice
but not in LTa"7" mice suggesting LT011P2 signalling is required in addition to
TRANCE signalling (Kim et al., 2000). TRANCE has been shown to induce LTaiPi
expression by LTICs (Yoshida et al., 2002). Bypassing this interaction by the
injection of a LT^R agonist into TRANCE"7" embryos did not result in the formation
of LNs (Kim et al., 2000), however, suggesting that TRANCE plays additional vital
roles in LN development. The signalling pathway utilised by TRANCE for the
formation of lymph nodes likely involves both TRANCE receptor (TRANCER) and
TNF receptor associated factor 6 (TRAF6) as both TRANCER"7" mice and TRAF6"7"
mice also lack all lymph nodes (Dougall et al., 1999; Naito et al., 1999).
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1.3.3 Development of mesenteric lymph nodes
There is a striking contrast in the formation of mesenteric lymph nodes (MLNs) as
compared to other LNs and PPs in that they do not depend on LTCI1P2 signalling, the
central interaction in the formation of those lymphoid tissues mentioned so far. Mice
lacking LTP have MLNs (Koni et al., 1997) and those lacking LTa have MLNs only
2-4% of cases where one single MLN is found (Banks et al., 1995; Togni et al.,
1994). Experiments have been carried out to determine if preventing the expression
of another gene in conjunction with LTP can prevent the formation ofMLNs. Lack
of TNF receptor (TNFR1; Koni & Flavell, 1998; Rennert et al., 1998) and LTPR
(Futterer et al., 1998) did block the formation of MLNs, whereas knocking out the
TNF gene did not (Kuprash et al., 1999). This suggests that the formation ofMLNs
is reliant on signalling through these receptors triggered by an as yet unidentified
ligand. The absence ofMLNs from LTa7" mice (Banks et al., 1995; Fu et al., 1997)
and LTpR7" mice (Futterer et al., 1998) and comparison of the levels of LTPR
expressed by the cells present in MLN anlage compared to other lymph node anlage
(Cupedo et al., 2004b) gives some indication that in the absence of LTaiP2, MLNs
may form by the interaction of LTa3 with LTPR. However, there is no published
evidence to suggest that LTa3 is a ligand for LTpR. The formation ofMLNs is also
independent ofCXCR5 and CXCL13 as MLNs develop in mice deficient in either of
these molecules (Ansel et al., 2000) further demonstrating that different molecules
are involved in the formation ofMLNs compared to the formation of other lymphoid
tissues.
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1.3.4 Development of nasal associated lymphoid tissue
Nasal associated lymphoid tissue (NALT) is very similar to PPs in its structure and
function and it was initially thought that the molecular mechanisms involved in its
development would be very similar. This, however, was not the case.
Immunostaining revealed that NALT was present in LTa7", LTp7", IL-7R7",
TRANCE7", TNF7" and TNFRl7" mice (Fukuyama et al., 2002; Fukuyama et al.,
2006; Flarmsen et al., 2002), implying that totally different pathways are utilised for
the formation of NALT anlagen. NALT forms after birth unlike most other
lymphoid tissues (Fukuyama et al., 2002; Flarmsen et al., 2002). LTICs were found
to be present in NALT anlagen (Fukuyama et al., 2002) suggesting that these cells
play a role in the genesis ofNALT. NALT does not form in Id27" mice, suggesting
the involvement of Id2 in this process, however other ligands and receptors that the
NALT forming LTICs express are unidentified at present. As in the spleen, the
organisation of the microarchitecture ofNALT is disrupted in LTa7" mice (Flarmsen
et al., 2002), but the tissue is present, showing that although different signalling
molecules are utilised for the formation of lymphoid tissues, the organisation of
lymphoid tissues follows the same pathway.
1.3.5 Development of isolated lymphoid follicles
As well as PPs, the lymphoid tissue of the murine intestine also includes isolated
lymphoid follicles (ILFs; Hamada et al., 2002). The term ILF incorporates a plethora
of structures ranging from a loose cluster of B lymphocytes at the base of a villus to
highly organised structures the width of one or more villi. ILFs are small solitary
follicles unlike PPs that are an aggregation of several large follicles (Lorenz et al.,
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2003). Like NALT, ILFs are formed postnatally (Hamada et al., 2002). However,
unlike NALT, ILF formation is dependent upon the LT011P2 -signalling pathway as
mice treated continuously with LTpR-Ig, LTa_/" mice or LTpR_/" mice do not possess
them (Lorenz et al., 2003). LTICs appear not to be involved in the organogenesis of
ILFs as the source of LT011P2 required for their formation has been identified as B
lymphocytes, T lymphocytes and NK cells (Lorenz et al., 2003; McDonald et al.,
2005).
1.4 Aims
The main aim of this thesis is to investigate the importance of draining lymphoid
tissues in TSE agent neuroinvasion. Previous work has shown that the TSE agent
accumulates in draining lymphoid tissues prior to spread to non-draining lymphoid
tissues or the CNS (Andreoletti et al., 2000; Hadlow et al., 1987; Heggebo et al.,
2003; Heggebo et al., 2002; Heggebo et al., 2000; Hilton et al., 1998; Keulen et al.,
1996; Keulen et al., 1999; Mabbott et al., 2003; Mohan et al., 2005a; Sigurdson et
al., 1999). However, the importance of this stage in the pathogenesis of TSE
diseases is not clear. Understanding the importance of this stage may aid the design
of therapeutic strategies for the treatment of TSE diseases. In this thesis mice
lacking the draining lymphoid tissues for various routes of inoculation were used to
assess the importance of particular lymphoid tissues in the pathogenesis of scrapie.
Investigations into the development of secondary lymphoid tissues revealed that
LT011P2 signalling through LTpR is crucial for the development of most secondary
lymphoid tissues. Thus LTa7" mice have only spleen and NALT (Banks et al., 1995;
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Fukuyama et al., 2002; Togni et al., 1994) and LTP"7" mice have spleen, NALT,
cervical lymph nodes (CLNs) and mesenteric lymph nodes (MLNs; Fukuyama et al.,
2002; Koni et al., 1997). Mice lacking LTa or FTP also lack FDCs (Koni et al.,
1997; Matsumoto et al., 1996). As FDCs are important for efficient TSEi
neuroinvasion (section 1.2.3), it was vital to reconstitute these mice with wild-type
bone marrow to restore the differentiation of FDCs without inducing the formation of
the missing lymphoid tissues (Koni & Flavell, 1998; Mariathasan et al., 1995). This
ensured that the results could be attributed to the lack of lymphoid tissues and not the
lack of FDCs. Progeny of mice treated with LTpR-Ig during gestation to disrupt LT
signalling in utero have spleen, NALT, CLNs, MLNs and also lumbar and sacral
lymph nodes (Rennert et al., 1997; Rennert et al., 1996). In this instance, LT
signalling was temporarily blockaded during gestation and was restored following
catabolism of LTpR-Ig promoting subsequent FDC maturation in the progeny mice.
LTa"7" mice, LTP"7" mice and mice treated in utero with LTpR-Ig were inoculated
with scrapie to investigate the importance of draining lymphoid tissues in scrapie
agent neuroinvasion via the following routes:
1. Oral inoculation. The lymphoid tissues draining this route are the tissues that
make up the gut-associated lymphoid tissues (GALT) such as PPs, MLNs and ILFs.
LTa"7" mice lack all GALT, LTP"7" mice and in utero LTPR-Ig treated mice lack PPs
but possess MLNs. The remaining lymphoid tissues in individual models varies
allowing the contributions of non-draining lymphoid tissues to be investigated.
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2. Inoculation via scarification of the skin of the thigh. The inguinal lymph nodes
are the draining lymphoid tissues of this route. LTofA mice, LT(3_/" mice and in atero
LT(3R-Ig treated mice lack the inguinal lymph nodes but, again, the specific sets of
lymphoid tissues that remain in these models vary allowing the contributions of non-
draining lymphoid tissues to be investigated.
3. Inoculation via intra-peritoneal inoculation. The cranial mediastinal lymph nodes
drain this route. LTa_/" mice and LTp_/" mice lack these lymph nodes but, again, the
remaining lymphoid tissues in individual models varies allowing the contributions of
non-draining lymphoid tissues to be investigated.
Data generated from this thesis permitted an additional point to be addressed:
characterisation of isolated lymphoid follicles. These lymphoid tissues have only
recently been discovered in the murine small intestine (Hamada et al., 2002; Lorenz
et al., 2003). Their cellular characteristics and potential involvement in TSE
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2. Materials and Methods
2.1. Mice
2.1.1 C57BL/Dk
This mouse strain has been extensively used at the Neuropathogenesis Unit (NPU),
Institute for Animal Health, Edinburgh, in scrapie agent transmission studies.
2.1.2 LTa7
LTa_/" mice were obtained from B & K Universal Ltd (Hull, UK). Disruption of the
Lta gene was achieved by insertion of a neomycin resistance cassette in the sense
orientation in exon 2 (Riminton et al., 1998). Mice were maintained on a C57BL/6
background. Age matched C57BL/6 mice were used as immunocompetent controls in
all experiments using LTa_/~ mice.
2.1.3 LTB A
LTP"7" mice were obtained from B & K Universal Ltd (Hull, UK). Disruption of the
Ltb gene was achieved by insertion of a neomycin resistance cassette in reverse
orientation in exon I (Ngo et al., 1999). Mice were maintained on a C57BL/6
background. C57BL/6 mice were used as immunocompetent controls in all
experiments using LTp~A mice.
2.1.4 Severe Combined Immunodeficiency (SCID1 IPrtw+l+
SCIDIPrnp+l+ mice were produced at NPU by crossing C.B-17 SCID mice with
129/Ola Prnp+,+ mice (Brown et al., 1999b; Manson et al., 1994a). At the F2
generation mice were selected for the SCID phenotype and Prnp+,+ genotype. These
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mice were used as negative controls for the measurement of faecal IgA by ELISA
(section 2.4.5).
2.1.5 Housing
All mice used in these studies were housed under specific pathogen free conditions in
a conventional animal facility with a 12 h light and 12 h dark cycle. Immunodeficient
mice (SCID mice, LTa_/" mice, LTp_/" mice and C57BL/Dk mice treated in utero with
LTpR-Ig) were housed in individually ventilated cages. All experiments were
conducted under the provisions of the Animals (Scientific Procedures) Act 1986.
2.2 Pre-inoculation treatments/manipulations
2.2.1 In utero LTBR-Ig treatment
To create mice deficient in Peyer's patches (PPs), inguinal lymph nodes (ILNs) and
many other lymphoid tissues, timed pregnant C57BL/Dk mice were given a single
intravenous (i.v.) injection of 100 pg of a fusion protein containing the soluble
lymphotoxin P receptor (LTpR) domain linked to the Fc portion of human
immunoglobulin G1 (LTpR-Ig; Force et al., 1995) on day 11.5 of gestation. This
reagent was a kind gift from Jeffrey Browning (Biogene Inc, Cambridge, MA, USA).
2.2.2 y-irradiation and bone-marrow reconstitution
Groups of LTa_/", LTp_/~ and C57BL/6 mice were y-irradiated (950 rad) 24 h prior to
bone-marrow reconstitution. Bone-marrow from the femurs and tibias of adult
C57BL/6 mice was prepared as single-cell suspensions (3 x 107 - 4 x 107 cells) in
Hank's balanced salt solution (HBSS; Life Technologies, Paisley, UK). Recipient
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mice were reconstituted with 0.1 ml bone-marrow by injection into the tail vein. Mice
were inoculated with ME7 scrapie 5 weeks later.
2.2.3 Injection of Indian ink
Groups of LTa"/_mice, LTP_/" mice and C57BL/6 mice were injected with 0.5 ml of a
10% solution of Indian ink via the intra-peritoneal route as described (Marco et al.,
1992). The thoracic cavities of these mice were examined 4 - 7 h later.
2.3. Inoculation with the scrapie agent
All pathogenesis studies in this thesis involved inoculation with the ME7 scrapie
agent strain (section 2.3.1). Mice were inoculated via various routes: intra-cranial
(section 2.3.2); intra-peritoneal (section 2.3.3); via scarification of the skin of the
thigh (section 2.3.4) and orally (2.3.5). After inoculation mice were monitored and
individuals showing adverse reactions were killed using a schedule 1 method. Mice
were coded and assessed weekly for clinical signs of disease and killed at the endpoint
of disease (section 2.3.6). Confirmation of diagnosis was obtained by
histopathological scoring of vacuolation of the brain (section 2.3.7)
2.3.1 ME7 scrapie agent strain
The scrapie agent strain ME7 was originally isolated from spleen tissue of a case of
natural scrapie in a Suffolk sheep and passaged by intra-gastric inoculation into
Moredun random-bred mice (Zlotnik & Rennie, 1963). This was then further
passaged by intra-cranial inoculation in Moredun random-bred mice before being
passaged nine times through C57BL/Dk mice at NPU. The ME7 strain of scrapie has
been extensively used and results in well characterised prominent neuronal
64
vacuolation. Following peripheral inoculation (for example, intra-peritoneal, oral or
via the skin) an initial phase of agent accumulation in peripheral lymphoid tissues has
been found to be necessary for the pathogenesis of this scrapie agent strain (Brown et
al., 1999b; Fraser & Dickinson, 1970, , 1978; Fraser & Farquhar, 1987; Mabbott et
al., 2000a; Mabbott et al., 2002; Mabbott et al., 2000b; Mabbott et al., 2003; Taylor et
al., 1996b). The ME7 scrapie agent strain is, therefore, ideal for use in addressing the
aims of this thesis.
2.3.2 Intra-cranial inoculation
Mice were anaesthetised with 3% fluorothane gas (delivered in oxygen) before
inoculation. 20gl unspun brain homogenate from C57BL/Dk mice terminally affected
with the ME7 scrapie strain was injected into the right mid temporal cortex using a 1
ml syringe with a 26 gauge needle. The needle was sheathed to expose 2 mm length to
ensure accuracy. Doses used were 1.0% (wt/vol) and 0.01% (wt/vol) dilution of
scrapie-affected brain homogenate in physiological saline as indicated.
2.3.3 Intra-peritoneal inoculation
Mice were inoculated by injection into the upper flank with a 26 gauge needle. The
dose used was 20 pi of a 1.0% (wt/vol) dilution of scrapie-affected brain homogenate.
2.3.4 Inoculation via scarification of the skin
Mice were inoculated by scarification of the medial surface of the right thigh as
previously described (Mohan et al., 2004; Taylor et al., 1996b). Approximately 1 cm
of hair was removed from the site of inoculation, then 24 h later a 23 gauge needle
was used to make a 1 cm long abrasion of the upper epidermal layer of the skin. A 26
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gauge needle was then used to place one droplet (~6 pi) of scrapie affected brain
homogenate on the abrasion site, which was then worked in with sweeping strokes
and the abrasion sealed with Op-Site (Smith & Nephew Medical Limited, Hull, UK).
The dose used was a 1.0% (wt/vol) dilution of brain homogenate.
2.3.5 Oral inoculation
Mice were fed individual food pellets doused with 50 pi of a 1.0% (wt/vol) dilution of
brain homogenate as described (Mabbott et al., 2003).
2.3.6 Determination of scrapie incubation period
The time elapsed (in days) between the day of inoculation and the clinical endpoint of
disease is termed the incubation period. The clinical endpoint of disease was
determined by rating the severity of clinical signs of TSE disease exhibited by the
mice. Clinical status was recorded from around day 120 post inoculation (depending
on route of exposure) and was carried out by experienced animal technicians. Mice
were assessed weekly on the same day each week and were given a clinical score as
"unaffected", "possibly affected" and "definitely affected" using standard criteria
(pronounced spinal hunching, ataxia or paralysis and "freezing" behaviour or
hyperactivity). Terminal stages of disease were also associated with weight-loss or
urinary incontinence in some cases. The clinical endpoint of disease was defined in
one of four ways:
1. The day on which a mouse received a second consecutive "definite" rating;
2. The day on which a mouse received a third "definite" rating within four
consecutive weeks;
3. The day on which a mouse was culled in extremis',
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4. The day on which a mouse was found dead in its cage having received a "definite"
rating the previous week.
This system has been applied to a wide range of TSE experiments and has been in use
at NPU for many years.
2.3.7 Lesion profiles
Whole brains were fixed in formal saline and cut into five defined areas (Fraser &
Dickinson, 1968) and embedded in paraffin wax. 6 pm thick sections were cut and
stained with haemotoxylin and eosin. These sections were then examined and the
degree of scrapie-specific vacuolation in the neutropil scored by experienced
histology staff. Vacuolation in the brain was scored on a scale of 0-5 in the following
grey matter (G1-G9) and white matter (W1-W3) areas: Gl, dorsal medulla; G2,
cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6,
hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex; G9,
cingulated and adjacent motor cortex; Wl, inferior and middle cerebellar penduncles;
W2, decussation of superior peduncles; W3, cerebral peduncles.
2.4. Ex vivo analysis of tissues
2.4.1 Immunohistochemical and immunofluorescent histochemical analysis of
frozen tissues
Spleen or mesenteric lymph nodes were snap frozen at the temperature of liquid
nitrogen. Small intestine was divided into three roughly equal parts, gently squeezed
to remove gut contents, coiled and embedded in Tissue-Tek® O.C.T. Compound™
(Bayer PLC, Newbury, UK) and snap frozen. Serial frozen sections (10 pm in
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Target Antigen/residue Antibody/clone/lectin Source/Ref
FDCs C4 mAb FDC-M2
AMS Biotechnology,
Oxon, UK, (Taylor et al.,
2002)
FDCs CD35/CD21 mAb 7G6 BD Pharmingen
FDCs CD35 mAb 8C12 BD Pharmingen
FDCs C3 mAb RMC7H8 Connex
B lymphocytes CD45R (B220) mAb RA36B2 Caltag, Towcester, UK
Germinal centre
B lymphocytes




Vector Labs, (Rose et al.,
1980)





Lyve-1 Upstate, Dundee, UK
Table 2.1. Primary antibodies and lectins used for immunohistochemical and
immunofluorescent analysis of frozen spleen, mesenteric lymph node and small
intestine tissue. mAb = monoclonal antibody.
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thickness) were cut on a cryostat. Sections were then analysed using the antibodies
and lectins detailed in Table 2.1.
For light microscopy, following the addition of primary antibody, biotin conjugated
species specific secondary antibodies (Stratech, Soham, UK) were applied followed
by alkaline phosphatase coupled to the avidin/biotin complex (Vector Laboratories,
Peterborough, UK). Vector Red (Vector Labs) was used as a substrate. Sections
were counterstained with haematoxylin to distinguish cell nuclei and mounted using
Pertex (CellPath, Powys, UK) mounting medium.
For fluorescent microscopy, following the addition of primary antibody, species
specific secondary antibodies coupled to Alexa dyes (Invitrogen, Paisley, UK) 488
(green) or 594 (red) were used. Sections were mounted using fluorescent mounting
medium (Dako, Ely, UK) and examined using a Zeiss LSM5 confocal microscope
(Zeiss, Welwyn Garden City, UK).
2.4.2 Immunohistochemical and immunofluorescent histochemical
analysis of paraffin embedded tissues
Small intestines or brains were fixed in 2% periodate-lysine-paraformaldehyde (0.1
M periodate; 0.075 M D-L lysine; 2% paraformaldehyde in 0.05 M phosphate
buffer pH 7.4) and embedded in paraffin wax. Sections (6 pm in thickness) were
cut on a microtome and deparaffinised. Small intestine sections were then analysed
using the antibodies and lectins detailed in Table 2.2. Brain tissue sections were






FDCs CD35/CD21 mAb 7G6 BD Pharmingen TRS
B lymphocytes CD45R (B220) mAb RA3 6B2 Caltag N/A
Germinal centre B
lymphocytes




Vector Labs, (Rose et al.,
1980)
TRS
Prion protein PrP polyclonal Ab 1B3 (Farquhar et al., 1989) HW+FA
M cells a-L-fucose Ulex europaeus
agglutinin (UEA)
Vector Labs N/A
Nerves S-100 Polyclonal anti-S- Dako TRS
100
Table 2.2- Primary antibodies and lectins used for immunohistochemical and
immunofluorescent analysis of paraffin embedded small intestine tissue. mAb
= monoclonal antibody. TRS = sections were microwaved (low power, 650W
microwave for 13 mins with periodic agitation) in Target Retrieval Solution (Dako)
prior to application of primary antibody or lectin. HW+FA = sections were
immersed for 30 min in water at 55 °C and then in 98 % formic acid for 5 min prior
to application of primary antibody. N/A = not applicable.
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Prion protein PrP mAb 6H4 Prionics, Zurich, HA+FA
Switzerland





Table 2.3- Primary antibodies used for immunohistoehemieal analysis of
paraffin embedded brain tissue. mAb = monoclonal antibody. HA+FA = sections
were treated with hydrated autoclaving (15 min, 121 °C, hydration) and then in 98
% formic acid for 5 min prior to application of primary antibody. N/A = not
applicable
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For light microscopy, following the addition of primary antibody, biotin conjugated
species specific secondary antibodies were used followed by alkaline phosphatase
coupled to the avidin/biotin complex (Vector Labs). Vector Red was used as a
substrate. Sections were counterstained with haematoxylin to distinguish cell nuclei
and mounted using Pertex mounting medium.
For fluorescent microscopy, following the addition of primary antibody, species
specific secondary antibodies coupled to Alexa dyes 488 (green) or 594 (red) were
used. Sections were mounted using fluorescent mounting medium and examined
using a confocal microscope.
2.4.3 Detection of PrPSc by immunoblotting
PrPSc was enriched from tissue homogenates by sodium phosphotungstic acid
(NaPTA) precipitation (Wadsworth et al., 2001). Briefly, tissue homogenates were
prepared from spleen fragments (approximately 20 mg) or MLNs or ILNs
(approximately half the total from each mouse assayed) and centrifuged for 10 mins
at 2000 x g. Supernatants were removed, mixed with an equal volume of 2 %
(wt/vol) N-laurylsarcosine in Tris pH 7.4 and incubated for 10 mins at 37 0 C with
constant agitation. Samples were divided into two equal parts. To one half, 2 pi of
20 mg/ml proteinase K (VWR, Lutterworth, UK) was added and the contents were
incubated for 60 mins at 37°C with constant agitation. The other half was held at
4°C. Following incubation, to each fraction 4% (wt/vol) NaPTA, pH 7.4, containing
170 mM MgCU was added to achieve a final concentration of 0.3% NaPTA.
Samples were incubated for 30 mins at 37°C with constant agitation followed by
centrifugation at 13000 x g for 30 mins. Pellets were washed with 200 pi 0.1%
72
(wt/vol) N-lauroylsarcosine in Tris pH 7.4 plus 100 pi 250 mM EDTA and
centrifuged at 13000 x g for 30 mins. Pellets were resuspended and assayed for
protein concentration using a BCA protein assay (Pierce, Chester, UK) and adjusted
to 0.5 mg/ml where possible. Samples were then subjected to electrophoresis
through sodium dodecyl sulphate 12% polyacrylamide gels (Invitrogen) and then
transferred to polyvinylidene difluoride (PVDF) membranes (Bio-Rad, Hemel
Hemstead, UK) by semidry blotting. PrP was detected with the PrP-specific mouse
monoclonal antiserum 8H4 which bind amino acids 147-164 of murine PrP. This
epitope is present on PrPSc truncated by PK treatment (Zanusso et al., 1998). Horse
radish peroxidase-conjugated goat anti-mouse antiserum (Jackson Immunoresearch
Laboratories, Inc., West Grove, Pa, USA) was then applied and bound horse radish
peroxidase activity was detected with Supersignal West Dura Extended Duration
Substrate (Pierce).
2.4.4 Morphometric analysis
The number of isolated lymphoid follicles (ILFs) was counted microscopically
using CD45R expression for identification. The maturity of the ILFs was then
determined depending on the presence of CR1/CR2 expressing FDCs. An image of
each mature ILF was captured using a confocal microscope (Zeiss) and the area
covered by the CR1/CR2 expressing cells was measured using Image Pro Plus
(Media Cybernetics, Wokingham, UK).
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2.4.5 Measurement of faecal IgA levels by enzyme-linked immunosorbant
assay 1ELISA1
Faecal pellets were collected and faecal IgA levels were determined by ELISA as
previously described (McDonald et al., 2005). Briefly, 10% faecal homogenates
were prepared in carbonate-bicarbonate coating buffer (Sigma) and centrifuged for
10 min at 12,000 x g. Supernatant was removed and adsorbed to flat-bottomed high
binding microwell plates (Costar®, High Wycombe, UK) for 18-24 hrs at 4 °C.
Plates were then blocked with 0.01 M PBS (pH 7.5) containing 5 % bovine serum
albumin (BSA). Bound IgA was then detected using alkaline phosphatase
conjugated goat anti-mouse IgA (Southern Biotechnology, AL, USA). Bound
alkaline phosphatase activity was measured by incubation with p-nitrophenyl
phosphate liquid substrate (Sigma). Optical density (OD) was measured at 450 nm
using a V-max kinetic microplate reader (Molecular Devices, CA, USA). Faecal
pellets from C57BL/6 wild-type mice, C57BL/Dk control mice and SCID mice
were used as reference controls.
2.5. Statistical analysis
2.5.1 Statistical analysis
Data are presented as mean ± standard error of the mean (S.E.M.). Significant
differences between samples in different groups were sought by one-way analysis of
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The presence of IgA in the intestines of mice lacking Peyer's patches (PPs) has led to
the recent discovery of intestinal lymphoid tissues known as isolated lymphoid
follicles (ILFs). ILFs have previously been found in greater numbers in mice lacking
PPs compared to immunocompetent controls. In this chapter ILFs were investigated
in the small intestines of mice that lack PPs either due to in utero lymphotoxin-P
receptor (LTpR) signalling blockade or due to genetic deficiency of either LTa or
LTp. In both cases, follicular dendritic cell (FDC) presence was found to be a
consistent marker of ILF maturity. Increased numbers of larger mature ILFs (mILFs)
were found in mice lacking PPs compared to relevant control mice, and these mILFs
were found to adequately compensate for the lack of PPs in terms of the total area
covered by FDCs in the small intestine. mILFs were also found to contain T
lymphocytes, germinal centre B lymphocytes, lymphatic vessels and the follicle
associated epithelium (FAE) overlying the mILFs contained M cells. The detection
of IgA in the intestines of mice lacking PPs or both PPs and mesenteric lymph nodes
(MLNs) correlated with the presence of mILFs. Taken together these data clearly
demonstrate that mILFs are fully functional gut-associated lymphoid tissues. As
FDCs are important for the peripheral pathogenesis of TSEs these data also suggest
that mILFs might be an important additional site of TSE agent neuroinvasion.
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3.2 Introduction
The gastrointestinal tract is a major interface between the host and potential
pathogens. Therefore, the immunological components that defend the
gastrointestinal tract have been extensively studied. Intestinal immune responses are
initiated in highly organised lymphoid tissues such as the Peyer's patches (PPs),
mesenteric lymph nodes (MLNs), appendix and tonsils (collectively known as gut
associated lymphoid tissues; GALT). These responses are executed by loosely
distributed effector cells such as intra-epithelial lymphocytes and lamina propria
lymphocytes. One of the major defences of the immune system against invading
pathogens is the secretion into the intestine of secretory immunoglobulin (Ig) A. The
production of IgA is thought to be initiated in PPs and effected by plasma cells in the
lamina propria of villi (MacPherson et al., 2001). The finding that IgA is present in
the intestines of mice which have been manipulated to lack PPs (Yamamoto et al.,
2000) has led to the recent discovery of additional organised lymphoid tissues within
the intestine, known as isolated lymphoid follicles (ILFs; Hamada et al., 2002).
ILFs are present in both the small and large intestines of mice (Hamada et al., 2002;
Kweon et al., 2005; Lorenz & Newberry, 2004) rabbits (Keren et al., 1978), guinea
pigs (Rosner & Keren, 1984) and humans (Moghaddami et al., 1998). The term ILF
incorporates a plethora of structures ranging from a loose cluster of B lymphocytes at
the base of a villus to highly organised structures the width of one or more villi.
ILFs are small solitary follicles unlike PPs which are an aggregation of several large
follicles. ILFs have been found to contain T lymphocytes, germinal centre B
lymphocytes, dendritic cells and epithelia overlying ILFs contain M cells (Hamada et
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al., 2002; Lorenz et al., 2003), but whether these structures also contain follicular
dendritic cells (FDCs) is not known.
Since lymphotoxin (LT) (X1P2 signalling through the LTP receptor (LTpR) during
gestation has been shown to be crucial for the formation of PPs (Banks et al., 1995;
Honda et al., 2001; Koni et al., 1997; Rennert et al., 1996; Togni et al., 1994;
Yoshida et al., 1999), it follows that mice in which this signalling has been
interrupted during gestation will lack PPs. Studies have shown that mice which lack
PPs but have functional lymphotoxin signalling as adults have increased numbers of
ILFs in both the large and small intestines (Hamada et al., 2002; Kweon et al., 2005;
Lorenz et al., 2003).
As FDCs are important for efficient TSE agent neuroinvasion from the
gastrointestinal tract after oral inoculation (Mabbott et al., 2003), ILFs were
examined for the presence of FDCs. FDC presence within ILFs might identify




3.3.1 In utero LTBR-Ig treatment of mice induces the maturation of ILFs
To temporarily block the LTPR signalling pathway in utero, pregnant mice were
given a single i.v. injection of 100 pg of LTpR-Ig (section 2.3.1; Force et al., 1995)
on day 11.5 of gestation. In accordance with previous studies, PPs in the intestines
of progeny LTpR-Ig treated mice were macroscopically absent (Rennert et al., 1996).
Intestines from age-matched, untreated, immunocompetent C57BL/Dk (control) mice
contained approximately 7 PPs (Fig 3.1). Microscopical analysis revealed the
presence of both PPs and ILFs in the intestines of untreated control mice, whereas
only ILFs were found in the intestines of mice treated in utero with LTpR-Ig (termed
PP-deficient C57BL/Dk mice; Fig 3.2)
3.3.2 Mature ILFs contain FDCs
The maturity of ILFs has previously been defined depending on the density of
component cells and location of the structure, such that loosely clustered B220-
positive cells located at the base of a villus were considered to be immature ILFs
(ilLFs) whereas well organised, nodular structures with the same or greater width
than one villus were considered to be mature (mILFs; Lorenz et al., 2003). Here,
double immunostaining of B lymphocytes (CD45R-positive cells) and FDCs
(CD21/35-positive cells) on the same tissue section revealed that the presence of
FDCs could also be used to reliably determine ILF maturation status. Experiments
showed that mILFs contained FDCs whereas ilLFs did not (Fig 3.2). A major













" I" ' *
Figure 3.1- Effect of in utero LTpR-Ig treatment on the development of Peyer's
patches (PPs). Small intestine from untreated, immunocompetent, C57BL/Dk
(control) mice (top) showed the presence of PPs (red circles). Small intestine from
progeny mice treated in utero with LT(3R-Ig showed the macroscopic absence of PP
development. Sections were stained with CD45R-specific antiserum B220 to detect
B lymphocytes (red) and counterstained with haematoxylin (blue). Original
magnification X40.
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Peyers patch ilLF mILF
Figure 3.2- Effect of in utero LTpR-Ig treatment on the development of
lymphoid tissue in the small intestine. Sections were stained with the CD45R-
specific monoclonal antiserum B220 to detect B lymphocytes (green) and 7G6
monoclonal antiserum to detect CD21/35 expressing follicular dendritic cells (FDCs;
red). Tissues from untreated, immunocomptetent, C57BL/Dk (control) mice (top
row) showed the presence of B lymphocyte and FDC containing Peyers patches
(left column), B lymphocyte containing immature isolated lymphoid follicles (ilLFs;
middle column) and B lymphocyte and FDC containing mature ILFs (mILFs; right
column). Tissues from progeny mice treated in utero with LTpR-Ig (lower row)
showed the presence of only ilLFs (middle column) and mILFs (right column).
Original magnification X200.
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lymphocytes. The attachment of antigen to FDCs is mediated via interactions
between complement components and complement receptors (CR) on the surface of
FDCs (Berg et al., 1995). Complement components C3 and C4, in association with
CR1 (CD35) and CR2 (CD21) expressing FDCs, were detected within mILFs (Fig
3.3) but not in ilLFs (not shown). Taken together these data clearly demonstrate that
mILFs in the intestines of PP-deficient C57BL/Dk mice contain immune complex
trapping FDCs.
3.3.3 mILFs can compensate for PP deficiency
The total number of ILFs in the small intestine of PP-deficient mice was significantly
greater than in control mice (p < 0.001; Fig 3.4a). Approximately 9 ± 2 ILFs were
detected in the intestines of control mice, whereas those from PP-deficient mice
contained 35 ± 5 ILFs. Although the small intestines of both groups of mice were
found to contain both mILFs and ilLFs (Fig 3.2), a greater proportion of ILFs in PP-
deficient mice were mature when compared to those in control mice (-46 % and
-15% respectively; p < 0.001; Fig 3.4b). When FDC area per mILF was taken as a
measure of mILF size, PP-deficient mice were found to have significantly larger
mILFs when compared to control mice (p < 0.001; Fig 3.4c). Further investigation
revealed that the greater number of larger mILFs present in PP-deficient mice
compensated for the PP deficiency in terms of the total area covered by FDCs in the
small intestine. The total area covered by the FDCs in all the mILFs in PP-deficient
mice was found to be equivalent to the total area covered by the FDCs in all the PPs
and the few mILFs found in control mice (p < 0.572; Fig 3.4d).
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mILF Spleen
Figure 3.3- Mature isolated lymphoid follicles (mILFs) contain functional
follicular dendritic cells (FDCs). Sections of small intestine (left) or spleens
(right) sections were stained with the CD45R-specific monoclonal antiserum B220
to detect B lymphocytes (green; top row) and CD21/35-specific (red; top row) and
CD35-specific (red; 2nd row) monoclonal antisera to detect FDCs and monoclonal
antisera specific for complement components C4 (FDC-M2; red; 3rd row) and C3



























































Figure 3.4- Enumeration of isolated lymphoid follicles (ILFs) and follicular
dendritic cells (FDCs) in the small intestine of Peyer's patch (PP) -deficient
C57BL/Dk mice and immunocompetent C57BL/Dk (control) mice. a. Intestines
from PP-deficient mice contained significantly more (~ 3 fold more) ILFs than
intestines from control mice. b. Intestines from PP-deficient mice were found to
have a significantly higher percentage (46 %) of mature ILFs (mILFs) when
compared to control mice (13 %). c. FDC area per mILF was taken as a measure of
mILF size. PP-deficient mice contained significantly larger mILFs when compared
to control mice. d. The total area covered by FDCs in the mILFs in PP-deficient
mice was equivalent to the total area covered by FDCs from all the PPs and mILFs in
control mice. Each bar represents the mean ± S.E.M. for each group of mice (n = 12
for PP deficient mice, n = 11 for control mice). * indicates a p value of < 0.05 when
compared to control mice.
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3.3.4 LT-expressing bone marrow-derived cells induce the development of ILFs
in LT deficient mice
LT-signalling is required for the formation of PP and ILFs, hence both are absent in
LTa_/" mice and LTp_/" mice (Fig 3.5; Hamada et al., 2002; Koni et al., 1997; Lorenz
et al., 2003; Togni et al., 1994). The source of the LT required for the formation of
ILFs has been shown to be bone marrow derived cells, as reconstitution of LTa"7"
mice with immunocompetent wild-type (WT) bone marrow restores the formation of
ILFs (Fig 3.5; Lorenz et al., 2003). Data presented here show, in addition, that WT
bone marrow reconstitution stimulates the formation of ILFs in LTP"/_ mice.
However, WT bone marrow reconstitution does not restore the formation of PPs in
either LTa"A mice or LTp7" mice (Fig 3.5; Koni & Flavell, 1998; Mariathasan et al.,
1995). Both PPs and ILFs are found in the intestines of WT mice before and after
reconstitution with WT bone marrow (Fig 3.5).
The total number of ILFs present in the small intestines ofWT mice, LTa_/" mice and
LTp_/" mice before and after y-irradiation and WT bone marrow reconstitution was
determined (Fig 3.6). ILFs were present in the small intestine ofWT mice prior to y-
irradiation and WT bone marrow reconstitution, whereas none were detected in
either LTa-/" mice or LTP_/" mice at this time. By 35 days after bone marrow
reconstitution the number of ILFs in the small intestines of recipient WT mice
(termed WT->WT mice) had significantly declined (p < 0.004, n = 4 when
compared to the number in WT mice pre-bone marrow reconstitution) and none were
detected in recipient LTa_/" mice (termed WT->LTa"A mice) or LTp_/" mice (termed
WT->LTp7' mice). However, by 105 days after WT bone marrow reconstitution, the
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Grafted with WT bone marrowUng rafted
Figure 3.5- Effect of reconstitution with wild-type (WT) bone marrow on the
development of Peyer's patches (PPs) and isolated lymphoid follicles (ILFs) in
recipient WT mice (WT->WT mice), lymphotoxin -a deficient mice (WT->LTa~
mice) and lymphotoxin -0 deficient mice (WT->LTp /_ mice). Small intestine
from unreconstituted mice (left column) and bone marrow reconstituted mice (right
column) were stained with the CD45R-specific antiserum B220 to detect B
lymphocytes (red) and counterstained with haematoxylin (blue). In WT mice PP
development (red circle) was unaffected by bone marrow reconstitution and ILFs
were macroscopically invisible. In both LTa7" mice (middle row) and LTp_/" mice
(lower row), PPs were not detectable prior to (left column), or after (right column)
bone marrow reconstitution. In LTav~ mice and LTpv~ mice ILFs were
macroscopically undetectable in unreconstituted mice but visible in bone marrow
reconstituted animals (arrows, right column, middle and lower panels). Original
magnification X40.
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number of ILFs in the intestines ofWT->WT mice, WT->LTa~" mice and WT->LTP"
A mice was comparable to the number detected in WT mice before y-irradiation and
WT bone marrow reconstitution (p < 0.560, n = 6; p< 0.779, n = 6; andp < 0.185, n
= 5; respectively, when compared to the number in WT mice before bone marrow
reconstitution; Fig 3.6).
3.3.5 mILFs in WT bone marrow reconstituted LT deficient mice contain FDCs
Intestines from WT->WT mice, WT->LTav" mice and WT->LTp~/_ mice were
analysed 105 days after y-irradiation and reconstitution with WT bone marrow. In
each of the three groups of mice, both mILFs and ilLFs were detected (Fig 3.7).
Consistent with data presented in Fig 3.3, mILFs were found to contain functional
CRl/CR2-expressing FDCs (Fig 3.8). Although the numbers of ILFs in the small
intestines ofWT->WT mice, WT->LTa"/_ mice and WT->LTP"/_ mice were found to
be similar (Fig 3.9a), the percentage ofmILFs was significantly higher in WT->LTa"
mice and WT->LTp7" mice when compared to WT->WT mice (55 %,p< 0.028, n
= 6 and 62 %, p < 0.002, n = 5 respectively, when compared to 30 %, n = 6 in WT-
>WT mice; Fig 3.9b). The mILFs in the intestines of WT->LTa*A mice and WT-
>LTpv" mice were found to be significantly larger than those ofWT->WT mice (p <
0.009, n = 6, and p < 0.026, n = 5 respectively when compared to WT->WT mice (n
= 6; Fig 3.9c). The total area occupied by FDCs in the small intestines of all three
types of mice was found to be equivalent (p < 0.099, n = 6, and p < 0.162, n = 5, in
WT->LTa_/" mice and WT->LTP_/" mice respectively when compared to WT->WT;
Fig 3.13d). This suggests that analogous to the results found in PP-deficient
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Figure 3.6- Numbers of isolated lymphoid follicles (ILFs) in the small intestine of
wild-type (WT) mice, lymphotoxin -u deficient (LTa "7") mice and lymphotoxin -0
(LTP"") mice pre and post WT bone marrow reconstitution. Prior to bone marrow
reconstitution ILFs were present in the intestines of WT mice (squares) but not in
either LTa"7" mice (circles) or LTP"7" mice (triangles). 35 days after bone marrow
reconstitution the number of ILFs in WT->WT mice had fallen and none were
detectable in either WT->LTa"7" mice or WT->LTp"7" mice. 105 days after bone
marrow reconstitution the number of ILFs in WT->WT mice, WT->LTa"7" mice and
WT->LTP"7" mice was comparable to unreconstituted WT mice. Each point represents
the mean ± S.E.M. for each group ofmice.
88
Peyer's Patch ilLF mILF
Figure 3.7- Lymphoid tissue microarchitecture in the small intestine of wild-type
(WT) bone marrow reconstituted WT mice, lymphotoxin -a deficient mice and
lymphotoxin -p deficient mice (WT->WT mice, WT->LTa"/_ mice and
WT->LTp_/" mice respectively). Sections were stained using the CD45R-specific
monoclonal antiserum B220 to detect B lymphocytes (green) and CD21/35 specific
antiserum to detect follicular dendritic cells (FDCs; red). Tissues from WT->WT
mice (top row) showed the presence of B lymphocyte and FDC containing Peyer's
patches (PPs; left column), B lymphocyte containing immature isolated lymphoid
follicles (ilLFs) (middle column) and B lymphocyte and FDC containing mature ILFs
(mILFs; right column). Tissues from both WT->LTa"/_ mice (middle row) and
WT->LTp~" mice (lower row) showed the presence of B lymphocyte containing ilLFs








Figure 3.8- Mature isolated lymphoid follicles (mILFs) contain functional
follicular dendritic cells (FDCs). Sections of small intestine from wild type bone
marrow reconstituted lymphotoxin -a deficient mice (WT->LTa"/_ mice; left column)
and WT->LTP"/_ mice (middle column) or spleens (right column) were stained with
the CD45R-specific monoclonal antiserum B220 to detect B lymphocytes (green; top
row) and CD21/35-specific (red; top row) and CD35-specific (red; 2nd row)
monoclonal antisera to detect FDCs and monoclonal antisera specific for complement


























































Figure 3.9- Enumeration of isolated lymphoid follicles (ILFs) and follicular dendritic
cells (FDCs) in the small intestine of WT->WT mice, WT->LTa_/" mice and WT-
>LTP mice 105 days after reconstitution with wild-type (WT) bone marrow.
a. Similar numbers of ILFs were found in WT->WT mice, WT->LTa_/" mice and WT-
>LTp_/" mice. b. WT->LTa_/" and WT->LTP"A mice were found to have a significantly
higher percentage of mature ILFs (mILFs) when compared to WT->WT mice. c. FDC
area per mILF was taken as a measure of mILF size. WT->LTav" mice and WT->LTpv"
mice were found to have significantly larger mILFs when compared to WT->WT mice,
d. The total area covered by FDCs in all the mILFs in WT->LTav" mice or WT->LTp_/"
mice was equivalent to the total area covered by FDCs in all the PPs and mILFs in WT-
>WT mice. Each bar represents the mean ± S.E.M for each group of mice (n = 4 for each
group). * indicates a p value of < 0.05 compared to the WT->WT value.WT->WT, WT-
>LTa"A and WT->LTp_/" are WT mice, lymphotoxin -a deficient mice and lymphotoxin -P
deficient mice respectively, reconstituted with WT bone marrow.
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deficiency in terms of the total area covered by FDCs in the small intestine.
3.3.6 mILFs resemble fully functional lymphoid tissue
Further immunohistochemical analysis revealed the presence of CD3-positive T
lymphocytes within both mILF and ilLFs of C57BL/Dk (control) mice, PP-deficient
C57BL/Dk mice, WT->WT mice, WT->LTa_/" mice and WT->LTp~/_ mice although
these cells appeared to be more frequent in mILFs (Fig 3.10). Germinal centre B
lymphocytes (PNA-positive cells) were detected in mILFs in all five groups of mice
and were rarely detected in ilLFs (Fig 3.11). Studies suggest that 97.2 % of follicle
associated epithelial (FAE) M cells stain with UEA-1, which detects a-L-fucose
expressing cells (Clark et al., 1993). In comparison, only 1 % of enterocytes are
UEA-1 positive and goblet cells do not stain with UEA-1 (Fig 3.12, white
arrowheads; Clark et al., 1993). A recent study has also revealed the presence of
UEA-1 positive M cells in the epithelia of villi in the murine small intestine (Jang et
al., 2004). UEA-1 positive M cells were detected in the FAE of PPs from C57BL/Dk
(control) mice and WT->WT mice as well as in the epithelia of the ILFs and villi in
the intestines of C57BL/Dk (control) mice, PP-deficient C57BL/Dk mice, WT->WT
mice, WT->LTa"A mice and WT->LTP_/" mice (Fig 3.12, black arrows). Lyve-1 is a
receptor for hyaluronan, and is expressed predominantly on lymph vessels such that
anti-Lyve-1 immunostaining in the intestine is lymphatic vessel specific (Banerji et
al., 1999). Lyve-1 positive cells were detected within villi and ILFs of PP-deficient
C57BL/Dk mice, WT->LTa_/" mice and WT^LTP"7" mice (Fig 3.13) suggesting that
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a C57BL/Dk (control) PP-deficient C57BL/Dk
Figure 3.12- M cells are present in the epithelium overlying Peyer's patches
(PPs), isolated lymphoid follicles (ILFs) and villi. Sections of small intestine from
a. C57BL/Dk (control) mice and PP-deficient C57BL/Dk mice and b. wild-type
(WT) mice, lymphotoxin -a deficient mice and lymphotoxin ~p deficient mice
reconstituted with WT bone marrow (WT->WT mice, WT->LTa"A mice and WT-
>LTp_/" mice respectively) were stained with Ulex enropaeus agglutinin- 1 (UEA-1)
to detect M cells (red) and counterstained with haematoxylin (blue). Goblet cells
(white arrowheads) were left unstained by UEA-1. Original magnification X200 (top
row) or X600 (lower row).
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PP-deficient C57BL/Dk WT->LTa"'" WT->LTp'-
Figure 3.13- Lymphatic vessels were found within isolated lymphoid follicles
(ILFs; top row) and villi (lower row) in the small intestine of PP-deficient
C57BL/Dk mice, wild-type bone marrow reconstituted LTa"7" mice (WT->LTav"
mice) and WT->LTP"7" mice. Sections of small intestine were stained with
monoclonal antiserum Lyve-1 to detect lymphatic vessels (brown) and
counterstained with haematoxylin (blue). Original magnification X200.
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3.3.7 Enhanced intestinal IgA synthesis in the presence of mILFs
The results in this chapter and the work of others (Hamada et al., 2002; Lorenz et al.,
2003) have shown that mILFs resemble fully functional lymphoid tissue. To
investigate whether mILFs could facilitate the synthesis of IgA in the intestine levels
of faecal IgA were measured. Whereas IgA was detected in the faeces ofWT->WT
and C57BL/Dk (control) mice, no faecal IgA was detected in faeces from SCID mice
(Fig 3.14). Likewise, due to an absence of PPs and ILFs in LTav~ mice and LTp"/_
mice, no IgA was detected in the faeces of these mice. The level of IgA was also
low in WT->LTa"A mice and WT->LT(37" mice 35 days after reconstitution with WT
bone marrow and not significantly different from their unreconstituted counterparts
(p < 0.491, n = 4 and p < 0.392, n = 4, respectively) consistent with mILFs being
absent from the intestines of these mice at this time point (Fig 3.6). Interestingly,
only low levels of IgA were detected in WT->LTP_/" mice despite the presence of
FDC-containing MLNs in these mice at this point (Fig 4.8). In contrast, 105 days
after bone marrow reconstitution when the formation of mILFs had been induced in
WT->LTa~A mice and WT->LTp A mice, the levels of faecal IgA were significantly
higher than those detected in their unreconstituted counterparts (p < 0.010, n = 4 and
p < 0.030, n = 4, respectively) and similar to those detected in the faeces ofWT mice
(p < 0.722, n — 4 and p < 0.152, n = 4 respectively; Figure 3.14). Similarly, in PP-
deficient C57BL/Dk mice which had no PPs but increased numbers ofmILFs in their
intestines due to in ntero LTpR signalling blockade, similar levels of faecal IgA were
found when compared to C57BL/Dk (control) mice (p < 0.245, n = 4; Fig 3.14).
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Figure 3.14- Faecal IgA levels. Each point represents the mean optical density (OD)
at 450 nm for triplicate samples from individual mice. — represents mean OD at 450
nm for each experimental group of between 4 and 8 mice. Wild-type (WT) mice were
found to have similar levels of IgA before (closed diamonds, a and b) and after (open
diamonds, a and b) reconstitution with WT bone marrow. Faecal IgA levels in both
LTa_/" mice (squares) and LTpv~ mice (triangles) mice were extremely low before
reconstitution with WT bone marrow (closed symbols, a and b) and at 35 days after
reconstitution (open symbols a) but increased significantly by 105 days after
reconstitution (open symbols, b). c. C57BL/Dk (control) mice (diamonds) and PP-
deficient C57BL/Dk mice (squares) were found to have equivalent levels of faecal
IgA. SCID/Prnp+/+ mice (crosses) were used as negative controls. * indicates a p
value of < 0.05 compared to the value from WT mice.
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sites of intestinal IgA production and that MLNs do not contribute to intestinal IgA.
3.3.8 Effect of age on ILF development
Next, the effect of host age on ILF development was investigated. C57BL/Dk mice
were aged to 900 days and compared with younger mice aged ~ 300 days old. In
contrast to younger mice where both ilLFs and mILFs were detected, no mILFs and
significantly fewer ilLFs were detected in old mice (p < 0.020; Table 3.1). The
number of PPs was similar in both old and young mice. However, in old mice, FDC
networks were undetectable by CR1/2 staining in 3 out of 11 PPs analysed, and
showed only weak staining in a further 7 PPs. In only one PP from an old mouse
was CR1/2 staining comparable to that of young mice (Fig 3.15). This suggests that
the immunosenescence observed in PPs with increased age also occurs in mILFs.
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Table 3.1- Lymphoid tissue in the small intestine of young and aged mice. Small
intestine sections of young C57BL/Dk mice were compared to those of aged (-900
days old) mice. Numbers represent the mean figure for each group of mice ± S.E.M.
PP = Peyer's patch; ilLF = immature isolated lymphoid follicle; mILF = mature
isolated lymphoid follicle.
* denotes p < 0.05 compared to young
f 1/11 PPs contained both FDCs and B cells
7/11 PPs contained strong B220 staining and weak FDC staining






Figure 3.15- Lymphoid tissue architecture in the small intestine of young (~300
day old) and aged (~900 day old) mice. Small intestine sections were stained with
the CD45R-specific monoclonal antiserum B220 to detect B lymphocytes (green)
and 7G6 monoclonal antiserum to detect CD21/35 expressing follicular dendritic
cells (FDCs; red). Tissues from young mice (top row) showed the presence of B
lymphocyte and FDC containing Peyer's patches (PPs; left column), B lymphocyte
containing immature isolated lymphoid follicles (ilLFs; middle column) and B
lymphocyte and FDC containing mature isolated follicles (mILFs; right column).
Tissues from aged mice (lower row) showed the presence of PPs (right column) and




In this chapter ILFs were investigated in the small intestines of mice that lack PPs
either due to in utero treatment with LTpR-Ig or due to genetic deficiency of either
LTa or LTp. In both cases, FDC presence was found to be a consistent marker of
ILF maturity. Increased numbers of larger mILFs were found in mice lacking PPs
compared to relevant control mice, and these mILFs were found to adequately
compensate for the lack of PPs such that the total area covered by FDCs in the
intestines of all groups of mice investigated were equivalent. mILFs were also found
to contain T lymphocytes, germinal centre B lymphocytes, lymphatic vessels and the
FAE overlying the mILFs contained M cells. The detection of IgA in the intestines
of mice lacking PPs or both PPs and MLNs correlated with the presence of mILFs.
Taken together these data clearly demonstrate that mILFs are fully functional gut-
associated lymphoid tissues.
The formation of PPs is critically dependent on LTaip2 signalling through LTpR
during gestation (Banks et al., 1995; Honda et al., 2001; Koni et al., 1997; Rennert et
al., 1996; Togni et al., 1994; Yoshida et al., 1999). As a consequence, PPs do not
develop in mice in which this signalling is interrupted during gestation, either by
treatment with LTpR-Ig (Rennert et al., 1996) or due to genetic deficiency of either
LTa (Togni et al., 1994) or LTp (Koni et al., 1997). Unlike PPs, the development of
ILFs, while still being critically dependent on LT signalling, occurs postnatally
(Hamada et al., 2002; Lorenz et al., 2003). ILFs are, therefore, present in in utero
LTPR-Ig treated mice as the LTpR signalling blockade is temporary and LT
signalling is restored by the time ILFs form (from approximately 25 days after birth;
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Hamada et al., 2002). However, ILFs are not present in mice genetically deficient in
either LTof7" or LTp~A as the required signalling can never take place in these
animals.
The cells providing the source of LT for the generation of PP anlage and ILF anlage
are phenotypically distinct. PP formation is critically dependent on LT011P2-
expressing CD4+CD3~ lymphoid tissue initiating cells of bone marrow origin
interacting with LTpR-expressing stromal cells of mesenchymal origin (Adachi et
al., 1998; Finke et al., 2002; Honda et al., 2001; Yoshida et al., 2002). The
formation of ILFs, on the other hand, has been found to be critically dependent on
LTaiP2-expressing NK cells, B lymphocytes or T lymphocytes interacting with
LTpR-expressing stromal cells (Lorenz et al., 2003; McDonald et al., 2005). Thus, it
follows that the reconstitution of either LTa_/" mice or LTP"7" mice with WT bone
marrow results in the restoration of ILF development without causing PPs to be
formed. Previous work has shown that mILFs do not form in LTa~A mice
reconstituted with LT-sufficient NK cells and T lymphocytes (McDonald et al.,
2005). Flowever, the formation of mILFs does occur in both LTa"7" mice and LTp"7"
mice reconstituted with LT-sufficient NK cells and B lymphocytes and T
lymphocytes (Figs 3.5 & 3.6; Lorenz et al., 2003; McDonald et al., 2005). Taken
together these results show the necessity of LT-sufficient B lymphocytes for the
formation of mILFs. The source of LT011P2 for the formation of ilLFs can be either
B-lymphocytes, T-lymphocytes or NK cells as ilLFs were found in the intestines of
mice reconstituted with LT-sufficient T-lymphocytes and NK cells, or NK cells
alone (Lorenz et al., 2003; McDonald et al., 2005).
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The work of others demonstrated the presence of ILFs in LTa_/" mice 12 weeks after
reconstitution with WT bone marrow (Lorenz et al., 2003). Consistent with this, data
presented here describes the absence of ILFs in LTa-/" mice 5 weeks after
reconstitution with WT bone marrow, and their presence by 15 weeks after bone
marrow reconstitution. In addition, data presented here also shows that the formation
of ILFs in WT->LTP_/" mice occurs similarly to WT->LTa"/_ mice which is
confirming that ILF formation is dependent upon a signalling pathway in which both
LTa and LTp play a part.
Immature ILFs have previously been defined as loose clusters of B220-positive cells
located at the base of a villus, and mILFs as well organised nodular structures the
width of one or more villi (Lorenz et al., 2003). In this chapter, the presence of
FDCs was demonstrated in mILFs but not in ilLFs. Thus the presence of FDCs can
also be used as criterion for determining the maturity of ILFs. In the morphometric
analysis described in this chapter anti-CRl/CR2 antiserum was used to detect FDCs
as they characteristically express these receptors at high levels. Flowever, in the
mouse CR1 and CR2 are also expressed on B lymphocytes, but at lower levels than
on FDCs. Thus calculations were based solely on CR1/CR2+ CD45R" cells. The
presence of FDCs in mILFs was confirmed by the colocalisation of immunostaining
for complement receptors CR1 and CR2. Co-incident immunostaining between CR1
and CR2 and complement components C3 and C4 demonstrated that the FDCs in
mILFs were also exhibiting the function of immune-complex trapping.
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The number of ILFs in mice lacking PPs due to in utero LT|3R-Ig treatment was
found to be increased when compared to the C57BL/Dk (control) mice. However,
the number of ILFs in WT->LTav" mice and WT->LTp_/" mice was similar to the
number in WT->WT control mice. The mILFs ofWT->LTa"A mice were found to be
significantly larger than the mILFs of the LTpR-Ig treated mice. These variations
might be explained by the different strains of mice that were used as there are also
significant differences in the number and size of ILFs between C57BL/Dk mice and
WT (C57BL/6) mice, and the work of others has shown similar differences in ILF
number between different mouse strains (Hamada et al., 2002; Lorenz & Newberry,
2004). In both cases, the absence of PPs induced a significant increase in the size
and maturity of ILFs when compared to the respective controls. The increase in size
and maturity of ILFs resulted in the total area occupied by FDCs in the intestines of
the mice being similar to the respective controls and to each other. This showed that
although the distribution of FDCs within the intestines of these distinct groups of
mice was different, the overall area occupied by FDCs was the same, suggesting that
the reason why ILFs form in both cases is to make sure the intestines are not
unprotected immunologically in the absence of PP function.
Consistent with previous reports (Hamada et al., 2002; Lorenz et al., 2003), mILFs
were found to contain T lymphocytes and germinal centre B lymphocytes. Previous
work using electron microscopy has also shown the presence of M cells in the FAE
overlying ILFs (Hamada et al., 2002; Lorenz et al., 2003). Consistent with this, the
presence of UEA-1 positive M cells was detected in FAE overlying ILFs and also in
villi in the work described here. The pathogenic bacterium Yersinia enterocolitica
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exploits M cells to invade the host (Clark et al., 1998; Dube et al., 2003; Isberg &
Leong, 1990). Thus the presence of Y. enterocolitica within the GALT can be used
to demonstrate M cell-mediated transcytosis. The work of others has shown that Y.
enterocolitica can infect mILFs demonstrating that the M cells overlying these
structures are functional (Lorenz & Newberry, 2004). Experiments described here
also show that ILFs are connected to the lymphatic vasculature by the presence of
Lyve-1 positive vessels in ILFs. PPs have efferent lymphatics but no afferent
lymphatics and so represent the beginning of a lymphatic vessel. Lymph nodes, in
contrast, have both afferent and efferent lymphatic vessels. It is likely that, as ILFs
are more similar to PPs than they are to lymph nodes, they would also represent the
beginning of a lymphatic vessel. Taken together, these results show that mILFs
resemble fully functional lymphoid tissue.
IgA was detected in the intestines of mice containing mILFs and lacking PPs and
MLNs. IgA was absent from mice lacking PPs, MLNs and mILFs despite the
presence of FDCs in remaining lymphoid tissues in these mice. This suggested that
IgA synthesis in the intestines of mice with no PPs or MLNs was dependent on the
presence ofmILFs. These observations are consistent with the work of others which
has shown that after infection with Salmonella typhimurium, specific IgA was
present in intestines of mice which had mILFs, but lacked PPs or MLNs (Lorenz &
Newberry, 2004). Likewise, cells isolated from the mILFs of sheep red blood cell
(SRBC) immunised mice have been shown to be capable of making SRBC-specific
IgA upon restimulation (Lorenz & Newberry, 2004). Collectively, these data suggest
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that mILFs are capable of producing IgA, and, therefore, display similar functionality
to other gut-associated lymphoid tissues.
Most mutations that would give rise to PP deficiency will also result in general
immunodeficiency and, therefore, increased susceptibility to many infectious
diseases. For example, mice lacking various components of the LT011P2 signalling
pathway have been shown to control intracellular bacterial (Bopst et al., 2001; Ehlers
et al., 2003; Engwerda et al., 2004; Fontan et al., 2001; Jacobs et al., 2000; Trueb et
al., 1995; Wilhelm et al., 2002), protozoan (Engwerda et al., 2004; Wilhelm et al.,
2002), viral (Banks et al., 2005; Benedict et al., 2001; Berger et al., 1999;
Kamaraguru et al., 2001; Lund et al., 2002; Suresh et al., 2002) and metatastic
(Dobrzanski et al., 2004; Ito et al., 1999; Smyth et al., 1999) disease less well than
immunocomptetent counterparts. A naturally occurring PP deficient mouse is,
therefore, unlikely to survive long enough to be able to reproduce. Thus the chances
of a compensatory mechanism for PP deficiency evolving on this basis are not high.
The formation of mILFs has been postulated to occur when factors secreted by PPs
are absent (Lorenz et al., 2003). The precise identity of these stimuli is unknown. As
PP size decreases with age (Fujihashi & McGhee, 2004), the induction of ILF
maturation might provide a mechanism to compensate for PP decline. If this were
true, it could be postulated that the intestines of old mice may contain more mILFs
than young counterparts. However, when the intestines of old mice were
investigated no mILFs could be detected at all, suggesting that ILFs are affected by
age in a similar way to PPs.
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This leaves the reason for the evolution of the formation of ILFs open to question.
One possible explanation is that the mechanism of formation of ILFs occurred earlier
on the evolutionary timescale and has since been superceded by the development of
PPs (Hamada et al., 2002). In event of disruption to the mechanism of PP
development, however, the mechanism for the formation of ILFs is still utilisable to
prevent the intestines being unprotected immunologically. These ideas have yet to
be investigated fully.
In conclusion, data presented here, consistent with the data of others, showed that the
absence of PPs induced the development of an increased number of mILFs in the
intestines. In this study, FDCs were found to be present in mILFs, but not in ilLFs
and the total area covered by FDCs in the intestine was found to be equivalent
between all three types of PP deficient mice studied and their relevant controls.
mILFs were found to both resemble and function as fully differentiated lymphoid
tissue. As FDCs are important for the peripheral pathogenesis of TSEs these results
would suggest that mILFs are likely to be an important site of TSE agent
neuroinvasion from the intestine.
108
4





4.3.1 Lymphoid tissues of lymphotoxin -a deficient (LTa"A )
mice and lymphotoxin ~p deficient (LT(3_/") mice lack
FDCs 114
4.3.2 Effect of lymphotoxin (LT) deficiency on susceptibility to
scrapie infection 114
4.3.3 Effect of lymphoid tissue and FDC deficiency on early and
late PrPSc accumulation in lymphoid tissues 118
4.3.4 Reconstitution of LTa_/" mice or LTP_/" mice with WT bone
marrow restores FDCs in remaining lymphoid tissues but
does not initiate the formation of PPs or MLNs 123
4.3.5 Effect ofGALT component-deficiency on oral scrapie
susceptibility 130
4.3.6 Effect ofGALT deficiency on early and late PrPSc
accumulation in lymphoid tissues 130
4.3.7 Effect of PP deficiency on oral scrapie pathogenesis in
mice containing mILFs 137
4.3.8 Effect of PP deficiency on early and late accumulation of




Mice lacking specific combinations of lymphoid tissues were inoculated orally with
the ME7 scrapie agent to investigate the role of gut-associated lymphoid tissues
(GALT) in scrapie agent neuroinvasion from the intestine. Signalling via the
lymphotoxin (LT) -0 receptor during gestation is crucial for the formation of Peyer's
patches (PPs) and other secondary lymphoid tissues; LTp~/_ mice lack PPs and
isolated lymphoid follicles (ILFs) and LTav" mice lack PPs, ILFs and mesenteric
lymph nodes (MLNs). In addition follicular dendritic cells (FDCs) also require LT-
signalling to maintain their differentiated state; therefore, both LTu_/~ mice and LTp"/_
mice have no FDCs. In the absence of FDCs neither LTa"/_ mice nor LTP"7" mice are
susceptible to oral infection with scrapie as FDCs are important for scrapie agent
neuroinvasion after oral inoculation. Reconstitution of LTa"/_ mice and LTP"A mice
with wild-type (WT) bone marrow restores FDCs and lymphoid tissue
microarchitecture, but does not initiate the formation of the missing PPs or MLNs.
After reconstitution of LTa"/_ mice and LTp_/" mice with WT bone marrow none of
the recipient mice succumbed to scrapie, despite the presence of FDCs in the
remaining lymphoid tissues. Thus in the absence of PPs and ILFs in the intestine,
neuroinvasion is blocked. The MLNs appear not to be crucial for neuroinvasion
from the intestines as FDC containing MLNs were present in WT bone marrow
reconstituted LTp"/_ mice. Progeny mice treated in utero with LTpR-Ig lack PPs, but
develop increased numbers of FDC-containing mature ILFs (mILFs) in their
intestines. After oral inoculation with scrapie, PrPd accumulated on the FDCs in
mILFs and both PP-deficient and immunocompetent control mice developed disease
at the same time following oral inoculation. Taken together these results show that
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after oral inoculation with the scrapie agent, efficient neuroinvasion occurs directly
from FDCs in lymphoid tissue within the intestine such as PPs and mILFs. Although
the scrapie agent accumulates in the MLNs shortly after oral inoculation, these
tissues are not critical for efficient neuroinvasion.
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4.2 Introduction
Many natural TSE infections are thought to be acquired via the oral route. For
example, the spread of BSE amongst UK cattle was most likely caused by the use of
BSE-contaminated feed (Wilesmith et al., 1991). The subsequent emergence of
vCJD in humans is thought to be principally due to the consumption of BSE-infected
meat as BSE and vCJD have been shown to be caused by the same strain of TSE
agent (Bruce et al., 1997; Hill et al., 1997). Although the precise route of infection
for natural scrapie remains unclear, the detection of disease specific PrP in the
lymphoid tissues draining the intestines (Andreoletti et al., 2000; Heggebo et al.,
2000) prior to detection within other lymphoid tissues or the central nervous system
(CNS; Keulen et al., 1999) implies that this disease may also be acquired orally. In
addition, both chronic wasting disease (CWD) in mule deer and elk (Williams &
Young, 1980) and transmissible mink encephalopathy (TME; Hartsough & Berger,
1965) are most likely transmitted via the oral route.
The involvement of lymphoid tissues in scrapie agent neuroinvasion was first
demonstrated in 1967 when it was reported that agent infectivity accumulates to high
levels in the spleen and peripheral lymph nodes before it is detected in the CNS in
experimentally infected mice (Eklund et al., 1967). The precise mechanism through
which the agent reaches the CNS is unclear, but in vitro and in vivo studies in rodents
and sheep suggest that the scrapie agent may be transported from the intestinal lumen
to the gut-associated lymphoid tissues (GALT) by dendritic cells (Huang et al., 2002;
Kaneider et al., 2003), macrophages (Beringue et al., 2000; Carp & Callaghan, 1982;
Jeffrey et al., 2000) or M cells (Beekes & McBride, 2000; Heggebo et al., 2002;
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Heppner et al., 2001). Once in the lymphoid tissues the scrapie agent accumulates
on follicular dendritic cells (FDCs; Jeffrey et al., 2000; McBride et al., 1992).
Scrapie agent accumulation on FDCs has been found to be of crucial importance for
neuroinvasion as treatment of adult mice with LTpR-Ig to temporarily de¬
differentiate FDCs 3 days prior to oral inoculation blocked the transmission of the
disease to the CNS (Mabbott et al., 2003). In contrast, mice treated with LTPR-Ig 14
days after oral inoculation were just as susceptible to scrapie as immunocompetent
controls (Mabbott et al., 2003) thus demonstrating that neuroinvasion following oral
inoculation was rapid and most likely occurred directly from lymphoid tissue within
the intestine.
The gut associated lymphoid tissue (GALT) comprises chiefly of appendix, tonsils,
Peyer's patches (PPs), mesenteric lymph nodes (MLNs) and isolated lymphoid
follicles (ILFs). Although TSE agents accumulate in the GALT following oral
exposure, which, if any, of these tissues are crucial for disease pathogenesis is
unclear. It is plausible that one component of the GALT (e.g. PPs) is of paramount
importance and the development of disease is prevented in its absence. It is also
plausible that neuroinvasion occurs from multiple sites, such that lack of one type of
lymphoid tissue (e.g. PPs) can be compensated for by the presence of another (e.g.,
MLNs). It is also plausible that the GALT is not critically required and that
neuroinvasion can take place from other sites (e.g. spleen) in its total absence. To
address this issue, mice lacking combinations of PPs, MLNs and ILFs were
inoculated orally with ME7 scrapie to determine the contribution of each of these
tissues to neuroinvasion from the intestine.
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4.3 Results
4.3.1 Lymphoid tissues of lymphotoxin a deficient (LTa"7") mice and
lymphotoxin I) deficient (LTB"/~) mice lack FDCs
First, FDC presence in the remaining lymphoid tissues of LTa_/" mice, LTpv" mice
and wild-type (WT) immunocompetent mice was compared. Sections of spleen and
MLN (where present) were stained with CD21/35 specific monoclonal antiserum
7G6 to detect CR1/CR2 expressing FDCs and CD45R-specific monoclonal
antiserum B220 to detect B lymphocytes. As expected, large FDC networks were
detected within the organised B lymphocyte follicles of PPs, MLNs and spleens from
WT mice. In contrast, FDCs and distinguishable B lymphocyte follicles were not
detected in the remaining lymphoid tissues from either LTa_/" mice or LT(3"A mice
(Figs 4.1 & 4.2).
4.3.2 Effect of lymphotoxin (LT) deficiency on susceptibility to scrapie infection
Next the potential effect LT deficiency may have on the pathogenesis of scrapie
directly within the CNS was determined. After intra-cranial inoculation ofWT mice,
LTa"A mice and LTp_/" mice with 20 pi of a 1.0 % dilution of ME7 scrapie brain
homogenate no significant differences in the incubation periods of disease were
observed (171 ± 4 days, n- 6; 175 ± 4 days,/? < 0.482, n — 5; and 175 ± 1 days; p <
0.395 n = 5 for WT mice, LTa_/" mice and LTP"/_ mice respectively; Table 4.1).
These data show that genetic deficiency of either LTa or LTP had no effect on the
pathogenesis of ME7 scrapie directly within the CNS. Therefore, any effects
observed in LTa_/" mice or LTP"A mice after peripheral inoculation could be attributed
to an altered efficiency of the translocation of the scrapie agent to the CNS.
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Figure 4.1- Effect of reconstitution with wild-type (WT) bone marrow on the
microarchitecture of gut-associated lymphoid tissue. Sections of a) Peyer's patches (PPs) from
wild-type (WT) mice and b) mesenteric lymph nodes (MLNs) from WT mice and lymphotoxin -(3
deficient (LTp~/_) mice were stained with the CD45R-specific antiserum B220 to detect B
lymphocytes (green) and monoclonal antiserum 7G6 to detect CD21/35 expressing follicular
dendritic cells (FDCs; red). PP and MLN tissues from WT mice (top rows) showed presence of
FDCs and organised follicles in both unreconstituted mice and those which had been reconstituted
with WT bone marrow. In unreconstituted LTP_/" mice, MLN tissues showed a lack of FDCs and
no distinct follicles (lower left). After reconstitution with WT bone marrow, FDCs and follicular
organisation was restored in MLNs of LTP"/_ mice (lower right). Original magnification X200.
115
Unreconstituted Reconstituted
Figure 4.2- Effect of reconstitution with wild-type (WT) bone marrow on the
microarchitecture of spleens ofWT mice, lymphotoxin -a deficient (LTa"") mice
and lymphotoxin -P deficient (LTp_/~) mice. Spleen sections were stained with the
CD45R-specific antiserum B220 to detect B lymphocytes (green) and monoclonal
antiserum 7G6 to detect CD21/35 expressing follicular dendritic cells (FDCs; red).
Spleen tissues from WT mice (top row) showed presence of FDCs and organised
follicles in both unreconstituted mice and mice which had been reconstituted with
WT bone marrow (WT->WT mice). In unreconstituted LTa"7" mice and LTP"7" mice,
spleen tissues showed a lack of FDCs and no distinct follicles (middle and lower
left). After reconstitution with WT bone marrow, FDCs and follicular organisation
was restored in spleens of both LTa"" mice (WT->LTa"7" mice; middle right) and
LTpv" mice (WT->LTP"/_ mice; lower right). Original magnification X200.
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Mean incubation
Incidence1 period (days) ±
S.E.M.
WT 6/6 171 ±4
LTav" 5/5 175 ±4
i/rp"A 5/5 175 ± I
Table 4.1- Effect of lymphotoxin (LT) deficiency on scrapie susceptibility after
intra-cranial inoculation.
1. Incidence = number of animals affected/ number of animals tested.
WT = wild-type mice; LTa"/_ = lymphotoxin -a deficient mice; LTp_/" = lymphotoxin
~P deficient mice.
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After oral inoculation, all WT mice succumbed to disease with a mean incubation
period of 311 ± 3 days (n = 20) whereas all LTa7" mice and LT(3"A mice remained
free of the signs of scrapie until at least 545 days post inoculation (dpi; Table 4.2).
In this thesis, disease-specific abnormal accumulations of PrP that are
characteristically found only in TSE-affected tissues are termed PrPd. Where
proteinase K resistance of these accumulations is confirmed the term PrPSc is used
(section 1.1.4). Characteristic spongiform pathology, PrPd accumulation and reactive
astrocytes were detected in the brains of all WT mice that developed clinical signs of
scrapie as described in section 2.3.6 (clinically positive; Fig 4.3). The severity and
distribution of the pathological targeting of vacuolation in the brains ofWT mice was
typical ofME7 scrapie (Fig 4.4). In contrast, no evidence of spongiform pathology,
PrPd accumulation or reactive astrocytes were detected in the brains of surviving
LTa"/_ mice or LTp_/" mice (Fig 4.3). Thus in the absence of FDCs and GALT, the
neuroinvasion of the scrapie agent from the intestine was blocked.
4.3.3 Effect of lymphoid tissue and FDC deficiency on early and late PrPSc
accumulation in lymphoid tissues
Within 70 days of oral inoculation with the ME7 scrapie agent high levels of the
proteinase K (PK) resistant, disease specific isomer of PrP (PrPSc) accumulate in the
MLNs, but levels detected in the spleen are variable and often undetectable (Mabbott
et al., 2003). Consistent with previous reports, high levels of PrPSc were found in the
MLNs and no PrPSc was found in the spleens ofWT mice at this time point (Fig 4.5).
In tissues of LTa"/_ mice and LTp~A mice PrPSc was undetectable (Fig 4.5). At the
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Figure 4.3- Histological analysis of brain tissue from terminally scrapie affected
mice or survivor mice. Large disease specific PrP (PrPd) accumulations were
detected in the hippocampi of all mice which developed clinical signs of scrapie
(brown; upper row). Immunostaining of adjacent sections for glial fibrillary acidic
protein (GFAP; red; middle row) showed diffuse gliosis in the hippocampi of all
terminally scrapie affected mice. Adjacent sections were also stained with
haematoxylin and eosin (H & E; lower row) and extensive vacuolation was
displayed in all mice terminally affected by scrapie. None of these pathological
signs of scrapie disease were detected in the brains of clinically negative mice at the
end of the experiment. All sections were counterstained with haematoxylin (blue).
Original magnification X200. WT, wild-type mice; LTa_/", lymphotoxin -a deficient
mice; LTp_/", lymphotoxin-P deficient mice; clin, clinical score, either positive (+) or
negative (-); path, pathological score, either positive (+) or negative (-); dpi, days




































Figure 4.4- Pathological targeting of vacuolation in the brains of mice
terminally affected by ME7 scrapie or survivor mice, a) wild-type (WTt mice,
lymphotoxin -a deficient (LTa~/ ) mice and lymphotoxin -(3 deficient (LTP~") mice
were inoculated orally with ME7 scrapie, b) WT mice, LTa"/_ mice and LTp_/" mice
were reconsitituted with WT bone marrow (WT->WT mice, WT->LTa~~ mice and
WT->LTp_/" mice respectively) and inoculated orally with ME7 scrapie 35 days
later. Vacuolation in the brain was scored on a scale of 0-5 in the following grey
matter (G1-G9) or white matter (W1-W3) areas: Gl, dorsal medulla; G2, cerebellar
cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6, hippocampus;
G7, septum; G8, retrosplenial and adjacent motor cortex; G9, cingulate and adjacent
motor cortex; Wl, inferior and middle cerebellar peduncles; W2, decussation of the
superior peduncles; W3, cerebral peduncles. Each point represents mean
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Figure 4.5- PrPSc accumulation in lymphoid tissues, (a) Mesenteric lymph nodes
(MLNs; or membrane where MLNs should have been in lymphotoxin-a deficient
(LTa"/_) mice) and (b) spleens of wild-type (WT) mice, LTav" mice and lymphotoxin
-p deficient (LTP_/") mice 70 days after oral inoculation with ME7 scrapie.
Proteinase K (PK) -resistant, disease specific prion protein (PrPSc) was detected in
all the MLNs but not in the spleens of WT mice. No PrPSc was detected in either
MLNs or spleens from either LTa" mice or LTP_/" mice. Samples were treated in the
presence (+) or absence (-) of proteinase K (PK) prior to electrophoresis.
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immunocompetent mice (Mabbott et al., 2003). Consistent with this, in the present
study high levels of PrPSc were detected in both the MLNs and spleens ofWT mice
(Fig 4.6). Flowever, the accumulation of PrPSc was blocked in lymphoid tissues of
LTa"7" mice and LTP"7" mice taken from clinically negative animals that remained free
from the signs of scrapie at 545 days after inoculation (end of the experiment; Fig
4.6).
4.3.4 Recoilstitution of LTa"7" mice or LTB"7" mice with WT bone marrow
restores FDCs in remaining lymphoid tissues but does not initiate the formation
of PPs or MLNs
As well as there being a complete absence of FDCs from lymphoid tissues in LTa"7"
mice and LTP"7" mice, PPs are also absent from both LTa"7" mice and LTP"7" mice and
MLNs are absent from LTa"7" mice (Figs 3.5 & 4.7). Further experiments were
therefore necessary to distinguish between the effect of FDC deficiency and
lymphoid tissue deficiency on scrapie pathogenesis. Reconstitution of LTa"7" mice or
LTp"7" mice with WT bone marrow restores FDCs in remaining lymphoid tissues, but
the absence of PPs and MLNs from LTa"7" mice and the absence of PPs from LTP"7"
mice is not recovered (Figs 3.5 & 4.7). WT mice, LTa"7" mice and LTP"7" mice were
y-irradiated and reconstituted with WT bone marrow (termed WT->WT, WT->LTa"7"
mice and WT->LTp"7" mice respectively) and tissues collected 35 days later.
Sections of PPs, MLNs (where present) and spleen were stained with CD21/35
specific antiserum to detect FDCs and anti-CD45R specific antiserum B220 to detect
B lymphocytes. Immunohistochemical analysis revealed that FDCs were retained in
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Figure 4.6- PrPSc accumulation in lymphoid tissues, (a) mesenteric lymph nodes
(MLNs; or membrane where MLNs should have been in lymphotoxin-a deficient
(LTa"/_) mice) and (b) spleens of clinically affected wild-type (WT) mice, or survivor
LTa"7" mice and lymphotoxin-P deficient (LTP"7") mice after oral inoculation with ME7
scrapie. Proteinase K resistant, disease specific prion protein (PrPSc) was detected in
the MLNs and the spleens of WT mice. No PrPSc was detected in either MLNs or
spleens from either LTa"7" mice or LTP"7" mice, or from mice which were not
inoculated with scrapie (U). Samples were treated in the presence (+) or absence (-)
of PK prior to electrophoresis. Clin, clinical score either positive (+) or negative (-);
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the lymphoid tissues of WT->WT mice. Furthermore, the maturation of FDC
networks and follicular organisation was induced in the remaining lymphoid tissues
of WT->LTa_/" mice and WT->LT(3"A mice (Figs 4.1 & 4.2). The presence of FDCs
at the time of oral inoculation has been found to be crucial for efficient scrapie agent
accumulation in lymphoid tissues and subsequent neuroinvasion (Mabbott et al.,
2003). Here, the presence of immune complex-trapping FDCs at the time of
inoculation in MLN and spleen tissues was shown by immunostaining for
complement receptor (CR) 1 and complement components C3 and C4 (Figs 4.8 &
p
4.9). The expression of PrP was similar in lymphoid tissues of WT->WT mice,
WT->LTa"/_mice and WT->LTp_/" mice (Fig 4.10).
The reconstitution of LTa"A mice and LTpv~ mice with WT bone marrow also
induces the development of isolated lymphoid follicles (ILFs) in the intestine (Figs
3.5 & 3.6). Investigations in Chapter 3 of this thesis have revealed that ILF
development in recipient LTa_/" mice or LT(3_/" mice takes much longer than 35 days,
hence ILFs were absent in WT->LTa_/" mice and WT->LTp~A mice 35 days after WT
bone marrow transfer (Fig 3.6). In summary, at 35 days after bone marrow transfer
WT^LTa"7" mice had no MLNs, PPs or ILFs and WT->LTP"7" mice had no PPs or
ILFs. However, in all three groups of mice (WT->WT mice, WT->LTa-/" mice and
WT->LTp_/" mice) functional FDCs were present in the remaining lymphoid tissues











Figure 4.8- Mesenteric lymph nodes (MLNs) from wild-type (WT) mice and
lymphotoxin-p deficient (LTp /_) mice reconstituted with WT bone marrow
(WT->WT mice and WT->LTp-/" mice respectively) contain functional follicular
dendritic cells (FDCs). MLN tissues were collected at the time of oral inoculation
with ME7 scrapie (5 weeks post reconstitution with WT bone marrow). Sections
were stained with CD35-specific monoclonal antisera to detect FDCs (red; top row)
and monoclonal antisera specific for complement components C4 (red; 2nd row) and
C3 (red; lower row). Complement components in association with complement







Figure 4.9- Spleens from wild-type (WT) mice, lymphotoxin-a deficient mice
(LTa"/_) mice and lymphotoxin-P deficient mice (LTp ") mice reconstituted with
WT bone marrow (WT->WT mice, WT->LTa_/" mice and WT->LTp_/" mice
respectively) contain functional follicular dendritic cells (FDCs). Spleen tissues
were collected at the time of oral inoculation with ME7 scrapie (5 weeks post
reconstitution). Sections were stained with CD35-specific monoclonal antisera to
detect FDCs (red; top row) and monoclonal antisera specific for complement
components C4 (red; 2nd row) and C3 (red; lower row). Complement components in
association with complement receptor expressing FDCs were found in the spleens of











Figure 4.10- Expression of the cellular form of the prion protein (PrPc) on
follicular dendritic cells (FDCs) in lymphoid tissues of wild-type (WT) bone
marrow reconstituted WT mice, lymphotoxin -a deficient mice and
lymphotoxin -p deficient mice (WT->WT mice, WT^LTa"7" mice and WT-
>LTp_/" mice respectively). Mesenteric lymph nodes (MLNs; where present) and
spleen tissue sections were stained with the PrP-specific monoclonal antiserum 1B3
(red). Levels of PrPc expression were similar in all tissues examined. Original
magnification X200.
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4.3.5 Effect of GALT component-deficiency on oral scrapie susceptibility
WT mice, LTa"7" mice and LTp7" mice were y-irradiated and reconstituted with WT
bone marrow. 35 days later (when FDC networks had developed in remaining
lymphoid tissues) mice were inoculated orally with the scrapie agent. Experiments
demonstrated that all WT->WT mice succumbed to disease with a mean incubation
period of 337 ± 4 days (« = 8). However, all WT->LTa_/' and WT->LTp_/" mice
remained free of the signs of scrapie up to at least 503 days after inoculation (Table
4.3). Characteristic spongiform pathology, PrPd accumulation and reactive
astrocytes were detected in the brains of all WT->WT mice that developed clinical
signs of scrapie (Fig 4.11). The severity and distribution of the pathological targeting
of vacuolation in the brains of WT mice was typical of ME7 scrapie (Fig 4.4). In
contrast, no evidence of spongiform pathology, PrPd accumulation or reactive
astrocytes were detected in the brains of surviving WT^LTa"7" mice or WT->LTpv"
mice (Fig 4.11).
4.3.6 Effect of GALT deficiency on early and late PrPSc accumulation in
lymphoid tissues
Within 70 days of oral inoculation with the ME7 scrapie agent high levels of PrPd
accumulate in association with FDCs in the germinal centres of PPs in the intestines
(Mabbott et ai, 2003). High levels of PrPd were found upon FDCs in the PPs and
the few mILFs present in the intestines ofWT->WT mice at 70 days after inoculation
(Fig 4.12). After the early onset of accumulation, high levels of PrPd were sustained
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Figure 4.11- Histological analysis of brain tissue from terminally scrapie affected
mice or survivor mice. Large disease-specific prion protein (PrPd) accumulations
were detected in the hippocampi of all mice which developed clinical signs of scrapie
(brown; upper row). Immunostaining of adjacent sections for glial fibrillary acidic
protein (GFAP; red; middle row) showed diffuse gliosis in the hippocampi of all
terminally scrapie affected mice. Adjacent sections were also stained with
haematoxylin and eosin (H & E; lower row) and extensive vacuolation was displayed
in all mice terminally affected by scrapie. None of these pathological signs of scrapie
disease were detected in the brains of clinically negative mice at the end of the
experiment. All sections were counterstained with haematoxylin (blue). Original
magnification X200. Clin, clinical score, either positive (+) or negative (-); Path,
pathological score either positive (+) or negative (-); dpi, days post-inoculation on
which tissues were taken for analysis. WT->WT, WT->LTa"/_ and WT->LT(3_/" are
wild-type mice, lymphotoxin-a deficient mice and lymphotoxin- P deficient mice
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Figure 4.14- PrPSc accumulation in lymphoid tissues, (a) Mesenteric lmph nodes
(MLNs; or membrane where MLNs should have been in WT->LTa~/_ mice) and (b)
spleens of wild-type (WT) bone marrow reconstituted WT mice, lymphotoxin -a
deficient mice and lymphotoxin ~P deficient mice (WT->WT mice, WT->LTa_/mice
and WT->LTp"A mice respectively) 70 days after oral inoculation with ME7 scrapie.
Proteinase K (PK) resistant, disease specific prion protein (PrPSc) was detected in
some spleens from WT->WT mice. No PrPSc was detected in MLNs from WT->WT
mice or MLNs or spleens from either WT->LTa"~ mice or WT->LTP_/" mice.
Samples were treated in the presence (+) or absence (-) of PK prior to
electronhoresis.
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Figure 4.15- PrPSc accumulation in lymphoid tissues, (a) Mesenteric lymph nodes
(MLNs; or membrane where MLNs should have been in WT->LTa~~ mice) and (b)
spleens of clinically affected wild-type (WT) bone marrow reconstituted WT mice
(WT->WT mice), or survivor WT bone marrow reconstituted lymphotoxin -a
deficient mice and lymphotoxin -0 deficient mice (WT->LTa"/_ mice and WT->
LTp-/~ mice respectively) after oral inoculation with ME7 scrapie. Proteinase K
resistant, disease specific prion protein (PrPSc) was detected in the MLNs and the
spleens ofWT->WT mice. No PrPSc was detected in either MLNs or spleens from
either WT->LTofAmice or WT->LTp_/" mice or from mice which were not inoculated
with scrapie (U). Samples were treated in the presence (+) or absence (-) of
proteinase K (PK) prior to electrophoresis. Clin, clinical score either positive (+) or
negative (-); dpi, days post inoculation on which the tissues were taken for analysis.
136
4.13). In contrast, no PrPd accumulations were observed in the mILFs in the
intestines of either WT-^LTa'^mice or WT->LTp~/_ mice at 70 days after inoculation
(Fig 4.12) or in the intestines of mice which remained free of the clinical signs of
disease 503 days after inoculation (the end of the experiment; Fig 4.13). In the
MLNs of WT->WT mice PrPSc was undetectable 70 dpi (Fig 4.14) but strong
accumulations were detected at the terminal stage of disease (Fig 4.15). Consistent
with the observations made in ILFs, no PrPSc was detected in the MLNs from WT-
>LTP"/_ mice 70 days after oral inoculation (Fig 4.14) or at the end of the experiment
(Fig 4.15). In the spleens of WT->WT mice variable levels of PrPSc were detected
70 dpi whereas high levels were detected at the terminal stage of disease (Fig 4.15).
In contrast, PrPSc was undetected in spleens from WT->LTa"A mice and WT->LTp"/_
mice 70 days after inoculation (Fig 4.14) or in spleens from clinically negative
survivor WT->LTa"A mice or WT->LTp_/" mice (Fig 4.15).
4.3.7 Effect of PP deficiency on oral scrapie pathogenesis in mice containing
mILFs.
The data described so far shows that the absence of PPs and mILFs at the time of
inoculation blocks scrapie pathogenesis, whereas the presence or absence of MLNs
does not influence scrapie susceptibility. Mice treated in atero with LTPR-Ig on day
11.5 of gestation had no PPs, but retained the MLNs and had numerous mILFs in
their intestines (Section 3.3.1). These mice (termed PP-deficient mice) were used
here to determine the potential contribution of mILFs to oral scrapie pathogenesis.
As the effects of LTPR-Ig treatment are temporary, the remaining lymphoid tissues
of PP-deficient mice (e.g. spleen and MLNs) had functional FDC networks at the
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time of inoculation. When inoculated orally with the scrapie agent,
immunocompetent control mice developed disease with a mean incubation period of
319 ± 2 days (n = 16). In contrast to the effects of PP and mILF deficiency on
disease pathogenesis, scrapie susceptibility was not affected in PP-deficient mice.
All PP-deficient mice developed disease with a mean incubation period of 313 ± 6
days (n = 10; Table 4.4). Histopathological analysis of brain tissue from clinically
affected control mice and PP-deficient mice revealed the presence of characteristic
PrPd accumulations, gliosis and spongiform pathology typical of mice terminally
affected by the ME7 scrapie agent (Fig 4.16). No significant differences in the
severity or distribution of the pathological targeting of vacuolation in the brain were
observed between PP-deficient mice and control mice (Fig 4.17).
4.3.8 Effect of PP deficiency on the early and late accumulation of PrPSc in mice
containing mILFs
In the PPs and the few mILFs of control mice and in the mILFs of PP-deficient mice
strong accumulations of PrPd were detected in association with FDCs 70 dpi (Fig
4.18) and were sustained through to the terminal stage of disease (Fig 4.19).
Immunostaining with S-100 specific antiserum to detect neurones and supporting
glial cells revealed the presence of neurones in close association with mILFs (Fig
4.20). 70 days after inoculation, PrPSc accumulation was found some MLNs but not
spleens of both PP-deficient mice and control mice (Fig 4.21). In terminally scrapie
affected mice PrPSc accumulations were found in both MLNs and spleens (Fig 4.22).
Taken together, the results show that mILFs are capable of compensating for the PP
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deficiency by supporting TSE agent accumulation in the intestine and facilitating
subsequent neuroinvasion. Furthermore these data show that TSE agent
neuroinvasion from mILFs is as efficient as neuroinvasion from other GALT.
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Figure 4.16- Histological analysis of brain tissue from terminally scrapie
affected mice. Large disease specific prion protein (PrPd) accumulations were
detected in the hippocampi of all mice which developed clinical signs of scrapie
(brown; upper row). Immunostaining of adjacent sections for glial fibrillary acidic
protein (GFAP; red; middle row) showed diffuse gliosis in the hippocampi of all
terminally scrapie affected mice. Adjacent sections were also stained with
haematoxylin and eosin (H&E; lower row) and extensive vacuolation was
displayed in all mice terminally affected by scrapie. All sections were
counterstained with haematoxylin (blue). Original magnification X200. Clin,
clinical score, either positive (+) or negative (-); Path, pathological score, either
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Figure 4.17- Pathological targeting of vacuolation in the brains of mice
terminally affected by ME7 scrapie, (a) first undertaking of experiment (b) second
undertaking of experiment. Vacuolation in the brain was scored on a scale of 0-5 in
the following grey matter (G1-G9) or white matter (W1-W3) areas: Gl, dorsal
medulla; G2, cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5,
thalamus; G6, hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex;
G9, cingulate and adjacent motor cortex; Wl, inferior and middle cerebellar
peduncles; W2, decussation of the superior peduncles; W3, cerebral peduncles. Each
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Figure 4.20- Association of neurones with isolated lymphoid follicles (ILFs).
Sections of small intestine were stained with the CD45R-specific monoclonal
antiserum B220 (green) and 7G6 monoclonal antiserum to detect CD21/35
expressing follicular dendritic cells (FDCs; red; left column). Adjacent sections were
stained with the prion protein (PrP) -specific monoclonal antisera 6H4 (green) and S-
100 specific monoclonal antisera to detect nerve fibres and supportive glial cells (red;
middle and right columns). Neurones were found in close association with both
mature ILFs (mILFs; top row) and immature ILFs (ilLFs; lower row). Original
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Figure 4.21- PrPSc accumulation in lymphoid tissues, (a) Mesenteric lymph nodes
(MLNs) and (b) spleens of C57BL/Dk (control) mice and PP-deficient C57BL/Dk
mice 70 days after oral inoculation with ME7 scrapie. Samples were treated in the
presence (+) or absence (-) of proteinase K (PK) prior to electrophoresis. At this
time point, PK resistant, disease specific prion protein (PrPSc) was detected in some
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Figure 4.22- PrPSc accumulation in lymphoid tissues, (a) mesenteric lymph nodes
(MLNs) and (b) spleens of clinically affected C57BL/Dk (control) mice and Peyer's
patch (PP)-deficient C57BL/Dk mice after oral inoculation with ME7 scrapie.
Proteinase K reistant, disease specific prion protein (PrPSc) was detected in both the
MLNs and the spleens. Samples were treated in the presence (+) or absence (-) ofPK
prior to electrophoresis. Clin, clinical score, either positive (+) or negative (-); dpi;
days post inoculation on which the tissues were taken for analysis.
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4.4 Discussion
Mice lacking FDCs and specific combinations of GALT were inoculated orally with
the ME7 scrapie agent to investigate the contribution of individual lymphoid tissues
in scrapie pathogenesis after oral inoculation. LTa"7" mice lack PPs and MLNs,
LT(3"7" mice lack PPs and neither have FDCs in the remaining lymphoid tissues.
Consistent with the important role for FDCs in TSE agent neuroinvasion, none of the
LTa"7" mice or LTP"7" mice succumbed to clinical disease following oral inoculation.
Reconstitution of LTa"7" mice and LTP"7" mice with WT bone marrow induces the
maturation of FDCs and microarchitecture in the remaining lymphoid tissues (for
example the spleen), but does not induce the development of the missing PPs or
MLNs. After reconstitution of LTa"7" mice and LTP"7" mice with WT bone marrow
none of the recipient mice succumbed to disease. Thus in the absence of PPs and
mILFs disease susceptibility was reduced. These results also suggest MLNs are not
important for oral scrapie pathogenesis even though early TSE agent accumulation
does occur in these tissues. Progeny mice treated in ntero with LTpR-Ig lack PPs but
contain increased numbers mILFs compared to untreated control mice. Furthermore,
the total area covered by FDCs in the intestines of PP-deficient mice was equivalent
to the total area covered by FDCs in immunocompetent control mice (Fig 3.5). Both
PP-deficient mice and control mice succumbed to clinical scrapie at the same time
and neuroinvasion occurred via the same pathway. The increased numbers ofmILFs
found in PP-deficient mice compensated for the PP deficiency by supporting
neuroinvasion. Taken together these results show that lymphoid tissue in the
intestine itself is important for effective pathogenesis of scrapie following oral
inoculation.
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In an adult mouse, LT011P2 signalling through LTP receptor (LTPR) is required for
the terminal differentiation of FDCs and for the organisation of the microarchitecture
of lymphoid tissues. Thus the remaining lymphoid tissues in mice genetically
deficient in either LTa or LTP also lack FDCs and show disorganised
microarchitecture (Koni et al., 1997; Matsumoto et al., 1996). y-irradiation and WT
bone marrow reconstitution of LTa"7" mice and LTP"A mice results in the restoration
of FDC networks and organisation of lymphoid tissue microarchitecture
demonstrating the necessity of LT expressing bone marrow derived cells for both
these processes.
As discussed in section 3.4, LTa_/" mice and LTP"7" mice lack PPs and ILFs as LTCI1P2
signalling is required for the formation of these tissues. The mechanism of formation
ofMLNs is distinct from the LTajp2 dependent mechanism involved in the formation
of most other secondary lymphoid tissues as demonstrated by the presence ofMLNs
in LTp_/" mice (Koni et al., 1997) and in utero LTpR-Ig treated mice (Rennert et al.,
1997). The absence ofMLNs from LTa"/_ mice (Banks et al., 1995; Fu et al., 1997)
and LTPR7" mice (Futterer et al., 1998) and comparison of the levels of LTPR
expressed by the cells present in MLN anlage compared to other lymph node anlage
(Cupedo et al., 2004b) gives some indication that in the absence of LT011P2, MLNs
may form by the interaction of LTa3 with LTPR. However, there is no published
evidence to suggest that LT013 is a ligand for LTpR. y-irradiation and WT bone
marrow reconstitution of LTa/_ mice and LTP" mice does not restore the formation
of the missing PPs and MLNs as the cells required to provide the source of LT for
this process are no longer able to carry out this function in adult mice (Cupedo et al.,
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2004a). FDCs are present and lymphoid tissue microarchitecture is normal in the
remaining lymphoid tissues of mice treated in utero with LTpR-Ig (Rennert et al.,
1996). In this instance LT signalling was temporarily blockaded during gestation
and was restored following catabolism of LTPR-Ig promoting subsequent FDC
maturation in the progeny mice.
LTamice and LTp_/" mice have previously been used to investigate the importance
of FDCs in the oral pathogenesis of TSEs (Oldstone et al., 2002). This study found
LTa"A to be less susceptible than controls, and LTP"A mice to be resistant to oral
RML scrapie agent challenge suggesting an important role for FDCs in oral scrapie
pathogenesis. Studies have also investigated the importance of FDCs in TSE
pathogenesis in other peripheral routes of inoculation using LTa_/" mice and LTpv"
mice (Manuelidis et al., 2000; Prinz et al., 2002). The results of these studies do not
concur as the first found no difference in susceptibility between LTpv~ mice and WT
mice when inoculated intra-peritoneally with a mouse passaged strain of CJD and the
second found both LTa_/" mice and LT(T/_ mice to have decreased susceptibility and
increased incubation periods to intra-peritoneal inoculation with RML scrapie.
These differences could be explained by the different strains of TSE agent and
different doses of inocula used. As these results are not consistent, and neither used
the ME7 strain of TSE agent, the susceptibility of LTa7" mice and LTp-/~ mice to oral
ME7 scrapie was investigated in this study. Both LTa"/_ mice and LT(3"/_ mice were
found to be resistant to oral ME7 scrapie which demonstrates that the combined
absence of both FDCs and draining lymphoid tissue prevents the onset of ME7
scrapie after oral inoculation.
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Other studies have also shown that in mouse models which had a combined lack of
both PPs and FDCs (TNFcf7- x LTa-/" mice and aly/aly mice; Horiuchi et al., 2006;
Prinz et al., 2003b), or atrophied PPs with reduced FDC networks (P7"/_ mice, RAG-
1" mice and pMT"/_ mice; Prinz et al., 2003b) scrapie disease did not develop after
oral inoculation. However, in each study, the separate roles that lymphoid tissues and
FDCs play in scrapie pathogenesis could not be distinguished. In this chapter, by
reconstituting LTa"' mice and FTP"'" mice with WT bone marrow and thus restoring
terminal FDC differentiation, data presented here shows the effect a specific lack of
lymphoid tissue has on pathogenesis ofME7 scrapie after oral inoculation.
Both WT->LTa_/" mice and WT->LTp-/" mice lacked PPs and mILFs at the time of
oral inoculation (35 days after WT bone marrow reconstitution). WT->LTav" mice
and WT->LT(3"/_ mice were resistant to oral scrapie challenge, demonstrating the
crucial importance of intestinal lymphoid tissue in oral scrapie pathogenesis. This
result is unlikely to be due to impaired uptake of the scrapie agent as WT->LTa_/"
mice and WT->LTp7" mice were found to have M cells and an intact lymphatic
vasculature (Figs 3.12 & 3.13). Macrophages appear to be unaffected by
lymphotoxin deficiency and although LT011P2 signalling via LTpR plays an important
role in the migration of DCs into lymphoid tissues, this defect is rectified by
reconstitution with WT bone marrow (Kabashima et al., 2005; Wu et al., 1999).
Previous work has shown the presence of FDCs at the time of oral inoculation with
the scrapie agent to be crucial for the establishment of disease, as mice lacking FDCs
at the time of inoculation were resistant to disease despite the re-appearance of FDCs
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around 28 days later (Mabbott et al., 2003). Consistent with this, data presented in
this chapter show that mice lacking PPs and mILFs at the time of inoculation did not
succumb to disease despite the induction of FDC-containing mILFs around 28 days
later (chapter 3). Data presented here also show, further to previous work, that FDCs
must be present in the intestine at the time of inoculation as FDCs were present in
other lymphoid tissues (e.g. MLNs and spleen) but these tissues were unable to
support neuroinvasion. These data are consistent with data from an epidemiological,
mathematical and pathological study which suggested that for sheep, cattle and
humans there was an association between the development of lymphoid tissues in the
gastrointestinal tract and susceptibility to natural TSE infection (St. Rose et al.,
2006).
The fact that WT->LTp_/" mice had MLNs containing functional FDCs at the time of
inoculation but the mice did not develop disease demonstrates that although early
PrPSc accumulation can occur in MLNs, these tissues are not critical for oral scrapie
pathogenesis. Additionally, although high levels of PrPd were detected in PPs 70
days after inoculation of WT->WT mice with scrapie, no PrPSc was found in the
MLNs at this time point. Taken together, these data indicate that MLNs are not
critical sites of scrapie neuroinvasion.
The demonstration that neuroinvasion does not occur in mice which lack lymphoid
tissue in the intestine, despite the presence of FDC-containing MLNs and spleen,
implies that after oral inoculation, neuroinvasion most likely occurs directly from
within the intestines. However, these experiments do not exclude the possibility that
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the lack of an initial site for accumulation and replication of the scrapie agent merely
prevents the onward spread of the agent and that the crucial neuroinvasion could be
taking place from sites outwith the intestines, for example, the spleen. The early
detection of PrPSc in the enteric nervous system of hamsters inoculated orally with
scrapie (Beekes & McBride, 2000) and the fact that splenectomy had no effect on
pathogenesis of 139A scrapie after intragastric inoculation of mice (Kimberlin &
Walker, 1989) gives some indication that neuroinvasion does occur directly from the
intestines after oral inoculation. The presence of FDCs at the time of oral scrapie
inoculation is critical for efficient neuroinvasion (Table 4.2; Mabbott et al., 2003).
However, treatment of mice with LTPR-Ig to temporarily de-differentiate FDCs 14
days after oral inoculation with the ME7 scrapie agent had no effect on pathogenesis
(Mabbott et al., 2003). Together these data imply that crucial neuroinvasion occurs
at a very early stage post inoculation and most likely from lymphoid tissue directly
within the intestine.
TSE infectivity has been found in the absence of the detection of PrPSc in mice
infected with BSE and transgenic mice infected with scrapie (Barron et al., 2001;
Lasmezas et al., 1997). The experiments described here do not exclude the
possibility that there may have been infectivity present, albeit at low levels, in the
absence of PrPSc in the lymphoid tissues or brains of the mice which did not develop
clinical disease. In experiments described in this thesis, PrPSc was extracted from
lymphoid tissues using a method which involved precipitation with sodium
phosphotungstic acid (NaPTA) allowing the highly sensitive detection of low levels
of PrPSc (Safar et al., 1998; Wadsworth et al., 2001). This would suggest that if
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infectivity was present in samples where no PrPSc was detected the level is likely to
be extremely low. ME7 is a very well characterised experimental strain of scrapie
and the presence of PrPSc is a reliable biochemical marker for infectivity for this
strain of TSE agent (Mabbott et al., 2003; Mohan et al., 2005a). Thus, it is highly
likely in the experiments described here that the absence of PrPSc and clinical signs
of disease equates to a lack of infectivity.
As discussed in section 3.4, the development of both PPs and ILFs is critically
dependent upon LT011P2 signalling through LT(3R during gestation. However,
differences in the timing and the type of cells that provide the source of LT permits
ILFs to develop in mice treated in utero with LT^R-Ig, but prevents the development
of PPs (section 3.4). PP-deficient mice had increased numbers of FDC-containing
mILFs compared with untreated control mice such that the total area covered by
FDCs in the intestines of these two types of mice were equivalent (section 3.3.3).
After oral inoculation with the scrapie agent both PP-deficient mice and control mice
developed clinical disease with similar incubation periods. Furthermore, PrPSc
accumulation in remaining MLNs and spleens, and brain pathology were also similar
in clinically affected PP-deficient and control mice. This suggests that neuroinvasion
occurred via a common pathway and was not influenced if the initial accumulation of
the scrapie agent occurred in PPs or mILFs. PrPd accumulated in association with
FDCs in mILFs and neurones and supportive glial cells were found in close
association with mILFs in the intestines of PP-deficient mice. Thus it is tempting to
speculate that following accumulation upon FDCs within mILFs scrapie agent
neuroinvasion occurred rapidly via the local enteric nerves.
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Data presented here showed that scrapie agent accumulation upon FDCs in lymphoid
tissue within the intestines (such as PPs or mILFs) was of crucial importance for the
successful development of clinical disease after oral inoculation. Although early
PrPSc accumulation also occurs within the MLNs their absence did not affect disease
susceptibility. These data demonstrate the crucial importance of the initial
accumulation and replication phase in lymphoid tissue local to the site of inoculation
for the development of clinical disease.
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Role of draining lymphoid nodes in scrapie pathogenesis after
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Inoculation with the scrapie agent via scarification of the skin has been shown to be
an effective route for the establishment of scrapie disease. Mice lacking inguinal
lymph nodes (ILNs) were inoculated with the scrapie agent via scarification of the
skin of the thigh to investigate the role of the draining lymph nodes in scrapie
pathogenesis. Lymphotoxin (LT) -a deficient mice (LTa"A) mice and LTpv" mice
were reconstituted with wild-type bone marrow to create mice which did not possess
ILNs but possessed follicular dendritic cells (FDCs) in remaining lymphoid tissues.
ILN-deficient mice were also created by in utero treatment with LTPR-Ig which
prevents the formation of the ILN in progeny mice. All groups of ILN-deficient
mice displayed decreased susceptibility to scrapie after inoculation with the ME7
scrapie agent via scarification. These data demonstrate that the draining lymph
nodes are important for efficient TSE neuroinvasion after inoculation via the skin.
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5.2 Introduction
Although many natural TSE infections are thought to be acquired orally, other
peripheral routes of exposure have been identified. Many examples of iatrogenic
transmission have been documented including; the transplantation of CJD
contaminated tissues or hormones (Duffy et al., 1974), or the transfusion of vCJD
contaminated blood (Llewelyn et al., 2004; Peden et al., 2004). Surgical instruments
contaminated with sCJD also have the potential to transmit disease (Flechsig et al.,
2001). Experimental inoculation of mice has revealed scarification of the skin to be
an effective means of scrapie transmission (Taylor et al., 1996b). Scarification of the
skin involves the creation of a superficial abrasion in the top layers of the skin into
which the scrapie agent inoculum is administered (section 2.4.4). The effectiveness
of this as a route for the transmission of scrapie raises the possibility that some cases
of natural scrapie may arise through skin lesions during close contact between
infected and non-infected animals, or through lesions in the mouth or digestive tract
(Bartz et al., 2003; Brotherston et al., 1968). This also raises the possibility that
pharmaceutical or cosmetic products derived from sheep or cattle tissues may
harbour TSE infectivity and therefore pose a risk when applied to abraded skin
(Birmingham, 2000; Lupi, 2002).
The involvement of lymphoid tissues in TSE pathogenesis after inoculation via
scarification has been demonstrated by the resistance of severe combined
immunodeficient (SCID) mice to scrapie administered in this way (Taylor et al.,
1996b). After inoculation via this route, neuroinvasion does not occur directly from
nerves within the skin but occurs following accumulation in lymphoid tissues
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(Mohan et al., 2004; Mohan et al., 2005a). The transport of the scrapie agent to the
lymphoid tissues from the skin appears to be independent of Langerhans cells
(Mohan et al., 2005b), but this does not exclude a role for other subsets of migratory
dendritic cells within the skin such as dermal dendritic cells (Lenz et al., 1993).
Further analysis has shown that follicular dendritic cells (FDCs) within the lymphoid
tissue are important in this route of infection as the de-differentiation of FDCs
shortly before or just after inoculation with scrapie extended survival time and
• creduced the incidence of disease (Mohan et al., 2005a). The expression of PrP by
lymphocytes is unimportant for pathogenesis via this route as SCID mice grafted
with PrP+/+ bone marrow and SCID mice reconstituted with PrP" " bone marrow
showed no differences in incubation period or disease susceptibility (Mohan et al.,
2004). This suggests that stromal cells expressing PrP are important, and, in the light
of the FDC study mentioned above (Mohan et al., 2005a), these stromal cells are
likely to be FDCs.
After inoculation via skin scarification of the thigh, the scrapie agent first
accumulates in the draining inguinal lymph node (ILN) prior to detection in the non-
draining lymph nodes and the spleen (Mohan et al., 2005a). However, whether
neuroinvasion occurs directly from the draining ILNs, spleen or a combination of
lymphoid tissues is not known. In this chapter, mice lacking ILNs were used to
investigate the importance of the draining ILN in scrapie pathogenesis after
inoculation via scarification of the skin of the thigh.
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5.3 Results
5.3.1 Creation of mice that lack ILNs but retain FDCs in remaining lymphoid
tissues
ILNs were absent in lymphotoxin (LT) -a deficient (LTa"/_) mice and LTff7" mice
(Fig 5.1), as LT011P2 signalling through LTP -receptor (LTpR) is crucial for the
formation of many secondary lymphoid tissues. The formation of ILNs was not
induced by the reconstitution of LTa"A mice or LTp_/" mice with wild-type (WT) bone
marrow (termed WT->LTa"A mice and WT->LTp_/" mice respectively; data not
shown). However, this treatment induced the terminal differentiation of FDCs and
organisation of the microarchitecture in the remaining lymph nodes and spleen of
WT->LTa"A mice and WT->LTp_/" mice (Fig 4.2). ILNs were also absent from mice
which had been treated in ntero with LTPR-Ig (data not shown). As discussed in
section 4.4, these mice have FDCs in the remaining lymphoid tissues as the effect of
the treatment on LT011P2 signalling is temporary and is restored following catabolism
of LTPR-Ig permitting subsequent FDC maturation.
5.3.2 Effect of 1LN deficiency on scrapie pathogenesis after inoculation via
scarification
WT mice, LTa_/" mice and LTp_/" mice were y-irradiated and reconstituted with WT
bone marrow (termed WT->WT mice, WT->LTa_/" mice and WT->LTpv" mice
respectively). 35 days later mice were inoculated with the scrapie agent via
scarification of the skin of the right thigh. All WT->WT mice developed disease
with a mean incubation period of 322 ± 9 days (Table 5.1). In contrast, only one out




Figure 5.1- Presence of inguinal lymph nodes (ILNs) in wild-type (WT) mice
and absence of ILNs in lymphotoxin -a deficient (LTa"") mice and
lymphotoxin ~p deficient (LTp_/~) mice. ILNs are clearly visible situated in the
subcutaneous fat close to the bifurcation of the superficial epigastric vein of WT
mice (upper row). ILNs are absent from the same anatomical location in LTa-/"
mice and LTp7" mice (middle & lower row).
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Presenceatinocula ionT.,, —prfTfIncidenceMeanincubationperiodSPLILNs^
WT->WT+9/9322± WT^LTa"7"+-1/7343,6<503 WT->LTP_/"+-2/8342±11,1<503a C57BL/Dk(control)+5/5322±10
ILNdeficientC57BL/Dk+-3/528±15,2<480
Table5.1-EffectofILNdeficiencynscrapiesusceptibilitft rinoculationviscarifi atiofthkhigh.
1.Incidence=numberofani alsff cted/ri alstest d. a.Fivemicewerkill d403,67n90daysfterinocu a ion.Thesicwerfre ft lini als gncr pieti ofcullandnohistop thologicalsignscrap eweredetecteithbr i(d athow ). SPL=spleen;ILNsinguinallymphnod s;WT->WT,T->LTa"~anT->LTp~'~ rwild-typc ,lymphotoxinadeficientc andlymphotoxin-|3deficientm ceresp ctively,reconstitut dw hild- ypebo earr w. +=presence,-absence
at 503 days post inoculation (dpi). Similarly 2 of seven WT->LTP"A mice developed
clinical signs of scrapie, and 5 mice culled between 403 and 490 dpi for ethical
reasons were clinically negative. One WT->LTP"/_ mouse remained free of the
clinical and pathological signs of scrapie at the end of the experiment (503 dpi). As
discussed in section 1.1.4, two terms are used in this thesis to describe disease
specific PrP. Where proteinase K resistance of disease specific PrP is confirmed the
term PrPSc is used. Otherwise, disease specific PrP is referred to as PrPd.
Histopathological analysis revealed characteristic spongiform pathology, PrPd
accumulation and reactive astrocytes in the brains of all WT->WT mice, WT->LTa_/"
mice and WT->LTP"A mice which were scored as having the clinical signs of disease
as described in section 2.3.6 (clinically positive; Fig 5.2). The severity and
distribution of the pathological targeting of the vacuolation in the brains ofWT->WT
mice was typical of an infection with the ME7 scrapie agent. No significant
differences were observed in the severity and distribution of the pathological
targeting of vacuolation in the brains of clinically positive WT->LTav" mice or WT-
>LTp_/" mice (Fig 5.3). In contrast, no evidence of spongiform pathology, PrPd
accumulation or reactive astrocytes was detected in the brains of surviving WT-
>LTav"mice or clinically negative WT->LTpv" mice (Fig 5.2).
Mice treated in ntero with LTpR-Ig (ILN-deficient C57BL/Dk mice) and untreated
C57BL/Dk mice (immunocompetent controls) were inoculated with the ME7 scrapie
agent via scarification at 8-12 weeks of age. All C57BL/Dk (control) mice
succumbed to disease with an average incubation period of 322 ± 10 days (n = 5;
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Figure 5.3- Pathological targeting of vacuolation in the brains of mice
terminally affected by ME7 scrapie or survivor mice, a) wildtype mice,
lymphotoxin -a deficient mice and lymphotoxin deficient mice were
reconstituted with wildtype bone marrow (WT->WT mice, WT->LTav" mice and
LTf3~/_ mice respectively) and inoculated 35 days later with ME7 scrapie via
scarification of the skin, b) Inguinal lymph node (ILN)-deficient C57BL/Dk mice
and C57BL/Dk (control) mice were inoculated with ME7 scrapie via scarification of
the skin. Vacuolation in the brain was scored on a scale of 0-5 in the following grey
matter (G1-G9) or white matter (W1-W3) areas: Gl, dorsal medulla; G2, cerebellar
cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6, hippocampus;
G7, septum; G8, retrosplenial and adjacent motor cortex; G9, cingulate and adjacent
motor cortex; Wl, inferior and middle cerebellar peduncles; W2, decussation of the
superior peduncles; W3, cerebral peduncles. Each point represents mean
vacuolation score ± S.E.M. for groups of 6-9 mice.
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disease in a similar time frame (mean incubation period 328 ±15 days, n = 3). Two
ILN-deficient C57BL/Dk mice remained free of the signs of scrapie until at least 480
dpi (Table 5.1). Histopathological analysis of the brain revealed characteristic
spongiform pathology, PrPd accumulation and reactive astrocytes in the brains of all
C57BL/Dk mice and ILN-deficient C57BL/Dk mice which were scored clinically
positive (Fig 5.4). The severity and distribution of the pathological targeting of the
vacuolation in the brains C57BL/Dk control mice was typical of an infection with the
ME7 scrapie agent. No significant differences were observed in the severity and
distribution of the pathological targeting of vacuolation in the brains of clinically
positive ILN-deficient C57BL/Dk mice (Fig 5.3). In contrast, no evidence of
spongiform pathology, PrPd accumulation or reactive astrocytes was detected in the
brains of the surviving ILN-deficient C57BL/Dk mice (Fig 5.4).
5.3.3 Effect of ILN deficiency on the early accumulation of PrPSc
Within 70 days of inoculation via scarification, the proteinase K (PK) resistant,
disease specific isomer of PrP (PrPSc) was detected in ILNs and in a few spleens of
WT->WT and C57BL/Dk (control) mice at this time point (Figs 5.5 & 5.6). Tissue
from the area where the ILN should have formed in WT->LTa"/_ mice, WT->LTP"A
mice and ILN-deficient C57BL/Dk mice was analysed and no PrPSc was detected
(Figs 5.5 & 5.6). PrPSc was also absent from the spleens of WT->LTa"A mice, WT-
>LTP_/" mice and ILN-deficient C57BL/Dk mice at this time point (Figs 5.5 & 5.6).
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C57BL/Dk (control) ILN-deficient C57BL/Dk ILN-deficient C57BL/Dk
Figure 5.4- Histological analysis of brain tissue from terminally scrapie affected
mice or survivor mice. Large PrPd accumulations were detected in the hippocampi
of all mice which developed clinical signs of scrapie (brown; upper row).
Immunostaining of adjacent sections for glial fibrillary acidic protein (GFAP; red;
middle row) showed diffuse gliosis in the hippocampi of all terminally scrapie
affected mice. Adjacent sections were also stained with haematoxylin and eosin (H
& E; lower row) and extensive vacuolation was displayed in all mice terminally
affected by scrapie. None of these pathological signs of scrapie disease were
detected in the brains of clinically negative mice at the end of the experiment. All
sections were counterstained with haematoxylin (blue). Original magnification
X200. Clin, clinical score, either positive (+) or negative (-); Path, pathological
score, either positive (+) or negative (-); dpi, days post-inoculation on which tissues





















Figure 5.5- PrPSc accumulation in lymphoid tissues of wild-type (WT) bone
marrow reconstituted WT mice, lymphotoxin -a deficient mice and
lymphotoxin ~p deficient mice (WT->WT mice, WT->LTa ~mice and WT-
>LTP"/_ mice respectively) 70 days after inoculation with ME7 scrapie via
scarification of the skin, (a) Inguinal lymph nodes (ILNs; or tissue where ILNs
should have been in WT->LTa_/" mice and WT->LTpA mice) and (b) spleens.
Proteinase K (PK) resistant disease specific prion protein (PrPSc) was detected in
ILNs and some spleens from WT->WT mice. No PrPSc was detected in tissues
where ILNs should have been or spleens from either WT->LTa_/" mice or
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Figure 5.6- PrPSc accumulation in lymphoid tissues in ILN-deficient
C57BL/Dk and C57BL/Dk (control) mice 70 days after inoculation via
scarification of the skin, (a) Inguinal lymph nodes (ILNs; or tissue where ILNs
should have been in ILN-deficient C57BL/Dk mice) and (b) spleens. Proteinase K
resistant, disease specific prion protein (PrPSc) was detected in some ILNs from
control mice. No PrPSt" was detected in tissues where ILNs should have been in
ILN-deficient C57BL/Dk mice or spleens from either control or ILN-deficient
C57BL/Dk mice. Samples were treated in the presence (+) or absence (-) of PK
prior to electrophoresis.
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5.3.4 Effect of ILN deficiency on the late accumulation of PrPSc
At the terminal stage of disease high levels of PrPSc are found in the ILNs and
spleens of immunocompetent mice (Mohan et al., 2004). Consistent with this, PrPSc
was detected in ILNs and spleens of all WT->WT and C57BL/Dk (control) mice at
the end stage of disease (Figs 5.7 & 5.8). Tissue from the area where the ILN should
have formed in WT->LTa"/_ mice, WT->LTpv" mice and ILN-deficient C57BL/Dk
mice was analysed and no PrPSc was detected in either clinically positive or clinically
negative cases (Figs 5.7 & 5.8). Spleens from all clinically positive WT->LTa~A
mice, WT-^LTP"7" mice and ILN-deficient C57BL/Dk mice were found to contain
high levels of PrPSc (Figs 5.7 & 5.8) In contrast, no PrPSc was detected in the spleens
of survivor WT->LTa /_ mice, WT^LTP"7" mice or ILN-deficient C57BL/Dk mice
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Figure 5.7- PrPSc accumulation in lymphoid tissues of wild-type (WT) bone
marrow reconstituted WT mice, lymphotoxin -a deficient mice and
lymphotoxin -p deficient mice (WT->WT mice, WT->LTa_/" mice and WT-
>LTp_/" mice, respectively), (a) Inguinal lymph nodes IILNs; or tissue where ILNs
should have been in WT->LTa_/" mice and WT->LTP" mice) and (b) spleens of
clinically affected WT->WT mice, WT->LTa_/" mice or WT->LTP~" mice, or
survivor WT->LTa"A mice and WT->LTpv~ mice after inoculation with ME7 scrapie
via scarification of the skin. Proteinase K (PK) resistant disease specific prion
protein (PrPSc) was detected in the ILNs and the spleens ofWT->WT mice and the
spleens of terminally scrapie affected WT->LTa_/" and WT->LTP"/_ mice. No PrPSc
was detected in tissues where ILNs should have been in WT->LTa"/_and WT->LTP"A
or spleens from survivor WT->LTa"/_ mice or WT->LTpv" mice or from mice which
were not inoculated with the scrapie agent. Samples were treated in the presence (+)
or absence (-) of PK prior to electrophoresis. Clin, clinical score, either positive (+)
or negative (-); dpi, days post inoculation on which the tissues were taken for
analysis.
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Figure 5.8- PrPSc accumulation in lymphoid tissues, (a) Inguinal lymph nodes
(ILNs; or tissue where ILNs should have been in ILN-deficient C57BL/Dk mice) and
(b) spleens of clinically affected C57BL/Dk (control) mice and ILN-deficient
C57BL/Dk mice after inoculation with ME7 scrapie via scarification of the skin.
Proteinase K (PK) resistant, disease specific prion protein (PrPSc) was detected in the
ILNs and spleens of clinically affected control mice and in the spleens of clinically
affected ILN-deficient mice. No PrPSc was detected in the tissue where the ILN
should have been in the ILN deficient mice or in the spleens of clinically negative
ILN deficient mice. Samples were treated in the presence (+) or absence (-) of PK
prior to electrophoresis. Clin, clinical score, either positive (+) or negative (-); dpi,
days post inoculation on which the tissues were taken for analysis.
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5.4 Discussion
Mice lacking ILNs were inoculated with ME7 scrapie via scarification of the skin of
the thigh to investigate the role of the draining lymph nodes in scrapie pathogenesis.
LTa"7" mice and LTP"7" mice were reconstituted with WT bone marrow to create mice
which lacked ILNs but possessed FDCs in remaining lymphoid tissues. ILN-
deficient mice were also created by in utero treatment with LTpR-Ig. All groups of
ILN deficient mice displayed decreased susceptibility to scrapie after inoculation
with the ME7 scrapie agent via scarification.
As discussed in section 3.4, the development of most secondary lymphoid tissue is
critically dependent upon LTa^ signalling through LTpR during gestation. As a
consequence, ILNs do not form in mice where this signalling has been interrupted
during gestation, either by genetic deficiency of LTa (Banks et al., 1995; Togni et
al., 1994) or LTP (Koni et al., 1997), or due to pharmacological LTpR-Ig blockade
(Rennert et al., 1996). As discussed in section 4.4 the remaining lymphoid tissues of
LTa"7" mice and LTP"7" mice lack FDCs and display disorganised microarchitecture,
y-irradiation and reconstitution of these mice with WT bone marrow induces the
development of FDC networks and organisation of lymphoid tissue microarchitecture
without inducing the formation of the missing lymphoid tissues (section 4.4). FDCs
are present and lymphoid tissue microarchitecture is normal in mice treated in utero
with LTPR-Ig, as in this case the blockade of LTaiP2 signalling is temporary and is
restored by the time FDCs begin to form (Rennert et al., 1996).
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Previous work has shown that a functional immune system is of paramount
importance for the development of scrapie disease after inoculation via scarification
as SCID mice do not develop disease when inoculated in this way (Taylor et al.,
1996b). The important role of FDCs in this process has been shown by the de-
differentiation of FDCs (by treatment of adult mice with LT(3R-Ig) prior to
inoculation which decreased the incidence and increased the incubation period of
disease (Mohan et al., 2005a). The results of these two studies also demonstrate an
important role for another immune system component, independent of FDCs, as
some cases of scrapie disease were able to occur in the absence of FDCs (Mohan et
al., 2005a) whereas none were able to occur in the absence of a functioning immune
system (Taylor et al., 1996b).
Treatment of adult mice with LT(3R-Ig as described above (Mohan et al., 2005a) de¬
differentiates FDCs in all lymphoid tissues. Here, by using mice that lack the
draining ILNs, the effects of a lack of FDCs local to the site of inoculation could be
determined. In these mice a decrease in the incidence of disease was observed
demonstrating the importance of the draining lymphoid tissues for the development
of disease. However, some mice did succumb to disease, most likely following
neuroinvasion from other lymphoid tissues as the remaining lymphoid tissues of
these mice contained FDCs. The time of onset of disease in mice lacking ILNs did
not differ significantly from control mice demonstrating that, in a few cases, non
draining lymphoid tissue can support neuroinvasion as effectively as the draining
ILNs.
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The function of the draining ILN in scrapie pathogenesis after inoculation via
scarification may be to support neuroinvasion after accumulation of the agent on
local FDCs. In the absence of the draining ILN the scrapie agent may, in a few
cases, be able travel to other lymphoid tissues from which neuroinvasion can occur.
It could be that in some cases in the absence of the draining ILN, the scrapie agent
enters the draining lymph and becomes so disseminated that the agent is cleared,
perhaps by macrophages (Carp & Callaghan, 1982) or dendritic cells (Mohan et al.,
2005c). However, in a few cases a small amount of the agent reaches other lymphoid
tissues from which neuroinvasion can occur. Alternatively, it could be that
neuroinvasion does not occur directly from the draining ILNs and instead the
draining ILN propagates the scrapie agent sufficiently to ensure the spread to other
lymphoid tissues prior to neuroinvasion. Thus in the absence of this initial
amplification stage, the level of the scrapie agent reaching more distant lymphoid
tissues is variable and sufficient only for the establishment of disease in some cases.
There is also the possibility that, particularly in the case of the one clinically positive
WT->LTofA mouse, that there could have been direct inoculation of a small amount
of infectivity into bloodstream or into a nerve at the site of inoculation thus by¬
passing the need for any replication of the scrapie agent in the draining lymphoid
tissues.
The lymphoid tissues remaining in WT->LTa_/" mice consist of spleen and nasal
associated lymphoid tissue (NALT; Banks et al., 1995; Fukuyama et al., 2002; Togni
et al., 1994). WT->LTp-/" mice, as well as containing spleen and NALT, also have
mesenteric lymph nodes (MLNs) and cervical lymph nodes (CLNs; Fukuyama et al.,
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2002; Koni et al., 1997). The remaining lymphoid tissues in mice treated in utero
with LTpR-Ig on day 11.5 of gestation consist of spleen, NALT, MLNs, CLNs and
also lumbar and sacral lymph nodes (Rennert et al., 1997; Rennert et al., 1996). It is
possible that some of these remaining lymphoid tissues may drain the skin but it is
unlikely that they would drain the skin of the thigh due to their anatomical location.
However, these lymphoid tissues may accumulate the scrapie agent once the draining
lymph has passed through the thoracic duct into the bloodstream. Data presented
here showed that WT->LTav" mice have a slightly lower incidence of scrapie
compared to WT->LTp_/" mice, and WT->LTP"A mice had a lower incidence
compared to in utero LTpR-Ig treated mice. Thus in mice with more remaining
lymphoid tissues there was a higher incidence of scrapie after inoculation via
scarification. This could be because there would be a higher chance that the scrapie
agent would reach the remaining lymphoid tissues in mice where more are present.
Data presented here showed that lymphoid tissue local to the site of inoculation was
important for the successful development of clinical disease after inoculation with
ME7 scrapie via scarification of the skin of the thigh. Neuroinvasion was able to
occur from more distant lymphoid tissue in some cases, demonstrating that other
lymphoid tissues were able to compensate for the absence of the local lymphoid
tissues, but this route is extremely inefficient.
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Role of the draining lymph nodes in scrapie pathogenesis after
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Inoculation via intra-peritoneal (i.p.) injection is a commonly used route for the
investigation of the peripheral pathogenesis of TSEs. The peritoneal cavity is
thought to be drained by the cranial mediastinal lymph nodes (CMLNs). Mice
lacking the CMLNs were inoculated with the ME7 strain of the scrapie agent via i.p.
injection to determine the importance of draining lymphoid tissues in scrapie
pathogenesis. Lymphotoxin (LT)-a"A mice and LTP"/_ mice lack the CMLNs and lack
follicular dendritic cells (FDCs) in the remaining lymphoid tissues. These mice and
wild-type (WT) control mice were inoculated with the ME7 strain of the scrapie
agent via i.p. injection to determine the importance of both lymphoid tissues and
FDCs on scrapie pathogenesis. LTav" mice and LTP_/" mice exhibited reduced
susceptibility and delayed onset of disease compared to WT mice. These data are
consistent with previous studies demonstrating that neuroinvasion after i.p.
inoculation is less efficient in the absence of both the local lymph nodes and FDCs in
remaining lymphoid tissues. Next, LTof/_ mice and LTp_/" mice were reconstituted
with WT bone marrow (termed WT->LTa"A mice and WT->LTp_/" mice respectively)
to restore FDCs to the remaining lymphoid tissues without inducing the formation of
the missing lymphoid tissues. WT->LTa"A mice displayed reduced susceptibility and
delayed onset of disease, whereas WT->LTp_/" mice were as susceptible and
developed disease in the same time frame as WT->WT control mice. These data
demonstrate that the CMLNs are not important in scrapie pathogenesis and raised the
possibility that another lymphoid tissue present in WT->LTP"" mice, but absent from
WT->LTa""mice, was playing an important role in scrapie pathogenesis. These data
also demonstrate the importance of restoring the differentiation of FDCs in studies
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using LTav" mice, as both LTa/_ mice and WT->LTa_/" mice displayed decreased
susceptibility to i.p. inoculated scrapie agent.
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6.2 Introduction
Although the pathology caused by TSEs occurs predominantly within the central
nervous system (CNS), considerable effort has been put into determining the
peripheral course of the disease. As neurodegeneration is not at present
pharmacologically reversible, intervention targets in the periphery prior to the onset
of neurodegeneration are desirable. Much of the work on the peripheral pathogenesis
of TSEs has involved the experimental inoculation of rodents via the intra-peritoneal
(i.p.) route. Although the i.p. route does not directly model the routes postulated for
the establishment of natural TSE disease, the ease of the inoculation procedure and
certainty with which all animals can be assumed to have been dosed equally make
this route attractive. The draining lymphoid tissue after i.p. inoculation is commonly
perceived to be the spleen. However, studies have shown that the diaphragm initially
drains the peritoneum (Shinohara, 1997), lymph from the peritoneum then drains
towards the lymph nodes within the thoracic cavity. There is some confusion about
the nomenclature of the lymph nodes draining the peritoneal cavity. These have
been referred to as parathymic lymph nodes (Hill, 1976) and also mediastinal lymph
nodes (Marco et al., 1992). A recent paper has addressed the issue of lymph node
nomenclature and has termed both of these as cranial mediastinal lymph nodes
(CMLNs; Broeck et al., 2006). In this thesis the lymph nodes will therefore be
described as CMLNs. From the CMLNs lymph enters the bloodstream via the
thoracic duct and disseminates systemically, thus reaching other lymphoid tissues






















Figure 6.1- Proposed model of lymphatic drainage of the peritoneal cavity.
1. Injection of antigens or particles into the upper flank. 2. Peritoneal fluid drains
towards the diaphragm. 3. From the diaphragm lymph travels in lymph vessels
towards the cranial mediastinal lymph nodes. 4. Efferent lymphatics from these
lymph nodes connect directly with the thoracic duct. 5. Lymph is returned to the
blood via the thoracic duct. 6. Antigens or particles from the peritoneal cavity are
then widely distributed via the blood-stream and may be sequestered in other
lymphoid tissues including the spleen (7).
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The involvement of lymphoid tissues in TSE pathogenesis via i.p. inoculation was
initially demonstrated by the extended incubation period observed in mice which had
been splenectomised prior to or slightly after inoculation (Fraser & Dickinson, 1978).
Follicular dendritic cells (FDCs) within lymphoid tissues have since been shown to
be involved in the pathogenesis of TSEs after i.p. inoculation. Mice lacking FDCs
either through genetic deficiency of tumour necrosis factor (TNF)-a (Mabbott et al.,
2000b; Prinz et al., 2002), lymphotoxin (LT)-a (Oldstone et al., 2002; Prinz et al.,
2002) or LTp (Manuelidis et al., 2000; Oldstone et al., 2002; Prinz et al., 2002), or
temporary depletion of FDCs at the time of inoculation by treatment with LTpR-Ig
(Mabbott et al., 2000a; Mabbott et al., 2003; Montrasio et al., 2000) or TNFR-Ig
(Mabbott et al., 2002) show decreased susceptibility to disease. How the TSE agent
is transported from the site of inoculation to the lymphoid tissues is unclear. This
may involve uptake by dendritic cells (Huang et al., 2002; Kaneider et al., 2003) or
macrophages (Beringue et al., 2000; Carp & Callaghan, 1982; Jeffrey et al., 2000) or
may involve a cell free pathway.
Although it is clear from the work described above that lymphoid tissues are
involved in TSE pathogenesis, from which lymphoid tissues neuroinvasion occurs
after i.p. inoculation with the scrapie agent is uncertain. Mice lacking particular sets
of lymphoid tissues were used in this chapter to determine the importance of
lymphoid tissue draining the peritoneal cavity in disease pathogenesis after
inoculation with the scrapie agent via i.p. injection.
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6.3 Results
6.3.1 LTa"7" mice and LTB"7" mice lack CMLNs
Wild-type (WT) mice, LTa"7" mice, and LTP"7" mice were inoculated intra¬
peritoneal^ with Indian ink to visualise the lymph nodes draining the peritoneal
cavity. CMLNs stained blue-black with Indian ink were clearly visible around the
thymus in WT mice and clearly absent from both LTa"7" mice and LTP"7" mice (Fig
6.2).
6.3.2 Effect of LT deficiency on scrapie pathogenesis following intra-cranial
inoculation
LTa"7" mice, LTP"7" mice and WT mice were inoculated with either a 1.0 % or 0.01 %
dilution of ME7 scrapie brain homogenate via intra-cranial injection. No significant
differences were observed in the mean incubation periods of disease in WT mice,
LTa"7" mice or LTP"7" mice when inoculated intra-cranially with 1.0 % scrapie brain
homogenate. All mice developed clinical disease between 154 and 182 days after
inoculation (Table 6.1). Similarly, no significant differences in the incubation
periods of disease were observed between WT mice, LTa"7" mice and LTP"7" mice
after intra-cranial inoculation with 0.01 % dilution of scrapie brain homogenate. All
mice developed clinical disease between 192 and 281 days after inoculation (Table
6.1). This demonstrates that, following inoculation with either moderate (1.0 %) or
limiting doses (0.01 %) of the scrapie agent, genetic deficiency of either LTa or LTP
had no effect on the pathogenesis of ME7 scrapie directly within the CNS.
Therefore, any effects observed in LTa"7" mice or LTP"7" mice after peripheral
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Figure 6.2- Effect of lymphotoxin deficiency on the development of cranial
mediastinal lymph nodes (CMLNs). Mice were inoculated intra-peritoneally with
Indian ink (blue-black staining). The thoracic cavity was examined 4 hours later.
CMLNs were present in wild-type (WT) mice (upper row) and absent from
lymphotoxin -0 deficient (LTP"/_) mice (lower left) and lymphotoxin -a deficient
(LTa"/_) mice (lower right).
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1.0 % dilution brain homogenate 0.01 % dilution brain homogenate
T .. i Mean incubation T • j l Mean incubationIncidence . . ,, . , „ „ , , Incidence . , , = . , „ „ . .period (days) ± S.E.M. period (days) ± S.E.M.
WT 6/6 171 ±4 6/6 212 ±4
LTa"7" 5/5 175 ±4 6/6 216 ±13
LTp_/" 5/5 175 ± 1 6/6 204 ±4
Table 6.1- Effect of lymphotoxin deficiency on scrapie susceptibility after intra¬
cranial inoculation
1. Incidence = number of animals affected/ number of animals tested.
WT = wild-type mice; LTa"A = lymphotoxin -a deficient mice; LTp_/" = lymphotoxin
~P deficient mice.
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inoculation could be attributed to an altered efficiency of translocation of the scrapie
agent to the CNS.
6.3.3 Effect of LT deficiency on scrapie pathogenesis after i.p. inoculation
Next, WT mice, LTa"A mice and LTP"/_ mice were inoculated with either a 1.0 % or
0.01 % dilution of ME7 scrapie brain homogenate via i.p. injection. At the lower
dose (0.01 %), 10 out of 11 WT mice developed scrapie disease with a mean
incubation period of 339 ± 4 days. In contrast, disease susceptibility of LT-deficient
mice was dramatically reduced as none of the LTa_/" mice and only one of 8 LTP"7"
mice developed clinical scrapie by the time the experiment was terminated at 545
days post inoculation (dpi; Table 6.2). At the higher dose all the WT mice developed
disease with a mean incubation period of 288 ± 6 days (Table 6.2). In contrast, 11 out
of 15 LTav~mice and 15 of 16 LTP"7" mice developed scrapie disease by the time the
experiment was terminated at 545 dpi. Disease incubation periods were longer and
much more variable in the LT-deficient mice (217 to 482 days for LTa" mice; and
226 to 502 days for LTP"/_ mice; Table 6.2). As discussed in section 1.1.4, two terms
are used in this thesis to describe disease specific PrP. Where proteinase K
resistance of disease specific PrP is confirmed the term PrPSc is used. Otherwise,
disease specific PrP is referred to as PrPd. Histopathological analysis of the brain
revealed characteristic spongiform pathology, PrPd accumulation and reactive
astrocytes in the brains of all WT mice, LTa"" mice and LT[37" mice which were
scored as having the clinical signs of disease as described in section 2.3.6 (clinically
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dpi 343 545 490 545
Figure 6.4- Histological analysis of brain tissue from terminally scrapie affected
wild-type (WT) mice or lymphotoxin -p deficient (LTp /_) mice; or survivor
lymphotoxin -a deficient (LTa~/_) mice or LTp-/~ mice inoculated intra-
peritoneally with 1.0 % dilution of ME7 scrapie brain homogenate. Large
disease specific prion protein (PrPd) accumulations were detected in the hippocampi
of all mice which developed clinical signs of scrapie (brown; upper row).
Immunostaining of adjacent sections for glial fibrillary acidic protein (GFAP; red;
middle row) showed diffuse gliosis in the hippocampi of all terminally scrapie
affected mice. Adjacent sections were also stained with haematoxylin and eosin (H
& E; lower row) and extensive vacuolation was displayed in all mice terminally
affected by scrapie. None of these pathological signs of scrapie disease were
detected in the brains of clinically negative mice at the end of the experiment. All
sections were counterstained with haematoxylin (blue). Original magnification
X200. Clin, clinical score, either positive (+) or negative (-), Path, pathological score,
either positive (+) or negative (-); dpi, days post-inoculation on which tissues were
taken for analysis.
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of the vacuolation in the brains of WT mice was typical of ME7 scrapie. No
significant differences were observed in the severity and distribution of the
pathological targeting of vacuolation in the brains of clinically positive FTa"7" mice or
FTP"7" mice (Fig 6.5). In contrast, no evidence of spongiform pathology, PrPd
accumulation or reactive astrocytes was detected in the brains of surviving FTa"7"
mice or FTP"7" mice (Figs 6.3 & 6.4).
6.3.4 Effect of LT deficiency on the early and late accumulation of PrPSc in the
spleen
Within 70 days of i.p. inoculation of WT mice with the ME7 scrapie agent high
levels of the proteinase K (PK) resistant, disease specific isomer of PrP (PrPSc) are
detected in spleen (Fig 6.6). In contrast, no PrPSc was detected in spleens from FTa"7"
mice or FTP"7" mice at this time point. At the terminal stage of disease high levels of
PrPSc were detected in spleens from WT mice, but no PrPSc was detected in spleens
from either clinically positive or survivor FTa"7" mice and FTP"7" mice (Fig 6.7).
Similar results were described in experiments involving TNFa"7" mice, which, like
LTa"7" mice and FTP"7" mice, lack FDCs (Mabbott et al., 2000b). This suggests that
when FDCs are absent the ME7 scrapie agent is unable to accumulate in the spleen.
6.3.5 Effect ofCMLN deficiency on scrapie pathogenesis via i.p. inoculation
WT mice, FTa"7" mice and FTP"7" mice were y-irradiated and reconstituted with WT
bone marrow to restore FDCs to the remaining lymphoid tissues (termed WT->WT
mice, WT->FTa"7" mice and WT->FTp"7" mice, respectively). 35 days after bone
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Figure 6.5- Pathological targeting of vacuolation in the brains of mice terminally affected
by ME7 scrapie or survivor mice. Mice were inoculated intra-peritoneally with a) 0.1 %
dilution of ME7 scrapie brain homogenate, b) 0.001 % dilution of ME7 scrapie brain
homogenate or c) 0.1 % dilution of ME7 scrapie brain homogenate. Vacuolation in the brain
was scored on a scale of 0-5 in the following grey matter (G1-G9) or white matter (W1-W3)
areas: Gl, dorsal medulla; G2, cerebellar cortex; G3, superior colliculus; G4, hypothalamus;
G5, thalamus; G6, hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex; G9,
cingulate and adjacent motor cortex; Wl, inferior and middle cerebellar peduncles; W2,
decussation of the superior peduncles; W3, cerebral peduncles. Each point represents mean
vacuolation score ± S.E.M. for groups of 6-9 mice. WT, wild-type mice; LTa~/~, lymphotoxin -
a deficient mice; LTP_/", lymphotoxin -P deficient mice. WT->WT, WT->LTa_/" and WT->LTP"
are WT mice, LTav" mice and LTP~/_ mice respectively reconstituted with WT bone marrow.
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Figure 6.6- PrPSc accumulation in spleens of wild-type (WT) mice, lymphotoxin
-a deficient (LTa~A) mice and lymphotoxin -p deficient (LTP"A )mice 70 days
after intra-peritoneal inoculation with ME7 scrapie. Proteinase K (PK) resistant,
disease specific prion protein (PrPSc) was detected in some spleens from WT mice.
No PrPSc was detected in spleens from either LTa*A mice or LTP_/" mice. Samples
were treated in the presence (+) or absence (-) of PK prior to electrophoresis.
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Figure 6.7- PrPSc accumulation in spleens. Spleens were collected from clinically
affected wild-type (WT) mice, lymphotoxin -a deficient (LTa"7") mice and
lymphotoxin -(3 deficient (LTP"7") mice, and survivor LTa"7" mice and LTP"7" mice
after intra-peritoneal inoculation with a) 0.01 % dilution of ME7 scrapie brain
homogenate or b) 1.0 % dilution of ME7 scrapie brain homogenate. Proteinase K
(PK) resistant, disease specific prion protein (PrPSc) was detected in spleens from
clinically affected WT mice, LTa"7" mice and LTP"7" mice. No PrPSt was detected in
spleens from survivor LTa"7" mice or LTP"7" mice or from mice which had not been
inoculated with scrapie (U). Samples were treated in the presence (+) or absence (-)
ofPK prior to electrophoresis. Clin, clinical score either positive (+) or negative (-);
dpi, days post inoculation on which tissues were taken for analysis
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 1718 19 20 21 22 23 24 25
tote* Ml*'*
- + - + - + - + - + - + - + - + - + - + - + - + +
+ ++ - -
WT LTa LTp
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 1718 19 20
MUM"!'!!
- + - + -+ .+ - + -+ - + -+-+- +
+ + + + +- + + + -
262 265 265 287 261 545 274 322 363 545
193
brain homogenate via i.p. injection. WT->WT mice developed disease with a mean
incubation period of 286 ± 4 days (Table 6.3) which was not significantly different
from WT mice (p < 0.863). Following the restoration of FDCs in remaining
lymphoid tissues of WT->LTp_/" mice, all mice developed scrapie disease with a
mean incubation period of 290 ± 11 days (Table 6.3) similar to that of WT->WT
mice (p < 0.957). In contrast, eight out of 9 WT->LTa_/" mice developed scrapie
disease with one animal surviving to the time the experiment was terminated at 545
dpi. The mean incubation period for WT->LTa_/" mice was 337 ± 6, which is
significantly longer than the WT->WT mice and WT->LTP_/" mice (p < 0.011).
Histopathological analysis of the brain revealed characteristic spongiform pathology,
PrPd accumulation and reactive astrocytes in the brains of all WT->WT mice, WT-
>LTa"~ mice and WT->LTp_/" mice which were scored clinically positive (Fig 6.8).
The severity and distribution of the pathological targeting of the vacuolation in the
brains of WT->WT mice was typical ofME7 scrapie. No significant differences were
observed in the severity and distribution of the pathological targeting of vacuolation
in the brains of clinically positive WT->LTav" mice or WT->LTP"/" mice (Fig 6.5).
In contrast, no evidence of spongiform pathology, PrPd accumulation or reactive
astrocytes was detected in the brain of the surviving WT->LTa"A mouse (Fig 6.8).
6.3.6 Effect of CMLN deficiency on the early and late accumulation of PrPSc in
the spleen
Within 70 days of inoculation with the ME7 scrapie agent, high levels of PrPSc were
detected in the spleens ofWT->WT mice (Fig 6.9). PrPSc was detected only in some
spleens from WT->LTa"/_ mice and in none of the WT->LTP_/" mice at this time
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point. At the terminal stage of disease high levels of PrPSc were detected in spleens
from all clinically positive WT->WT mice, WT->LTa_/" mice and WT->LTpv" mice
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Figure 6.8- Histological analysis of brain tissue from terminally scrapie affected
mice or survivor mice inoculated intra-peritoneally with 1.0 % dilution of ME7
scrapie brain homogenate. Large disease specific prion protein (PrPd)
accumulations were detected in the hippocampi of all mice which developed clinical
signs of scrapie (brown; upper row). Immunostaining of adjacent sections for glial
fibrillary acidic protein (GFAP; red; middle row) showed diffuse gliosis in the
hippocampi of all terminally scrapie affected mice. Adjacent sections were also
stained with haematoxylin and eosin (H & E; lower row) and extensive vacuolation
was displayed in all mice terminally affected by scrapie. None of these pathological
signs of scrapie disease were detected in the brains of clinically negative mice at the
end of the experiment. All sections were counterstained with haematoxylin (blue).
Original magnification X200. Clin, clinical score, either positive (+) or negative (-);
Path, pathological score, either positive (+) or negative (-); dpi, days post-inoculation
on which tissues were taken for analysis. WT->WT , WT->LTa_/" and WT->LTp_/"
are wild-type mice, lymphotoxin -a deficient mice and lymphotoxin —P deficient




Figure 6.9- PrPSc accumulation in spleens of WT->WT mice, WT->LTa_/" mice
or WT->LTp_/" mice 70 days after intra-peritoneal inoculation with ME7
scrapie. Proteinase K (PK) resistant, disease specific prion protein (PrPSc) was
detected in spleens from WT->WT mice and some WT->LTa_/" mice. No PrPSc was
detected in spleens from WT->LTP_/~ mice. Samples were treated in the presence (+)
or absence (-) of PK prior to electrophoresis. WT->WT, WT->LTav" and
WT->LTP"a are wild-type mice, lymphotoxin -a deficient mice and lymphotoxin -P
deficient mice respectively, reconstituted with wild-type bone marrow.
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Figure 6.10- PrPSc accumulation in spleens of clinically affected WT->WT mice,
WT-^LTa"'" mice and WT->LTP_/" mice or the survivingWT^LTa"'" mouse after
intra-peritoneal inoculation with ME7 scrapie. Proteinase K (PK) resistant,
disease specific prion protein (PrPSc) was detected in spleens of clinically affected
WT->WT mice, WT->LTa"A mice and WT->LTP"A mice. PrPSc was also detected in
the spleen of the surviving WT->LTav" mouse. Samples were treated in the presence
(+) or absence (-) of PK prior to electrophoresis. Clin, clinical score, either positive
(+) or negative (-); dpi, days post inoculation on which the tissues were taken for
analysis. WT->WT, WT->LTa_/~ and WT->LTP_/~ are wild-type, lymphotoxin -a




Inoculation via i.p. injection is a commonly used route for the investigation of the
peripheral pathogenesis of TSEs. The peritoneal cavity is thought to be drained by
the CMLNs. LTa_/" mice and LTP_/" mice lack the CMLNs and lack FDCs in
remaining lymphoid tissues. These mice and WT control mice were inoculated with
the ME7 strain of the scrapie agent via i.p. injection. LTa_/" mice and LTfT7" mice
exhibited reduced susceptibility and delayed onset of disease compared to WT mice,
demonstrating that neuroinvasion is less efficient in the absence of both the local
lymph nodes and FDCs in remaining lymphoid tissues. LTa7" mice and LTP"/_ mice
were also reconstituted with WT bone marrow to restore FDCs to the remaining
lymphoid tissues and challenged with scrapie to determine the potential involvement
of the lymph nodes draining the peritoneal cavity in scrapie pathogenesis via the i.p.
route. WT^LTa7" mice displayed reduced susceptibility and delayed onset of
disease whereas WT->LTpv" mice were fully susceptible to scrapie and developed
disease in the same time frame as WT->WT control mice. This demonstrated that
the CMLNs were not important in scrapie pathogenesis and raised the possibility that
other lymphoid tissues, present in WT->LTp7 mice but absent from WT->LTaA
mice were playing an important role.
Within 10-15 min of injection of Indian ink into the peritoneal cavity, the lymphatic
capillaries on the peritoneal surface of the diaphragm stain strongly blue-black
(Marco et al., 1992; Shinohara, 1997). The diaphragm is thought to act as a
"lymphatic sieve" whereby fluid and small particles from the peritoneal cavity are
taken up non-specifically by stomata in lymphatic capillaries on the peritoneal
200
surface of the diaphragm. These stomata are peculiar to the peritoneal surface as
Indian ink placed on the peritoneal surface will be quickly taken up, in contrast only
small amounts of Indian ink are taken up slowly when placed on the pleural surface
of the diaphragm (Shinohara, 1997). The lymphatic capillaries of the diaphragm
converge into two lymphatic vessels which enter the thoracic cavity at the level of
the oesophageal hiatus (the opening in the diaphragm through which passes the
oesophagus and the two vagus nerves; Marco et al., 1992). Lymph is thought to flow
from the diaphragm to the thoracic duct via the lymph nodes of the thoracic cavity.
The accumulation of Indian ink or Listeria monocytogenes has been demonstrated at
early time points in the CMLNs prior to detection in the spleen and other lymph
nodes after i.p. injection (Hill, 1976; Marco et al., 1992). This demonstrates that
CMLNs drain the peritoneal cavity and would be the first lymphoid tissues to receive
the scrapie agent after i.p. inoculation.
As discussed in section 3.4 the development of most secondary lymphoid tissue is
critically dependent upon LT011P2 signalling through LTp receptor (LTpR) during
gestation. As a consequence, CMLNs do not form in mice where this signalling has
been interrupted during gestation by genetic deficiency of LTa (Rennert et al., 1997)
or LTp (data presented here). As discussed in section 4.4 the remaining lymphoid
tissues of LTa"A mice and LTp_/" mice lack FDCs and display disorganised
microarchitecture, y-irradiation and WT bone marrow reconstitution of these mice
results in the restoration of FDC networks and organisation of lymphoid tissue
microarchitecture without inducing the formation of the missing lymphoid tissues
(section 4.4).
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Several groups have utilised LTa"7" mice and FTP"7" mice to determine the importance
of FDCs in TSE pathogenesis after i.p. inoculation. The results of these studies have
not been consistent. One study found there to be no difference between LTP"7" mice
and immunocompetent control mice when inoculated with a mouse-passaged strain
of vCJD (Manuelidis et al., 2000). Other studies, however, found LTa"7" mice and
LTp7" mice to have reduced susceptibility or to be resistant to the RML strain of
scrapie agent (Oldstone et al., 2002; Prinz et al., 2002). These differences could be
explained by the different strains of TSE agent and different doses of inocula used.
In light of this conflicting evidence the work described in this thesis determined the
pathogenesis of the ME7 strain of scrapie agent in LTa"7" mice and LTP"7" mice.
LTa"7" mice and LTp"7" mice displayed reduced susceptibility to the ME7 scrapie
agent. However, some cases did occur in LTa"7" mice and LTP"7" mice demonstrating
the presence of an FDC-independent route of neuroinvasion, perhaps involving direct
uptake of the scrapie agent by nerve endings in the peritoneal cavity. This is
consistent with previous reports of cases of clinical scrapie in FDC-deficient TNFa"7"
mice after i.p. inoculation with ME7 scrapie agent (Mabbott et al., 2000b).
However, not all LTa"7" mice, LTP"7" mice or TNFa"7" mice inoculated contracted
disease and the incubation periods of disease in those that did varied considerably
from 216 - 503 days, in contrast to the small range in WT mice (typically 262 - 321
days). Clearly the FDC-independent route of neuroinvasion occurring in LTa"7"
mice, LTp"7" mice and TNFa"7" mice is much less efficient than the FDC-dependent
route in WT mice.
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In the studies utilising LTa_/" mice and LTpv" mice mentioned above (Manuelidis et
al., 2000; Oldstone et al., 2002; Prinz et al., 2002) the separate roles that lymphoid
tissues and FDCs play in TSE pathogenesis were not and cannot be distinguished
from each other. In this chapter, by reconstituting LTa_/" mice and LTP"A mice with
WT bone marrow and thus restoring terminal FDC differentiation, data presented
here shows the effect that a specific lack of lymphoid tissue has on pathogenesis of
ME7 scrapie after i.p. inoculation. WT->LTP~A mice all contracted disease with no
significant difference in the time of onset of disease when compared to WT->WT
mice. As WT->LTP"A mice lack CMLNs this demonstrates that the CMLNs are not
important in scrapie pathogenesis after i.p. inoculation and that neuroinvasion can
occur from another site. Intriguingly, there was delayed onset and decreased
susceptibility in WT->LTa_/" mice despite the presence of mature FDCs in remaining
lymphoid tissues.
Reconstitution adult LTa_/" mice and LTp7" mice with WT bone marrow should
restore the functions of both LTCI1P2 and LT013 equally in WT->LTa~'~ mice and WT-
>LTP"A mice as these cytokines are expressed by bone marrow derived cells
(Gommerman & Browning, 2003). This implies that the only difference between
WT->LTa~~ mice and WT->LTP"/_ mice is the number of remaining lymphoid
tissues. This raises the possibility that, although the CMLNs were clearly absent
from both types of mice, there may be another lymph node draining the peritoneum
which was present in WT->LTp~A mice and absent in WT->LTa"A mice, perhaps the
other lymph nodes within the thoracic cavity such as the caudal mediastinal lymph
nodes or tracheobronchal lymph nodes (Broeck et al., 2006). Thus the difference in
203
disease outcome between the two types of mice might be explained by the restoration
of FDCs (and therefore efficient neuroinvasion) to other lymph nodes in WT->LTP"A
mice which are not present in WT->LTa~A mice. However, to date, the presence or
absence of caudal mediastinal lymph nodes or tracheobronchal lymph nodes has not
been confirmed in either LTa"A mice or LTP~A mice, nor is there any data on the
involvement of these lymph nodes in the lymphatic drainage of the peritoneum. It
has been reported that LTpA mice have a single lymph node in the sacral region, in a
different anatomical location to the conventional sacral lymph nodes found in WT
mice (Soderberg et al., 2004). Therefore, it is also plausible that a similar
modification could have occurred in the thoracic region of LTP"A mice used in the
experiments in this thesis, although this was not noticed on examination of the
thoracic region of these mice after the injection of Indian ink.
The stromal cells of LTa~Amice will not express LTa, however, the stromal cells of
the LTP"7" mice will. Theoretically, it is also possible that a cell type that relies on
LTa expression by a stromal cell could be causing the differences seen when WT-
>LTa"A mice and WT->LTp~A mice were challenged with scrapie via the i.p. route.
However, there is no evidence that such a cell exists as LTa expression appears to be
restricted to bone marrow-derived cells (Gommerman & Browning, 2003).
Data here clearly identify an FDC-independent route of neuroinvasion after i.p.
inoculation but this route is clearly much less efficient than the FDC-dependent
route. It is plausible that neuroinvasion normally occurs by both FDC-independent
and FDC-dependent methods. Likewise, the crucial function of FDCs in scrapie
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pathogenesis may be to amplify the scrapie agent within the lymphoid tissues above
a threshold such that neuroinvasion can efficiently occur. WT->LTP"A mice have
more remaining lymphoid tissues than WT->LTa""mice and, therefore, a higher total
number of FDCs. This difference might contribute to the decreased susceptibility
and increased incubation periods observed in WT->LTa"/_ when compared to WT-
>WT mice and WT->LTP"/_ mice.
After inoculation via i.p. injection with the ME7 scrapie agent, neuroinvasion does
not occur solely from the spleen as splenectomy prolongs the onset, but does not
prevent disease from occurring (Fraser & Dickinson, 1978). Similarly, results
presented here show that neuroinvasion is delayed or even prevented in mice which
have a spleen containing FDCs (WT->LTa"/"mice) but lack other lymphoid tissues.
Taken together these results show that although neuroinvasion does occur from the
spleen after i.p. inoculation this is not the only location neuroinvasion occurs from
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7.1. The role of draining lymphoid tissues in TSE agent
neuroinvasion
Previous studies have demonstrated that TSE infectivity and PrPSc accumulate in the
lymphoid tissues draining the site of inoculation prior to their detection in non-
draining lymphoid tissues and the CNS in a number of natural (Andreoletti et al.,
2000; Heggebo et al., 2000; Keulen et al., 1999) and experimental (Mabbott et al.,
2003; Mohan et al., 2005a) studies. The main aim of this thesis was to determine the
importance of this initial accumulation phase in the draining lymphoid tissues in TSE
agent neuroinvasion. The approach taken here was to utilise mice which lack various
lymphoid tissues, such as LTa"A mice which possess only the spleen and nasal
associated lymphoid tissue (NALT; Banks et al., 1995; Fukuyama et al., 2002; Togni
et al., 1994), LTp_/" mice which, as well as containing spleen and NALT, also have
mesenteric lymph nodes (MLNs) and cervical lymph nodes (CLNs; Fukuyama et al.,
2002; Koni et al., 1997) and the progeny of mice treated in utero with LTpR-Ig on
day 11.5 of gestation which contain spleen, NALT, MLNs, CLNs and also the
lumbar and sacral lymph nodes (Rennert et al., 1997; Rennert et al., 1996). These
mice were inoculated with the scrapie agent via different routes of inoculation and
the effect on TSE disease progression analysed.
Mice which have no lymphoid tissues in the intestine were resistant to scrapie
challenge after oral inoculation (Chapter 4). After inoculation via scarification of the
skin of the thigh mice which lacked the draining inguinal lymph node were less
susceptible to scrapie challenge than immunocompetent controls (Chapter 5). After
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intra-peritoneal inoculation Lymphotoxin (LT) - a deficient mice (LTa"/_ mice)
which had been reconstituted with wild-type (WT) bone marrow (WT->LTa"/_mice)
were less susceptible and had delayed onset of disease compared to WT mice. LTp_/"
mice reconstitutued with WT bone marrow (WT->LTP~A) mice were as susceptible
and developed disease in the same timeframe as WT mice. This finding raised the
possibility that lymphoid tissue present in WT->LTpv~ mice and absent from WT-
>LTa_/" mice (or, theoretically, a cell type relying on LTa expression by a stromal
derived cell) was important in supporting neuroinvasion (Chapter 6). This
demonstrates that the accumulation of the TSE agent in the draining lymphoid tissues
is important, to a greater or lesser extent depending on the route of inoculation.
The initial spread of the TSE agent from the site of inoculation to the draining
lymphoid tissues most likely occurs via the lymphatic vasculature. If this occurred
by blood borne transport it would be expected that infectivity and PrPSc accumulation
would be detected in all lymphoid tissues more or less simultaneously. Therefore,
results showing accumulation in draining lymphoid tissues prior to detection in non-
draining lymphoid tissues (Andreoletti et al., 2000; Ileggebo et al., 2000; Keulen et
al., 1999; Mabbott et al., 2003; Mohan et al., 2005a) demonstrate that the initial
spread of the TSE agent occurs most likely via the lymphatic system rather than
haematogenously.
Once the TSE agent has entered the body a competitive state exists whereby
phagocytic cells destroy the agent while cells in the lymphoid tissues replicate it.
Normally, when draining lymphoid tissues are present replication prevails resulting
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in neuroinvasion and the subsequent development of TSE disease. However, results
presented in this thesis show that when the draining lymphoid tissues are missing, the
prevailing situation is altered to a greater or lesser extent, depending on the route of
inoculation.
After oral inoculation it is likely that very little of the inoculum crosses the intestinal
epithelial barrier. Some of the inoculum may be digested by enzymes in the stomach
or small intestine (Jeffrey et al., 2006; Mishra et al., 2004) and most of the inoculum
that reaches the intestine will be passed from the body. Thus in a normal situation
the very little of the starting inoculum will reach the Peyer's patches (PPs).
Although there is no direct in vivo evidence, it has been postulated that the TSE
agent may cross the intestinal epithelium through uptake by M cells (Heppner et al.,
2001), dendritic cells (Huang et al., 2002) or enterocytes (Mishra et al., 2004; Morel
et al., 2005). WT bone marrow reconstituted LTa"A mice and LTP"/_ mice should be
equally as capable as WT mice of taking up the scrapie agent as they have M cells,
dendritic cells and intact lymphatics (Chapter 3; Kabashima et al., 2005; Chapter 3;
Tumanov et al., 2004; Wu et al., 1999). However, these mice do not develop disease
when inoculated orally (chapter 4). After oral inoculation, it is likely that destruction
of the agent by phagocytes prevails allowing complete clearance of the agent and
preventing subsequent disease. Thus it is plausible that in the absence of the PP the
small amount of inoculum that makes it across the intestinal epithelium is destroyed
before it reaches any other lymphoid tissues (such as the MLNs in WT^LTP"7"
mice).
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With both the scarification and i.p. routes it may be assumed that almost the entire
inoculum will enter the lymphatic vasculature as inoculation via these routes does
not involve passage through the stomach or intestine. Thus the difference in whether
destruction or replication of the agent prevails in the absence of the draining
lymphoid tissues between the oral compared to the scarification or i.p. routes may be
attributed to the amount of TSE infectivity which reaches the draining lymphatic
vessels.
The importance of follicular dendritic cells (FDCs) in TSE pathogenesis has been
demonstrated by experiments which have shown that a temporary (Mabbott et al.,
2000a; Mabbott et al., 2002; Mabbott et al., 2003; Montrasio et al., 2000) or
permanent (Mabbott et al., 2000b; Prinz et al., 2002) absence of FDCs at the time of
inoculation delays or prevents the onset of disease. As both LTa_/" mice and LTP_/~
mice lack FDCs, prior to use in scrapie inoculation experiments, these mice were
reconstituted with WT bone marrow. This restored terminal FDC differentiation
without inducing the formation of the missing lymphoid tissues. Thus results
obtained using these mice could be attributed to the lack of lymphoid tissues, rather
than a dual lack of both lymphoid tissues and FDCs. Studies in this thesis and
elsewhere have demonstrated an FDC independent route of neuroinvasion.
Inefficient neuroinvasion was able to occur after i.p. inoculation of mice which
lacked FDCs through genetic deficiency of LTa LTp (Chapter 6), TNFa (Mabbott et
al., 2000b) or TNFR1 (Klein et al., 1997). The reason for this could be the direct
uptake of the scrapie agent by nerve endings in the peritoneal cavity or skin by¬
passing the need for replication of the agent in the periphery. It has also been
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suggested that as macrophages in TNFa"7" or TNFR1"7" mice cannot be properly
activated, the lack of FDCs is perhaps compensated for by replication of the scrapie
agent in dormant macrophages (Prinz et al., 2002). This route of neuroinvasion is
much less efficient than the FDC-dependent route.
The work presented in this thesis has demonstrated that lymphoid tissue within the
intestine is crucial for neuroinvasion to occur. However, as discussed in section 4.4
it is not known whether the lack of lymphoid tissue in the intestine directly prevents
neuroinvasion from occurring, or if the scrapie agent is simply prevented from
spreading to other sites from which neuroinvasion occurs. Mice genetically deficient
for tumour necrosis factor-related activation induced cytokine (TRANCE) develop
PPs and spleens but do not develop any other lymphoid tissue (Dougall et al., 1999;
Kong et al., 1999). Utilising these mice in scrapie pathogenesis experiments would,
therefore, be a way of addressing this question, particularly if splenectomy was
carried out prior to inoculation. Thus, if neuroinvasion occurs directly from PPs
within the intestine after oral infection, splenectomised TRANCE"7" mice should be
as susceptible, and develop disease in the same time frame, as WT mice. If
neuroinvasion occurs from a combination of lymphoid tissues, such as PPs and
spleen, after oral inoculation then splenectomised TRANCE"7" mice would take
longer to develop disease, or have a lower incidence compared to WT mice. In this
case, non-splenectomised TRANCE"7" mice would be as susceptible and develop
disease in the same time frame as WT mice. If neuroinvasion occurs from the spleen
alone after oral inoculation then splenectomised TRANCE"7" mice or WT mice would
be resistant to disease, however this is unlikely as various pieces of evidence would
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suggest that neuroinvasion does, at least to some extent, occur from the intestine
itself (Beekes & McBride, 2000; Kimberlin & Walker, 1989; Mabbott et al., 2003).
Performing the experiments described above would resolve this issue.
Another approach to this experiment could be to inoculate WT->LTa"7" mice with the
scrapie agent at twelve weeks post bone marrow reconstitution. LTa"7" mice lack all
gut associated lymphoid tissues, but at this time point post reconstitution mature ILFs
have developed (Chapter 3; Lorenz et al., 2003; McDonald et al., 2005). Thus a
model could be created where lymphoid tissue is present in the intestine (mILFs) and
spleen but at no other sites in the body. These mice could then be utilised as
described above for TRANCE"7" mice to determine whether neuroinvasion occurs
directly from the intestine. It has previously been reported that some LTa"7" mice do
possess reduced numbers of MLNs (Fu et al., 1997). Thus TRANCE"7" mice
represent a cleaner system to address this question. Elowever, oral scrapie agent
inoculation of both WT->LTa"7" and WT->LTp"7" mice 12 weeks post bone marrow
reconstitution would be interesting to demonstrate that the mILFs ofWT->LTa"7" and
WT->LT(3"7" mice were capable of supporting neuroinvasion in the same way
described for in ntero LTpR-Ig treated mice (PP-deflcient mice) in chapter 4 of this
thesis.
One could also argue that the results detailed in this thesis are not due to the specific
lack of lymphoid tissues draining the site of inoculation but rather to the lower total
number of FDCs present in the mice. Thus, SCID mice which lack all FDCs are
resistant while wild-type mice with maximum numbers of FDCs are fully susceptible
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(Brown et al., 1997c; Fraser et ah, 1996; O'Rourke et al., 1994; Taylor et ah, 1996b).
Mice which lack some lymphoid tissues and have, therefore, an intermediate number
of FDCs vary in their response to infection as demonstrated by the various resistance,
decrease in susceptibility or increase incubation period outcomes described here. If
it were true that these results were due to a decrease in the overall number of FDCs
rather than a lack of lymphoid tissues (and, therefore, FDCs) at specific anatomical
locations, this would imply that neuroinvasion crucially occurs from all lymphoid
tissues regardless of the route of inoculation. Therefore a lack of lymphoid tissues
anywhere in the body would have an impact on disease via any route of inoculation.
This is not true, however, as the induction of mILF formation in the intestines of in
utero LTpR-Ig treated mice rendered the mice fully susceptible to oral scrapie agent
challenge (Chapter 4) despite the absence of many of the non-draining lymphoid
tissues and, therefore, a decreased total number of FDCs compared to control mice.
Thus, it is reasonable to conclude that the results described in this thesis can be
attributed to the absence of the lymphoid tissues draining the site of inoculation.
This is not to say that accumulation and replication of the agent and neuroinvasion
does not occur from non-draining lymphoid tissue. Indeed, results presented here
would suggest that following some routes of inoculation neuroinvasion from non-
draining lymphoid tissues can compensate for the absence of the draining lymphoid
tissues, but this route of neuroinvasion is much less effective (Chapters 5 & 6). The
accumulation and replication of the agent in draining lymphoid tissues is, therefore,
more important than in non-draining lymphoid tissues.
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7.2 Why are draining lymphoid tissues important in TSE
pathogenesis?
Data presented in this thesis show that the draining lymphoid tissue is important for
efficient neuroinvasion. Evidence suggests that the FDCs are the crucial component
within the lymphoid tissues for the accumulation and replication of the scrapie agent.
PrPd specific immunostaining in lymphoid tissues co-localises with FDC specific
immunostaining in both natural (Andreoletti et al., 2000; Fleggebo et al., 2000;
Flilton et al., 1998) and experimental (Brown et al., 1999b; Mabbott et al., 2000b;
McBride et al., 1992; Sigurdson et al., 1999) cases of disease. Furthermore, a
temporary (Mabbott et al., 2000a; Mabbott et al., 2002; Mabbott et al., 2003;
Montrasio et al., 2000) or permanent (Mabbott et al., 2000b; Prinz et al., 2002)
absence of FDCs at the time of inoculation delays or prevents the onset of disease.
Thus it is logical to conclude that when lymphoid tissues draining the site of
inoculation are missing it is the lack of FDCs local to the site of inoculation that
impacts on the development of disease.
However, there may be other reasons for the lack of draining lymphoid tissues
having an impact on the development of TSE disease. For example, although
experiments have demonstrated that WT bone marrow reconstitution of LTa" ~ mice
and LTp-" mice restores the migration of dendritic cells into lymphoid tissues
remaining in these mice (Wu et al., 1999), it is not known what happens at sites
where the lymphoid tissue itself is missing. The factors involved in the migration of
dendritic cells into lymphatic vessels are not fully understood. CCR7 expression by
dendritic cells is important in this process and a ligand for CCR7 (Martin-Fontecha et
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al., 2003) CCL21, is expressed by peripheral lymphatic vessels (Chen et al., 2002)
suggesting that an interaction between these two molecules may facilitate this
process. If this is the case, dendritic cell migration into lymphatic vessels should not
be affected by the absence of the local lymph nodes. However, there is currently no
evidence that this interaction does take place, nor is there any data on the factors
which regulate the expression of CCL21 by lymphatic endothelial cells. Thus it is
possible that the absence of the local lymphoid tissue results in the impaired
migration of cells carrying the scrapie agent from the site of inoculation to the
lymphoid tissues. This would prevent the early accumulation and replication of the
agent such that the agent could be destroyed before it reaches more distant remaining
lymphoid tissues.
7.3 Spread of the TSE agent from the draining lymphoid tissues to
the CNS
The spread of TSE agents from the sites of replication in lymphoid tissue to the CNS
is thought to occur via the peripheral nervous system. Early investigations in mice
found that after peripheral challenge replication of scrapie in the CNS consistently
began in the thoracic region of the spinal cord with replication in the brain and other
parts of the spinal cord occurring significantly later (Kimberlin & Walker, 1980).
This suggested that neuronal rather than haematological spread was occurring as this
ordered sequence of events would not be expected if the agent was spreading via the
bloodstream.
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Further evidence for neural spread came from experiments showing that the
expression of PrPc in the peripheral nerves is required for the development of disease
(Blattler et al., 1997; Glatzel & Aguzzi, 2000). When the scrapie agent was
cinoculated directly into peripheral nerves, mice over expressing PrP were found to
develop disease faster than control mice suggesting that peripheral nerves could
transport the scrapie agent to the CNS and that this transport occurred in a PrP
dependent manner, although this could be due to the increased availability of PrP
for conversion to PrPSc (Glatzel & Aguzzi, 2000). No disease was detected in the
brains of PrP_/" mice reconstituted with PrP+/+ neurones in the brain only when
challenged peripherally with scrapie (Blattler et al., 1997). PrP+/+
lymphohaemopoietic stems cells were then given to allow potential replication in the
lymphoid tissues and spread via the bloodstream. Once again resistance to scrapie
was detected suggesting that the spread of scrapie to the CNS occurs via the
peripheral nervous system, not via the blood stream, and was dependent on the
nerves expressing PrPc. It is possible to argue that no disease developed in the latter
study (Blattler et al., 1997) because the FDCs, which are not of haemopoietic origin,
would be PrP"7", and therefore, would not support scrapie replication. Flowever, it is
worth noting that the strain of scrapie used in this study was RML, which in some
circumstances accumulate in lymphoid tissues in the absence of PrP expression by
FDCs. (Klein et al., 1997). A further demonstration of the involvement of peripheral
nerves in TSE pathogenesis has been proposed through removal or over expression
of them (Glatzel et al., 2001). Removal of nerves before peripheral scrapie challenge
was found to delay the onset of disease in the CNS, whereas hyperinnervation
reduced the incubation period.
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Effort has also been put into trying to determine specifically which nerves are
involved in the spread of the TSE agent from the periphery to the CNS. Studies of
the enteric nervous system have revealed that both the sympathetic and the
parasympathetic nervous systems may be involved as PrPd has been found in the
efferent fibres of these nerves prior to detection in the CNS (Baldauf et al., 1997;
Beekes et al., 1996; Beekes & McBride, 2000; Beekes et al., 1998; McBride &
Beekes, 1999; McBride et al., 2001). This is further supported by work which
involved sympathectomies (either permanent or temporary) which delayed or in
some cases even prevented the onset scrapie symptoms (Glatzel et al., 2001). The
involvement of the enteric nervous system in natural TSE disease has been shown by
the accumulation of PrPd in these nerves in cases sheep scrapie (Heggebo et al.,
2003), humans with vCJD (Haik et al., 2003) and deer affected by CWD (Sigurdson
et al., 2001).
It is not clear how the TSE agent reaches the peripheral nerves from the FDCs within
the lymphoid tissue. In the spleen FDCs reside in the periphery of the white pulp and
nerves are closely associated with the blood vessels, thus direct transfer between the
two is unlikely (Defaweux et al., 2005). Sympathetic innervation of lymph nodes
has been observed but these innervate the cortical and medullary regions of the
lymph nodes and nerve fibres have not been observed in germinal centres within
lymph nodes (Mignini et al., 2003). It is possible that another cell type may be
responsible for the transfer of TSEs from FDCs to the peripheral nerves.
Experiments showed that in RAG1 ~/~ mice that lack B and T lymphocytes, and
therefore, mature FDCs, injection of infected DCs was able to cause TSE disease
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(Aucouturier et al., 2001). There could be no involvement of lymphocytes or FDCs
in this model since none were present in lymphoid tissue of RAGE7" mice. Further
work is required, however, before the conclusion that DCs carry TSE agents to the
nervous system in the course of natural infections can be reached or that DCs are
responsible for the infection of peripheral nerves when FDCs and lymphocytes are
present. It is also possible that release of the TSE agent by exosomes from FDCs or
other infected cells within lymphoid tissues may facilitate the infection of nerves of
the lymphoid tissue as exosomes in infected cells have been found to release PrPSc
(Fevrier et al., 2004).
Chemokines are important in directing FDCs to the correct microenvironment within
the spleen. In mice deficient in the CXCR5 chemokine receptor (CXCR5 A mice)
this direction does not happen and FDCs aggregate around splenic nerves (Prinz et
al., 2003a). When these mice were challenged peripherally with scrapie, infectivity
was found in the spinal cord 30 days earlier than in wild-type mice. This suggests the
involvement in scrapie pathogenesis of both FDCs and splenic nerves, as, if either
one was not necessary, putting them physically closer together would not affect the
speed in which neuroinvasion occurs. Thus it would seem that the TSE agent does
reach the peripheral nerves from FDCs, but the mechanism involved remains
obscure. In PPs FDC networks are situated distal from the intestinal lumen and lie
close to nerve fibres that run along the intestinal wall (Beekes & McBride, 2000).
Likewise, in this thesis, FDCs in mILFs are shown to be similarly situated (Chapter
4). As the distance between FDCs and nerves appears to modulate the rate of
neuroinvasion (Prinz et al., 2003a) it is likely that the close association of FDCs with
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nerve fibres in the intestinal wall facilitates the rapid spread of the TSE agent from
PPs and mlLFs to neighbouring enteric nerves.
7.4 Relevance of work in this thesis to natural TSE diseases
Accumulation of the TSE agent occurs in the lymphoid tissues of many cases of
natural disease. Patients with vCJD have both PrPd (Hill et al., 1999; Hilton et al.,
1998) and TSE infectivity (Bruce et al., 2001) in lymphoid tissues such as the tonsils
and appendix. A variety of different breeds of sheep with natural scrapie have PrPd in
lymphoid tissues in the preclinical and clinical phases of disease (Andreoletti et al.,
2000; Heggebo et al., 2002; Heggebo et al., 2000; Keulen et al., 1999) and deer
naturally affected by chronic wasting disease have accumulation of PrPd in tonsils
and other lymphoid tissues (Fox et al., 2006; Sigurdson et al., 1999; Wild et al.,
2002). However, lymphoid tissue tropism is not a feature of all TSEs as PrPd is not
detected in lymphoid tissues of cattle affected by BSE (Somerville et al., 1997a),
humans affected by sCJD (Hill et al., 1999) and some strains of natural sheep scrapie
(Ligios et al., 2006). The ME7 strain of scrapie agent was used for the experiments
described in this thesis because it is well studied and models the necessity for a
lymphoid tissue replication phase which likely occurs in many natural TSE diseases.
The data presented here demonstrate that draining lymphoid tissues are important for
scrapie disease to become established in a murine model of the disease. This
suggests that the early accumulation and replication of the TSE agent seen in
draining lymphoid tissues in cases of natural TSE disease is also likely to play an
important role in the successful establishment of disease.
219
The involvement of PPs in natural TSE disease has been shown by the detection of
S" • • •PrP c accumulation in the ileal PPs of 2 month old lambs in a naturally scrapie
infected flock (Andreoletti et al., 2000) and further supported by the demonstration
of nerves in close association with FDCs in ovine PPs (Heggebo et al., 2003). The
involvement of PPs has also been shown by the presence of PrPd in the submucosal
lymphatics around PPs within minutes of experimental inoculation of the sheep
intestine with scrapie, and within the PPs and MLNs 30 days after inoculation
(Jeffrey et al., 2006). This pattern of PrPd accumulation in sheep is similar to that
described in this thesis in mice, although data presented here suggests that the
accumulation of PrPd in MLNs is not important for the establishment of disease.
After experimental oral infection of mule deer fawns with CWD, PrPSc was detected
in PPs at early time points suggesting that PPs may also be involved in the
pathogenesis of this disease (Sigurdson et al., 1999). However, it is not known
whether the involvement of PPs in natural disease is of crucial importance for
neuroinvasion of the TSE agent. The data described in Chapter 4 of this thesis
demonstrate the crucial importance of PPs for the neuroinvasion of scrapie in an
experimental murine model of the disease, suggesting that the same may occur in
animals with natural disease.
Results presented here raise the possibility of targeting a potential therapeutic
treatment to the lymphoid tissues within the intestine (PPs or mILFs) for these
diseases. For example, in the future it may become possible to target a treatment to
lymphoid tissues in the intestine thus preventing the early replication and spread of
the TSE agent to the CNS where irreparable and fatal damage is caused, whilst not
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rendering the host completely immunocompromised as targeting a treatment to all
lymphoid tissues may do. However, this is hampered by the lack of a pre-mortem
diagnostic test and the rapid speed with which neuroinvasion occurs after oral
exposure. The development of a vaccine would be an ideal way of controlling TSEs
in the absence of a pre-mortem diagnostic or any therapeutic strategies to treat
clinical cases. Several recent studies have investigated the possibility of developing
a vaccine using either DNA (Fernandes-Borges et al., 2006; Muller et al., 2005) or
recombinant prion protein (Bade et al., 2006; Goni et al., 2005; Ishibashi et al.,
2006). There has been encouraging success with the onset TSE disease being
delayed after subsequent TSE challenge in all studies carried out. in this thesis, the
absence of lymphoid tissues in the intestine was shown to prevent neuroinvasion
after oral inoculation, thus a mucosal vaccine that prevents the TSE agent from
reaching the lymphoid tissues in the intestine is likely to be successful in preventing
subsequent disease from occurring.
7.5 The role of draining lymphoid tissues in other diseases
The accumulation of infectious agent in lymphoid tissue prior to systemic spread is
not a unique feature of TSEs. This has been observed in many other infectious
diseases a few examples of which are discussed below.
7.5.1 Simian Immunodeficiency virus (SIV)
The early pathogenesis of SIV has several features in common with TSEs. The
involvement of draining lymphoid tissue prior to the involvement of other lymphoid
tissue has been shown by the presence of SIV infected cells only in the iliac lymph
221
nodes 2 days after intra-vaginal inoculation of rhesus macaques, whereas infected
cells were detected systemically by 5 days post inoculation (Spira et al., 1996).
After rectal inoculation of rhesus macaques with SIV, provirus was detected in the
draining paracolic lymph nodes 7 days after inoculation but not seen in the non-
draining axillary lymph nodes until 10 days after inoculation (Couedel-Courteille et
al., 1999). Similarly, after application of SIV particles to the tonsils of macaques
replication of the virus was first observed in this lymphoid tissue prior to spread to
other lymphoid tissues (Stahl-Hennig et al., 1999). Thus these studies demonstrate,
like TSEs, the lymphoid tissue responsible for the initial accumulation and
replication of the infectious agent changes depending on route of exposure. It would
be interesting to investigate the importance of the initial phase of SIV replication in
draining lymphoid tissue in a similar way to the experiments described in this thesis
for the investigation of scrapie. There are also parallels to be drawn between cells
within lymphoid tissue responsible for the accumulation of the infectious SIV and
TSE agents. As described elsewhere in this thesis (section 1.2.4) the attachment of
the TSE agent to FDCs via complement components is important for the
development of TSE disease. Similarly, studies have also shown that FDCs can
harbour a reservoir of infectious HIV particles via interactions between HIV
particles, complement components and complement receptors on FDCs (Stoiber et
al., 2001).
7.5.2 Venezuelan equine encephalitis virus (VEE)
VEE is another disease which has some parallels to TSE disease. There is a distinct
lymphoid replication phase of this virus prior to spread to the CNS where disease
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including spongiform pathology is caused (Charles et al., 2001; Gleiser et al., 1962).
However, unlike TSEs, this disease is spread by mosquitoes and predominantly
affects horses and humans in Central and South America (Weaver et al., 2004). A
murine model of the disease has been established by the sub-cutaneous injection of
VEE viral particles into the foot pad of mice. After this route of inoculation
replication of viral particles is seen in the popliteal lymph node within four hours.
Replication of the virus is not detected in non-draining lymphoid tissues until 12-24
hours after inoculation (Grieder et al., 1995). This shows that initial drainage of the
virus was to the local lymphoid tissue. It would be interesting to determine the
importance of this initial replication phase in the popliteal lymph node performing
similar experiments to the ones described in this thesis. However, when SCID mice
were challenged with VEE all mice developed disease with an increased disease
incubation period (Charles et al., 2001). It is likely, therefore, that the same outcome
would be observed in mice lacking the popliteal lymph nodes.
7.5.3 Listeria monocytogenes
A study on the early pathogenesis of L. monocytogenes infection after inoculation of
ligated ileal loops in rats revealed initial targeting of cells in the PPs followed 6
hours later by the presence of infected cells in the MLNs (Pron et al., 2001). As data
presented here in chapter 4 revealed that in the absence of PPs the scrapie agent was
unable to spread to MLNs after oral inoculation it would be interesting to investigate
whether this is also the case with L. monocytogenes infection. If it were so, this
would suggest that the transport of antigens from the intestine to the MLNs may be
dependent on the presence of PPs or factors produced by PPs. After intra-peritoneal
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inoculation with L. monocytogenes bacteria were detected in the mediastinal
lymphocentrum (termed cranial mediastinal, tracheobronchal and caudal mediastinal
lymph nodes in this thesis) prior to detection in the spleen and other non-draining
lymph nodes (Marco et al., 1992). This again demonstrates the initial spread of
antigen to the local lymphoid tissue and that the site of initial accumulation of
antigen changes depending on the route of inoculation.
7.5.4 Other infectious diseases
Yersinia pestis inoculated via the intra-tracheal route was found in mediastinal lymph
nodes 24 hours after inoculation, but was not found in the spleen at this time point.
96 hours after inoculation Y. pestis was found in both the mediastinal lymph nodes
and spleen demonstrating spread from draining lymphoid tissues to other lymphoid
tissues (Bosio et al., 2005). When mice were treated with clodronate to deplete
antigen presenting cells (APCs) prior to inoculation a higher number of bacteria were
detected in the spleen compared to untreated mice (Bosio et al., 2005). This shows
that trafficking of Y. pestis to the local lymphoid tissue is an active process to prevent
early body wide dissemination. The immune response to Herpes simplex virus
injected sub-cutaneously into the right ears of mice elicited an immune response
characterised by the production of interferon-a/p in the draining lymph node of the
right ear but not in that draining the left ear or any other lymphoid tissue (Riffault et
al., 1996). These studies suggest that the mechanism of antigen trafficking to the
lymph node draining the site of inoculation has evolved to contain and deal with the
infection locally to the site of inoculation so that pathogens and potentially harmful
immune responses do not need to become bodywide. However, this mechanism is
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detrimental to the host as far as many TSEs are concerned as it brings the infectious
agent in contact with cells which may facilitate replication of the agent and support
neuroinvasion.
7.6 Isolated lymphoid follicles
Another important aim of this thesis was to characterise isolated lymphoid follicles,
structures that have only recently be described in the murine small intestine (Hamada
et al., 2002), with a view to determining their potential role in scrapie agent
neuroinvasion from the intestine. These structures have been classified into two
types, mature and immature (Lorenz et al., 2003). Here, the presence of FDCs in
ILFs was found to correlate directly with ILF maturity. Further analysis revealed
greater numbers of mILFs in the intestines of mice which lacked PPs compared to
mice which contained PPs (Chapter 3). Indeed, the total area covered by FDCs in
PP-deficient mice and control mice were found to be equivalent. These observations
raised the possibility that neuroinvasion might also take place from FDCs within
mILFs (Chapter 3). This was investigated in PP-deficient mice which contained
numerous mILFs. These mice were found to be as susceptible to orally inoculated
scrapie and develop disease in the same time frame (Chapter 4). Thus mILFs are
identified in this thesis as a novel site of neuroinvasion from the small intestine.
The consumption of TSE agent contaminated food and prion protein genotype are
important risk factors that affect TSE susceptibility (Goldmann et al., 1994;
Wadsworth et al., 2004). Recent studies suggest that inflammation may be another
factor, either enhancing uptake from mucosal sites (Thackray et al., 2004) or
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expanding the tissue distribution of these agents (Heikenwalder et at., 2005; Ligios et
at., 2005; Seeger et al, 2005). Results presented in this thesis have shown that
mILFs can support neuroinvasion (Chapter 4). The formation and maturation status
of ILFs can be modulated both by luminal bacterial flora (Fagarasan et at., 2002;
Lorenz et at., 2003) and pathogenic micro-organisms (Little et at., 2005) thus ILFs
share features with the ectopically-induced germinal centres described above. It is
possible to postulate, therefore, that neuroinvasion may also occur from lymphoid
tissues induced during chronic inflammation, supporting the argument that
inflammation is an important risk factor affecting TSE susceptibility. Mice
genetically deficient in the anti-inflammatory cytokine IL-10 were found to succumb
to scrapie disease much faster than WT counterparts (Thackray et at., 2004). The
effect of co-incident infection with a TSE agent and an inflammation inducing
pathogen, which would more closely model a natural situation, has not been
investigated. This could be done by infecting mice with, for example, Eimeria spp
which induce an acute inflammatory response in the intestine (Roberts et at., 1996),
at the same time as administering the scrapie agent via the oral route. In the light of
the evidence discussed above it would be expected that the scrapie disease incubation
period in mice with co-incident inflammation and scrapie agent infection may be
shortened.
Studies in this thesis and elsewhere have shown that LTotifc signalling through
LT(3R is vital for the formation of ILFs as LTa_/" mice and LTp_/" mice do not develop
ILFs (Chapter 3; Lorenz et at., 2003; McDonald et at., 2005). The source of LT011P2
for the formation of mILFs has been shown to be B lymphocytes (Lorenz et at.,
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2003; McDonald et al., 2005). mILF formation has also been found to be dependent
on TNFR1 and intestinal flora as both TNFRl"7" mice and germ-free mice lack mILFs
(Lorenz et al., 2003). None of these are required for the formation ilLFs, as ilLFs
are found in the intestines of germ-free mice, TNFRL" mice and LTa_/" mice grafted
with LT-sufficient NK cells and T lymphocytes alone (Lorenz et al., 2003;
McDonald et al., 2005). In the absence of Ig-isotype class switching and impaired
IgA production in activation-induced cytidine deaminase (AID)-deficient mice the
number of ILFs in the intestine is increased compared to control mice (Fagarasan et
al., 2002). This implies that inflammatory responses precipitated by a relative
deficiency of intestinal IgA also stimulates the formation of ILFs. There is a general
consensus that ilLFs become mILFs given the right conditions (McDonald et al.,
2005; Newberry & Lorenz, 2005; Taylor & Williams, 2005). However, there is no
direct evidence that ilLFs are a precursor to mILFs nor is there any evidence against
ilLFs and mILFs representing the terminal stages of discrete pathways of
development. Recent studies have shed some light on this issue. One study coined
the term solitary intestinal lymphoid tissues (SILT) to describe all isolated lymphoid
aggregations in murine small intestine (Pabst et al., 2006). These aggregations
include ilLFs, mILFs and also cryptopatches which are aggregations found in
intestinal crypts. Cryptopatches contain haematopoietic precursor cells and were
originally thought to be extra-thymic sites of T-lymphocyte development (Saito et
al., 1998; Suzuki et al., 2000). More recent work has challenged this idea and
suggested the predominant cell population within cryptopatches may adult
counterparts of foetal lymphoid tissue initiating cells (LTICs) and therefore
cryptopatches are precursors of ILFs (Eberl & Littman, 2004). The total number of
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SILT in germ-free mice was the same compared to control mice although in germ-
free mice SILT were of a predominantly small immature phenotype (Pabst et al.,
2006). However, when germ-free mice were colonised with commensal bacteria the
SILT became progressively larger demonstrated a more mature phenotype similar to
that found in control mice. This led the authors to propose that SILT are a secondary
lymphoid tissue whose maturation status depends on factors in the local environment
(Pabst et al., 2006). These findings suggest that ilLFs can mature into mILFs and
also that cryptopatches are part of the same spectrum of lymphoid aggregations.
The study of ILFs in this thesis has also revealed the presence of IgA in the intestines
of mice containing mILFs and lacking PPs and MLNs. IgA was absent from mice
lacking PPs, MLNs and mILFs despite the presence of FDCs in remaining lymphoid
tissues in these mice (Chapter 3). This suggested that IgA synthesis in the intestines
of mice with no PPs or MLNs was dependent on the presence of mILFs. These
observations are consistent with the work of others which showed that after infection
with Salmonella typhimurium, specific IgA was present in intestines of mice which
had mILFs, but lacked PPs or MLNs (Lorenz & Newberry, 2004). Likewise, cells
isolated from the mILFs of SRBC immunised mice have been shown to be capable of
making SRBC-specific IgA upon restimulation (Lorenz & Newberry, 2004).
Collectively, these data suggest that mILFs are capable of producing IgA, and,
therefore, display similar functionality to other gut-associated lymphoid tissues. This
is consistent with the hypothesis that the increased number of mILFs seen in mice
lacking PPs is to provide immunological protection for the intestines in the absence
of PP function. As deficiency of intestinal IgA is thought to be a trigger for ILF
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formation (Fagarasan et al., 2002) it is logical that mILFs should produce IgA in
order to compensate for this deficiency. Two recent studies, however, have
suggested that ILFs are not essential for the induction of intestinal IgA responses. In
this study, mice which lacked PPs and MLNs through combined in utero TNFR1-
and LTpR-signalling blockade failed to induce an IgA response after oral
immunisation with tetanus toxoid (Yamamoto et al., 2004). The maturation status of
ILFs in this study was not recorded and as TNFR1-stimulation is essential for mILF
formation (Lorenz et al., 2003) it is plausible that ILF maturation was significantly
impaired in these mice leading to a failure to induce an IgA response. Another study
showed near normal levels of IgA in the intestines of CD407" mice despite a failure
to detect germinal centres or Ig class-switching in the PPs, MLNs or ILFs (Bergqvist
et al., 2006). This led the authors to postulate that the induction of intestinal IgA
production occurs outwith the gut-associated lymphoid tissues (GALT), although
they do not suggest a location for this.
7.7 Conclusion
Data presented here show that lymphoid tissues local to the site of inoculation of the
ME7 scrapie agent are important for efficient neuroinvasion to occur. The relative
importance of the draining lymphoid tissues varies depending on the route of
inoculation. After oral inoculation PPs within the intestine are crucial, as in their
absence neuroinvasion does not occur. MLNs are not important after oral
inoculation as in the absence of PPs and presence of MLNs disease did not result,
demonstrating that lymphoid tissues within the intestine itselfwere required (Chapter
4). In the absence of PPs an increased number of mature ILFs develop within the
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intestine. Mature ILFs resemble PPs but are very much smaller and occur as single
follicles rather than being an aggregation of several follicles. The increased number,
size and maturity of ILFs in the intestines of PP-deficient mice results in an equal
number of FDCs being present in the intestines of PP-deficient and control mice
(Chapter 3). When inoculated orally with the scrapie agent the increased number,
size and maturity of ILFs in the intestines of PP-deficient mice results in PP-deficient
mice being as susceptible as control mice to scrapie disease (Chapter 4). After
inoculation via scarification of the thigh, mice which lacked the draining inguinal
lymph node were less susceptible to scrapie challenge than immunocompetent
controls (Chapter 5). After i.p. inoculation LTa_/" mice were less susceptible and had
delayed onset of disease compared to WT mice, whereas LTp"/_ mice were as
susceptible and developed disease in the same timeframe as WT mice. This raised
the possibility that lymphoid tissue present in LTp_/" mice and absent from LTa_/"
mice (or, theoretically, a cell type relying on LTa expression by a stromal derived
cell) were important in supporting neuroinvasion (Chapter 6). Taken together these
results suggest that the initial accumulation of the agent in lymphoid tissue draining
the site of inoculation is important for scrapie agent neuroinvasion. Understanding
the earliest stages of scrapie pathogenesis will help in the development of therapeutic
strategies for TSE diseases and further general understanding of the lymphatic
vasculature and the initial uptake of foreign particles.
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Summary
Isolated lymphoid follicles (ILFs) are recently identified lymphoid struc¬
tures in the small intestine with features similar to Peyer's patches (PPs).
Using immunohistochemistry we characterized the composition of ILFs in
the small intestines of immunocompetent mice and of mice that lacked
PPs as a result of either genetic deficiency of lymphotoxin or temporary
in utero lymphotoxin-p receptor-signalling blockade. We showed that
although both immature and mature ILFs were present in the intes¬
tines of immunocompetent mice, PP-deficiency induced a significantly
greater number of mature ILFs. We found that in addition to B-lympho-
cyte-containing germinal centres, mature ILFs also possessed large net¬
works of follicular dendritic cells (FDCs). These features were not
detected within immature ILFs. Indeed, the presence of FDCs could be
used to reliably distinguish ILF maturity. Further analysis revealed that
the area occupied by the FDCs within mature ILFs was substantial. The
total area occupied by FDCs in all the mature ILFs in mice lacking PPs
was equivalent to the total area occupied by FDCs in all the PPs and the
few mature ILFs in immunocompetent mice. Based on these data we rea¬
soned that in the absence of PPs, mature ILFs are important inductive
sites for intestinal immune responses. Indeed, in mice that lacked PPs,
ILF maturation coincided with a restoration of faecal immunoglobulin A
levels to values that were comparable to those found in immunocompe¬
tent mice. Taken together, these data imply that the induction of germinal
centres and FDC networks within mature ILFs in response to PP defici¬
ency provides an important compensatory mechanism.
Keywords: follicular dendritic cells; intestine; isolated lymphoid follicles;
lymphotoxin; Peyer's patches
Introduction
The gastrointestinal tract is a major interface between
host and potential pathogenic micro-organisms. Highly
organized lymphoid structures, such as Peyer's patches
(PPs) and diffusely distributed effector cells within the
epithelium and lamina propria, help to protect the
mammalian gastrointestinal tract against infection by
microbial pathogens. Secretory immunoglobulin A (IgA)
is an important component of the intestinal immune
response and is synthesized by plasma cells in the lam¬
ina propria.1 In the intestine, IgA isotype class switching
occurs only in organized lymphoid structures such as
PPs2 but antigen-specific IgA responses have been dem¬
onstrated in mice that are deficient in PPs.3 As a con¬
sequence, novel lymphoid clusters, termed isolated
lymphoid follicles (ILFs), were identified along the
antimesenteric wall of the mucosa of the small intes¬
tine.4 Isolated lymphoid follicles are much smaller than
PPs and comprise a single B-lymphocyte follicle with a
germinal centre (GC) and an overlying M-cell-containing
epithelium similar to the follicle-associated epithelium of
PPs.4 Isolated lymphoid follicles are distributed through¬
out the small and large intestines of mice4-6 and have
also been demonstrated in the intestines of rabbits,7
rats,8 guinea-pigs9 and humans.10
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Interactions between the membrane bound lympho-
toxin (LT) a!p2 heterotrimer and the LT0 receptor
(LTPR) during gestation are crucial for the formation of
PPs and other secondary lymphoid tissues. Accordingly,
mice that are deficient in LTa, LTP or LTPR lack PPs
and most other lymph nodes.11 Likewise, temporary
in utero LTflR-blockade during the period of embryonic
lymphoid tissue formation also blocks the development
of PPs and certain lymph nodes.12 The factors required
for ILF development share similarities with those
required for PP development but there are key differ¬
ences. For example, stimulation via LTPR is also import¬
ant for the development of ILFs because they are absent
in mice that are deficient in LT or LTPR.4'13 However,
unlike PP formation, ILF formation occurs postnatally
because in utero LTpR-signalling blockade does not inhi¬
bit ILF formation, and their development in adult LT-
deficient mice can be restored by reconstitution with
LT-expressing bone marrow.4,13,14
Follicular dendritic cells (FDCs) reside within B-lym-
phocyte follicles in GCs and are specialized to trap and
retain antigen on their surfaces. Antigen trapped on the
surface of FDCs is considered to promote immunoglob¬
ulin isotype class switching and affinity maturation of
naive IgM+ B lymphocytes.15-19 Consistent with their
role as important sites for the generation of IgA
responses,2 PPs contain all the necessary cellular compo¬
nents required to generate IgA-committed B lymphocytes
including B-lymphocyte follicles, with GCs, T cells and
FDC networks. The ILFs appear structurally and func¬
tionally similar to PPs4 and their inductive nature
implies that they are a complementary system for the
generation of intestinal IgA responses.13 In this study we
demonstrate that mature ILFs also contain large FDC
networks. The presence of FDC networks within gut-
associated lymphoid tissues is considered important for
the induction of intestinal IgA responses.20 Here, the
induction of FDC maturation within ILFs of mice lack¬
ing PPs and mesenteric lymph nodes (MLNs) coincided
with a restoration of faecal IgA to levels comparable
with those found in immunocompetent mice. Therefore,
our data suggest that the FDC networks within ILFs
provide the necessary microenvironment to promote effi¬
cient interaction between luminal derived antigens and B




Both LTa-'- mice21 and LTP-'- mice22 were obtained from
B & K Universal Ltd (Hull, UK) and were maintained on
a C57BL/6 background. Age-matched and sex-matched
C57BL/6 mice were used as immunocompetent wild-type
(WT) controls in the studies using LTa-'- mice and LTp-'-
mice. Severe combined immunodeficiency (SCID) mice
were maintained on a 129/Ola background.23
y-irradiation and bone marrow reconstitution
Bone marrow from the femurs and tibias of immuno¬
competent C57BL/6 WT mice was prepared as a single-
cell suspension (3 x 107 to 4 x 107 viable cells/ml) in
Hank's balanced salt solution (Life Technologies, Paisley,
UK). Recipient adult (6-8 weeks old) LTa-'- mice, LTP-'-
mice and C57BL/6 mice were y-irradiated (950 rads) and
24 hr later were reconstituted with 01 ml bone marrow
by injection into the tail vein.
PP-deficient mice
To create progeny mice that were deficient in PPs, timed
pregnant C57BL/Dk mice were given a single intravenous
injection of 100 pg of a fusion protein containing the sol¬
uble LTPR domain linked to the Fc portion of human
IgGl (LTPR-Ig24) on day 11-5 of gestation.
Immunohistochemical and immunofluorescent analysis
Spleens were snap-frozen at the temperature of liquid
nitrogen. Small intestine from each mouse was divided
into three roughly equal parts, gently squeezed to
remove the gut contents, coiled, embedded in Tissue-
Tek® OCT Compound1M (Bayer Pic., Newbury, UK)
and snap frozen at the temperature of liquid nitrogen.
Serial frozen sections (10 pm thickness) were cut on a
cryostat.
Follicular dendritic cells were visualized by staining
with 8C12 monoclonal antiserum to detect CR1 (CD35;
BD Biosciences PharMingen, Oxford, UK) or 7G6
monoclonal antiserum to detect CR2/CR1 (CD21/CD35;
BD Biosciences PharMingen). Complement components
C3 and C4 were detected using RMC7H8 (Connex,
Martinsreid, Germany) and FDC-M2 (AMS Biotech¬
nology, Oxon, UK) monoclonal antisera, respectively.
B lymphocytes were detected using B220 monoclonal
antiserum to detect CD45R (Caltag, Towcester, UK), or
biotin-conjugated peanut agglutinin (Sigma, Poole, UK)
to detect GC B lymphocytes. T lymphocytes were detec¬
ted using CD3e-specific monoclonal antiserum 2C11
(BD Biosciences Pharmingen).
For light microscopy, following the addition of pri¬
mary antibody, biotin-conjugated species-specific secon¬
dary antibodies (Stratech, Soham, UK) were applied
followed by alkaline phosphatase coupled to the avidin/
biotin complex (Vector Laboratories, Peterborough,
UK). Vector Red (Vector Laboratories) was used as a
substrate, and sections were counterstained with haema-
toxylin to distinguish the cell nuclei. For fluorescent
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microscopy, following the addition of primary antibody,
species-specific secondary antibodies coupled to Alexa
dyes (Invitrogen, Paisley, UK) 488 (green) or 594 (red)
were used. Sections were mounted in fluorescent
mounting medium (Dako, Ely, UK) and examined
using a Zeiss LSM5 confocal microscope (Zeiss, Welwyn
Garden City, UK).
ILF enumeration and morphometric analysis
of FDC networks
Entire small intestines were divided into three equal
parts, coiled, fixed in paraformaldehyde and embedded
in paraffin wax. Serial sections (10 pm thickness) were
deparafinnized and pretreated with Target Retrieval
Solution (DAKO Ltd, Ely, UK). Sections were immuno-
stained with antisera specific for CD45R or CR2/CR1
as described above and examined using a confocal
microscope. The total number of B-lymphocyte-contain-
ing ILFs in the entire small intestine of each mouse
analysed was counted microscopically using CD45R
expression for identification. The maturity of each ILF
was determined according to size and the location and
density of component cells as previously described.13
An image of each mature ILF was captured and the
area covered by FDCs (CR2/CR1+ CD45R" cells) was
measured using image pro plus software (Media Cyber¬
netics, Wokingham, UK).
Measurement offaecal IgA
Faecal pellets were collected from individual mice and
faecal IgA levels were compared by enzyme-linked immuno¬
sorbent assay. Briefly, 10% faecal homogenates were
prepared in carbonate-bicarbonate coating buffer (Sigma)
and centrifuged for 10 min at 12 000 g. Supernatant was
removed and absorbed to flat-bottomed, high-binding
microwell plates (Costar®, High Wycombe, UK) for 18-
24 hr at 4°. Plates were then blocked with 0 01 m phos¬
phate-buffered saline (pH 7-5) containing 5% bovine
serum albumin. Bound IgA was detected using alkaline
phosphatase-conjugated goat anti-mouse IgA (Southern
Biotechnology, Birmingham, AL). Bound alkaline phos¬
phatase activity was measured by incubation with p-nitro-
phenyl phosphate liquid substrate (Sigma). Optical
density was measured at 450 nm using a V-max kinetic
microplate reader (Molecular Devices, Sunnyvale, CA).
Faecal pellets from C57BL/6 WT mice, C57BL/Dk control
mice and SCID mice were used as reference controls.
Statistical analysis
Data are presented as mean ± standard error (SE). Signi¬
ficant differences between samples in different groups
were sought by one-way analysis of variance (anova).
Results
Temporary in utero LTpR-signalling blockade induces
the maturation of ILFs in progeny mice
To temporarily blockade the LTPR-signalling pathway
in utero, pregnant C57BL/Dk mice were given a single
intravenous injection of 100 pg LTpR-Ig on day 11-5 of
gestation. Consistent with previous reports,12 the intes¬
tines from age-matched, untreated, immunocompetent
C57BL/Dk (control) mice contained approximately six
PPs per mouse (n = 11), whereas no PPs were detected
in any of the small intestines taken from progeny mice
treated in utero with LTpR-Ig (n = 12). Microscopic ana¬
lysis revealed the presence of both PPs and ILFs in the
intestines of untreated C57BL/Dk (control) mice (Fig. 1),
whereas only ILFs were found in the intestines of mice
treated in utero with LTpR-Ig (termed PP-deficient
C57BL/Dk mice; Fig. 1).
The maturity of ILFs has previously been defined
according to size and the location and density of the
component cells.13 Immature ILFs (ilLFs) comprise
loosely clustered CD45R* (B220) cells located at the
base of a villus. Mature ILFs (mILFs), in contrast, are
well-organized nodular structures, of similar width to or
greater than the width of one villus, occurring singly or
in groups of two, with a GC and an overlying dome typ¬
ical of the follicle-associated epithelium of a PP. Using
these criteria, double immunostaining for B lymphocytes
(CD45R+ cells) and FDCs (CR2/CR1+ cells) on the same
tissue section revealed that the presence of FDCs (CR2/
CR1+ CD45R cells) could also be reliably used to distin¬
guish ILF maturation status. Our analysis showed that all
mILFs contained FDCs, whereas ilLFs did not (Fig. 1).
The FDCs characteristically trap and retain antigens in
the form of immune complexes composed of antigen,
antibody and/or complement components, storing them
in native form on the cell surface for long periods.25
Immune complex retention on FDCs is highly dependent
on complements and the expression of CR1 (CD35) and
CR2 (CD21). Complement components C3 and C4, in
association with FDCs expressing CR1 and CR2, were
detected within mILFs (Fig. 2) but not within ilLFs (not
shown). Taken together, these data clearly demonstrate
that mILFs in the intestines of PP-deficient C57BL/Dk
mice contain immune complex-trapping FDCs.
FDCs in mILFs compensate for PP deficiency
We next assessed the number of ILFs in the intestines of
PP-deficient mice and control mice, and also compared
the size of the FDC networks within them. Entire small
intestines were double immunostained with monoclonal
antisera specific for B lymphocytes (CD45R+ cells) and
CR2/CR1-expressing FDCs. Sections were examined
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Figure 1. Detection of B lymphocytes and FDCs within ILFs and
PPs in the small intestine. Entire small intestines were examined
from each mouse group and representative images are shown. Sec¬
tions were stained with the CD45R-specific monoclonal antiserum
B220 to detect B lymphocytes (green) and 7G6 monoclonal anti¬
serum to detect CR2/CR1 (CD21/35) expressing FDCs (red). In each
mouse group analysed, FDCs were absent within the B-lymphocyte
aggregations of immature isolated lymphoid follicles (ilLFs; left col¬
umn), whereas both B lymphocytes and FDCs were detected within
all mature ILFs (mILFs; middle column). Original magnification
X200.
microscopically, the ILFs were counted, their maturation
status was recorded and the area within them occupied
by FDCs was measured. The total number of ILFs in the
small intestine of PP-deficient mice was found to be sig¬
nificantly greater than the number in C57BL/Dk (control)
mice (P = 0 001; Fig. 3a). Approximately four-fold more
ILFs were detected in the intestines of PP-deficient mice
than in those of control mice. Although the small intes¬
tines of both groups of mice were found to contain both
mILFs and ilLFs (Fig. 1), a significantly greater propor¬
tion of the ILFs in PP-deficient mice were mature when
compared to those in control mice (46% and 15%,
respectively; P = 0 001; Fig. 3b).
Next, we measured the area of the FDC networks
within the mILFs in PP-deficient mice and those within
both the PPs and mILFs in control mice. We found that
the area occupied by FDCs within individual mILFs from
PP-deficient mice was significantly larger than the area
they occupied in mILFs from control mice (P = 0 001;
Fig. 3c). Furthermore, the total area occupied by FDCs in
all the mILFs in PP-deficient mice was equivalent to the
total area occupied by FDCs in all the PPs and the few
mILFs found in control mice (P = 0-572; Fig. 3d).
LT-expressing bone marrow-derived cells induce the
development of ILFs in LT-deficient mice
Both PPs and ILFs are absent in the intestines of LT-defi¬
cient mice because signalling via the LT(3R is required for
their formation.11,13,26 However, reconstitution of adult
LTor'~ mice13 or LTp~'~ mice with LT-expressing WT
bone marrow (termed WT—>LTa_/~ mice, and WT—>
LTp~'~ mice, respectively) restored the formation of ILFs
(Figs 1 and 4), but not the development of PPs (data not
shown). When assessed 105 days after WT bone marrow
reconstitution, the total number of ILFs in the intestines
of WT—>LToT'~ mice and WT—>LTp_/~ mice was equival¬
ent to the number detected in WT—>WT mice (Fig. 4a).
Mature ILFs in WT bone marrow reconstituted
LT-deficient mice contain FDCs
We next examined the ILFs in intestines from WT—>
WT mice, WT—>LToT/- mice and WT—>LTP_/~ mice
in greater detail. Entire small intestines were double
immunostained with monoclonal antisera specific for B
lymphocytes (CD45R3 cells) and CR2/CRl-expressing
FDCs. Sections were examined microscopically, the ILFs
were counted, their maturation status was recorded and
the area within them occupied by FDCs was measured.
Although both ilLFs and mILFs were detected in the
intestines of each group of mice (Fig. 1), a significantly
greater proportion of the ILFs in WT—»LTa mice and
WT—>LTP mice were mature when compared to those
in WT—>WT mice (P = 0 028, n = 6, and P = 0 002,
n = 5, respectively, when compared to WT—tWT mice;
Fig. 4b).
Consistent with data from the analysis of PP-deficient
mice, all the mILFs in the intestines of WT—>LToT/_ mice,
WT—>LTp-/~ mice and WT—>WT mice contained func¬
tional FDC networks (Fig. 2). When the area of these
FDC networks was measured, those within the mILFs of
WT—>LToT/- mice and WT—>LTp~'~ mice were found to
be significantly larger than those of WT—>WT mice (P =
0 009, n = 6, and P = 0-026, n = 5, respectively, when
compared to WT—>WT mice, n = 6; Fig. 4c). In accord¬
ance with data from PP-deficient C57BL/Dk mice, the
total area occupied by FDCs in all the mILFs in
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C57BL7Dk WT-LTa'" WT->LTp-'-
mlLF mILF mILF spleen
WT—>LTof/_ mice or WT—>LTP_/~ mice was equivalent to
the total area occupied by FDCs in all the PPs and the
mILFs found in WT—>WT mice (P = 0 099, n = 6,
and P = 0-162, n = 5, respectively, when compared to
WT—>WT mice; Fig. 4d).
Mature ILFs contain T lymphocytes and
GC B lymphocytes
Further immunohistochemical analysis revealed that GC
B lymphocytes (peanut agglutinin-positive cells) were
readily detected in the mILFs of all five groups of mice
and were rarely detected in ilLFs (Fig. 5a). Although ILFs
lack the interfollicular T-lymphocyte regions of PPs,
CD3-positive T lymphocytes were detected within both
ilLF and mILFs, and appeared to be more frequent in
mILFs (Fig. 5b).
Enhanced intestinal IgA synthesis in the presence
of mILFs
The finding that mILFs contain GC B lymphocytes and
large FDC networks suggests that mILFs have the potential
to function as inductive sites for mucosal immune
responses. To assess this potential, we next compared the
levels of IgA secreted into the intestines of mice lacking
PPs and/or ILFs. Coincident with the absence of both PPs
and mILFs, IgA levels in the faeces of LTa mice and
Figure 2. Immunohistochemical characteriza¬
tion of FDCs within mILFs. Sections of small
intestine or spleen (far right column) were
stained with CD45R-specific monoclonal anti¬
serum B220 to detect B lymphocytes (top row,
green), CR2/CR1 (CD21/35)-specific (top row,
red) or CR1 (CD35)-specific monoclonal anti-
sera to detect FDCs (second row, red) and
monoclonal antisera specific for complement
components C4 (third row, red) and C3 (bot¬
tom row, red). Complement components in
association with CR1- and CR2-expressing
FDCs were detected in both mILFs and the
spleen. Original magnification x200.
LTP~'~ mice were substantially lower than those in the fae¬
ces of immunocompetent WT mice (Fig. 6a). Similarly,
IgA was undetectable in the faeces of highly immunodefi-
cient SCID mice. In contrast, the induction of ILF matur¬
ation in WT—4LToT/- mice and WT—>LTp_/~ mice (Fig. 4)
coincided with a significant increase in intestinal IgA syn¬
thesis (P = 0-05, n = 4, and P = 0 020, n = 4, respect¬
ively, when compared to unreconstituted LTot-/~ mice and
FTP ~/_ mice) to levels equivalent to those in both WT
mice and WT—>WT mice (Fig. 6a). Similarly, in PP-defici-
ent C57BL/Dk mice which had no PPs but which had sig¬
nificantly increased numbers of mILFs (Fig. 3), faecal IgA
levels were equivalent to those found in C57BL/Dk (con¬
trol) mice (P = 0-245, n = 4; Fig. 6b). The absence of the
MLNs in WT—>LToT/_ mice did not adversely affect faecal
IgA levels because they were equivalent to those of WT
mice, WT—>WT mice and WT—>LTp~'~ mice, which pos¬
sess them. Taken together these results suggest that mILFs
are important inducible components of the mucosal
immune system.
Discussion
The composition of ILFs in the murine small intestine
was investigated. We found that although both ilLFs and
mILFs were present in the intestines of immunocompe¬
tent mice, a significantly greater number of mILFs was
induced in a LT-dependent manner in the absence of
340 © 2006 The Authors Journal compilation © 2006 Blackwell Publishing Ltd, Immunology, 120, 336-344


































































Figure 3. Enumeration of ILFs and FDC area in the small intestines
of PP-deficient C57BL/Dk mice and immunocompetent C57BL/Dk
(control) mice. For each mouse group, sections were stained with
B-lymphocyte- (CD45R) and FDC- (CD21/35) specific antisera and
the entire small intestine was examined microscopically. The number
of ILFs was counted and the area occupied by FDCs was measured,
(a) Intestines from PP-deficient mice contained significantly more
(approximately four-fold more) ILFs than control mice, (b) Intes¬
tines from PP-deficient mice were found to have a significantly
higher percentage of mILFs (46%) when compared to control mice
(13%). (c) The area occupied by FDCs in individual mILFs from
PP-deficient mice was significantly larger than those in mILFs from
control mice, (d) The total area covered by FDCs in the mILFs in
PP-deficient C57BL/Dk mice was equivalent to the total area covered
by FDCs from all the PPs and mILFs in control mice. Each bar rep¬
resents the mean ± SE for each group of mice {n = 12 for PP-defici¬
ent mice, n = 11 for control mice).
PPs. Immunohistochemical analysis revealed that the
presence of functional FDCs could also be used to reliably
distinguish ILF maturity: all mILFs contained large FDC
networks whereas none were detected within ilLFs. The
total area occupied by FDCs in all the mILFs in mice
lacking PPs was substantial and was equivalent to the
total area occupied by FDCs in all the PPs and the few
mILFs found in immunocompetent mice. These data
imply that the induction of GC and FDC network forma¬
tion within mILFs in response to PP deficiency provides a
mechanism to compensate for the absence of PPs. Indeed,
in mice that lacked PPs, ILF maturation coincided with
















Figure 4. Enumeration of ILFs and FDC area in the small intestines
of WT—»WT mice, WT—»LToT/_ mice and WT—»LTp_/_ mice
105 days after reconstitution with WT bone marrow. For each
mouse group, sections were stained with B-lymphocyte- (CD45R)
and FDC- (CD21/35) specific antisera and the entire small intestine
was examined microscopically. The number of ILFs was counted and
the area occupied by FDCs was measured, (a) Similar numbers of
ILFs were found in WT—»WT mice, WT—>LTa~/_ mice and WT—>
LTp_/_ mice, (b) However, WT—»LToT/_ and WT—»LTp~/_ mice were
found to have a significantly higher percentage of mILFs when com¬
pared to WT—>WT mice, (c) The area occupied by FDCs in individ¬
ual mILFs from WT—>LTa_/" mice and WT->LTp~/_ mice was
significantly larger that those in WT—»LTor7~ mice, (d) The total
area covered by FDCs in all the mILFs in WT—>LToT/_ mice or
WT—>LTP~/_ mice was equivalent to the total area covered by FDCs
in all the PPs and mILFs in WT—>WT mice. Each bar represents the
mean ± SE for each group of mice (n = 4 for each group).
The formation of ilLFs is dependent upon stimulation
from LT-expressing lymphocytes which interact with
LTpR-expressing stromal cells in the intestine and induce
the formation of clusters of B220+ cells at the base of a
villus. This initial stimulus can be provided by LT-expres¬
sing B lymphocytes, T lymphocytes or NK cells. Flowever,
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Figure 5. Immunohistochemical detection of (a) GC B lymphocytes
and (b) T lymphocytes within ILFs. Entire small intestines were
examined from PP-deficient C57BL/Dk mice and representative ima¬
ges are shown. Sections were stained with B lymphocyte- (CD45R,
green) and FDC- (CD21/35, red) specific antisera to distinguish
between ilLFs and mILFs (upper row), (a) To detect GC B lympho¬
cytes, adjacent sections were stained with peanut agglutinin (green)
(lower row). Peanut agglutinin-binding GC B lymphocytes were
detected only in mILFs. (b) To detect T lymphocytes, adjacent sec¬
tions were stained with CD3-specific monoclonal antiserum (green)
(lower row). T lymphocytes were found in mILFs, whereas few or































in response to exogenous stimuli, LT-expressing B
lymphocytes trigger the progression of ilLFs into mILFs
resembling lymphoid nodules containing a single B-Iym-
phocyte follicle of predominantly B2-B lymphocytes with
a GC and a follicle-associated epithelium containing
M cells.2'13'14 In this study we also demonstrate that
LT-expressing bone marrow-derived cells also induce the
differentiation of large FDC networks within mILFs.
Follicular dendritic cells trap and retain antigens on
their surfaces through interactions between complement
components and cellular CR1 and CR2.27'28 In our
morphometric analysis studies described above anti-CR2/
CR1 antiserum was used to detect FDCs as they charac¬
teristically express these receptors at high levels.27 Flow-
ever, in the mouse CR1 and CR2 are also expressed on B
lymphocytes, but at lower levels than on FDCs. Thus
CR2/CR1+ B lymphocytes were excluded from our assess¬
ments of FDC size and our calculations were based only
on CR2/CR1+ CD45R~ cells. Parallel studies also demon¬
strated complement components C3 and C4, in associ¬
ation with large networks of CRl-expressing and CR2/
CR1-expressing cells (Fig. 2). These data confirm that the
CR2/CR1+ CD45R" cells identified within mILFs were
functional FDCs capable of trapping and retaining
C3-bearing and C4-bearing immune complexes.27,29
Several lines of evidence support the conclusion that
antigen trapped on the surface of FDCs promotes immuno-
globulin-isotype class switching and affinity maturation of
naive IgM+ B lymphocytes.15""19 Follicular dendritic cells
require important cytokine stimulation from lymphocytes,
Figure 6. The presence of mILFs in mice lacking PPs and MLNs
correlates with enhanced IgA synthesis. Faecal IgA levels were deter¬
mined by enzyme-linked immunosorbent assay and are expressed as
the mean optical density (OD) at 450 nm for triplicate samples from
individual mice. The horizontal bar represents mean OD for each
experimental group of mice (n = 4). (a) In contrast to WT mice,
faecal IgA levels in both LTof'- and LT|V'~ mice were extremely low,
but increased significantly after reconstitution with WT bone mar¬
row. (b) C57BL/Dk (control) mice and PP-deficient C57BL/Dk mice
were found to have equivalent levels of faecal IgA. SCID mice (+)
were used as negative controls. ^Indicates significant difference from
WT mice (P = 0-05).
such as membrane LTcq ()2 and tumour necrosis factor-a,
to maintain their differentiated state.30 Hence, in the
absence of LTpR-stimulation in LToT~ mice, LTp~~ mice
and LTpR_/~ mice, FDC networks and GCs do not develop
and immunoglobulin-isotype class switching is dramatic¬
ally impaired. However, reconstitution of LTa mice and
LTP_/~ mice with WT bone marrow induces the develop¬
ment of FDC networks and GCs in the spleen, supporting
effective immunoglobulin-isotype class switching.15^18'31
Secretory IgA is a major component of the mucosal
immune system and provides an important first line of
defence against infection by microbial pathogens across
mucosal surfaces.1 In this study, coincident with the lack
of FDCs and organized gut-associated lymphoid tissues,
IgA levels were undetectable in the faeces of LTa-/ mice
and LTp-/~ mice. However, reconstitution of LToT" mice
and LTP~/- mice with WT bone marrow (WT—>LToT/_
mice and WT—>LTP~'~ mice, respectively), induced the
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formation of ILFs and the maturation of FDCs and GCs
within them, and coincided with an increase in faecal IgA
levels to those comparable ofWT mice. IgA isotype class-
switching has been shown to occur only within the GCs of
organized gut-associated lymphoid tissues such as PPs and
mILFs, and not in the diffuse lamina propria.2 In another
study the presence of FDC networks within gut-associated
lymphoid tissues was shown to be important for the induc¬
tion of intestinal IgA responses.20 Taken together, our data
imply that FDCs within the GCs of mILFs provide the
necessary microenvironment to promote efficient interac¬
tion between luminal derived antigens and B lymphocytes
to stimulate the generation of effective IgA responses.
Although PPs are absent in LT(3 mice, the MLNs are
retained,32 raising the possibility that IgA isotype class-
switching may also have occurred within GCs in the MLNs
ofWT^LTP"'" mice. However, although LTcT/_ mice lack
both PPs and MLNs,33 their absence in WT—»LTcT/_ mice
did not adversely affect faecal IgA levels, which were equiv¬
alent to those of WT mice, WT—>WT mice and
WT—>LTP" mice (which do possess them). These data
demonstrate that IgA isotype class-switching in response
to luminal antigens can occur in the absence of MLNs,
but is critically dependent upon the presence of organi¬
zed lymphoid tissues such as PPs and mILFs within the
intestine.
One study has suggested that ILFs are not essential for
the induction of intestinal IgA responses.20 In this study,
mice which lacked PPs and MLNs, as a result of com¬
bined in utero TNFR1-signalling and LTpR-signalling
blockade, failed to induce an IgA response after oral
immunization. However, TNFR1 -stimulation is essential
for mILF formation but not ilLF formation.13 Unfortu¬
nately, in the above study20 ILF maturation status in
TNFR1- and LTpR-treated mice was not recorded, but it
is plausible that ILF maturation was significantly impaired
in these mice.
Consistent with other studies,13'14 we found mILFs to
be highly infrequent in the intestines of unmanipulated
immunocompetent control mice in our SPF colony. How¬
ever, in mice that lacked PPs, stimuli from LT-expressing,
BM-derived cells significantly expanded the numbers of
mILFs. The stimuli that trigger ILF maturation and the
role these structures play in intestinal immune responses
are not fully understood. In the absence of immunoglob-
ulin-isotype class switching and impaired IgA production
in activation-induced cytidine deaminase (AID)-deficient
mice, the number of ILFs in the intestine is increased.3
This implies that inflammatory responses precipitated by
a relative deficiency in intestinal IgA stimulate the forma¬
tion of mILFs, providing a mechanism to compensate for
the absence of faecal IgA production. Indeed, our data
show that ILF maturation in mice that lack PPs coincides
with the restoration of faecal IgA levels to be comparable
with those of immunocompetent mice. ILF formation has
also been shown to be driven by the presence of luminal
bacterial flora.13,34 Furthermore, following infection of
mice with the parasitic helminth Trichuris muris,6 a signi¬
ficant increase in the numbers of ILFs in the large intes¬
tine has also been shown to occur.6
In summary, our study has demonstrated that PP-
deficiency intensifies ILF maturation in the murine small
intestine. We found that mILFs, unlike ilLFs, possessed
large FDC networks. The area occupied by the FDCs
within the mILFs of mice lacking PPs was substantial,
and was equivalent to the total area occupied by FDCs
in all the PPs and the few mILFs in immunocompetent
mice. ILF maturation coincided with a restoration of
faecal IgA to levels comparable with those in immuno¬
competent mice, suggesting that mILFs are important
inductive sites for intestinal immune responses. Taken
together, these data imply that the inducible nature of
ILFs and the components within them (e.g. GCs and
FDC networks) provide the intestine with an additional
capacity to respond to mucosal challenges.
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Role of the GALT in Scrapie Agent Neuroinvasion from
the Intestine1
Bridget R. Giaysher and Neil A. Mabbott2
Following oral exposure, some transmissible spongiform encephalopathy (TSE) agents accumulate first upon follicular dendritic
cells (FDCs) in the GALT. Studies in mice have shown that this accumulation is obligatory for the efficient delivery of the TSE
agent to the brain. However, which GALTs are crucial for disease pathogenesis is uncertain. Mice deficient in specific GALT
components were used here to determine their separate involvement in scrapie agent neuroinvasion from the intestine. In the
combined absence of the GALTs and FDCs (lymphotoxin (LT)a_/_ mice and LT/3_/~ mice), scrapie agent transmission was
blocked. When FDC maturation was induced in remaining lymphoid tissues, mice that lacked both Peyer's patches (PPs) and
mesenteric lymph nodes (wild-type (WT)->LTa_/_ mice) or PPs alone (WT—»LT/J_/_ mice) remained refractory to disease,
demonstrating an important role for the PPs. Although early scrapie agent accumulation also occurs within the mesenteric lymph
nodes, their presence in WT—»LT0_/_ mice did not restore disease susceptibility. We have also shown that isolated lymphoid
follicles (ILFs) are important novel sites of TSE agent accumulation in the intestine. Mice that lacked PPs but contained numerous
FDC-containing mature ILFs succumbed to scrapie at similar times to control mice. Because the formation and maturation status
of ILFs is inducible and influenced by the gut flora, our data suggest that such factors could dramatically affect susceptibility to
orally acquired TSE agents. In conclusion, these data demonstrate that following oral exposure TSE agent accumulation upon
FDCs within lymphoid tissue within the intestine itself is critically required for efficient neuroinvasion. The Journal of Immu¬
nology, 2007, 178: 3757-3766.
Transmissible spongiform encephalopathies (TSEs),3 or"prion diseases," are subacute neurodegenerative diseasesthat affect humans and both domestic and free-ranging
animals. The neuropathological features within the CNS charac¬
teristically include spongiform pathology, neuronal loss, glial ac¬
tivation, and amyloidal aggregations of an abnormally folded host
protein. There is little evidence of pathology in other tissues. The
host prion protein (PrPc) is widely expressed in both humans and
animals, and its expression is crucial for TSE disease suscepti¬
bility (1). In TSE-affected tissues, the PrP accumulates as an
abnormal, detergent-insoluble, relatively proteinase-resistant
isoform, termed PrPSc. TSE agent infectivity copurifies with
PrPSc (2) and is considered to be a major or possibly sole com¬
ponent of the infectious TSE agent. Indeed, the prion hypothesis
argues that PrPSc is itself the infectious agent and facilitates
conversion of cellular PrPc to PrPSc.
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TSE diseases typically have long incubation periods before the
onset of clinical signs, which in humans can vary from 1.5 to at
least 40 years. Following peripheral exposure, many of the ac¬
quired TSE agents accumulate in lymphoid tissues such as the
spleen, lymph nodes, tonsils, appendix, and Peyer's patches (PPs),
before spreading to the CNS, a process termed neuroinvasion. Ex¬
amples include sheep with natural scrapie (3), mule deer with
chronic wasting disease (4), and humans with variant Creutzfeldt-
Jakob disease (vCJD) (5). Within the lymphoid tissues of both
experimentally and naturally affected hosts, early PrPSc accumu¬
lation occurs within the germinal centers upon follicular dendritic
cells (FDCs) and within tingible body macrophages (4-9). FDCs
are a distinct lineage from migratory bone marrow-derived den¬
dritic cells because they are considered to derive from stromal
precursor cells, are nonphagocytic, and are nonmigratory (10). In
mouse scrapie models, mature FDCs are critical for scrapie agent
accumulation in lymphoid tissues, and in their absence, neuroin¬
vasion is significantly impaired (11-14). From the lymphoid tis¬
sues, translocation to the CNS occurs via the peripheral nervous
system (15, 16).
The suggestion that consumption of bovine spongiform enceph-
alopathy-contaminated meat products is the most likely cause of
vCJD in humans (17) has focused attention on the gastrointestinal
tract as an important portal of TSE entry. Following intragastric or
oral inoculation of rodents with scrapie, infectivity and PrPSc ac¬
cumulate first in PPs, mesenteric lymph nodes (MLNs), and gan¬
glia of the enteric nervous system long before their detection in the
CNS (18, 19). Natural sheep scrapie may also be acquired orally as
PrPSc is detected in the GALT before detection within the CNS (6).
Likewise, PrPSc is first detected in the GALT following experi¬
mental oral inoculation of mule deer fawns (Odocoileus hemionus)
with chronic wasting disease (4). The detection of disease-specific
PrP within the GALT of a human vCJD patient 8 mo before the
onset of clinical signs is also consistent with the transmission of
this disease by the oral route (5).
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The GALT comprises chiefly of appendix, tonsils, PPs, MLNs,
and ILFs, but which if any of these tissues are crucial for the oral
pathogenesis of TSEs is unclear. Previous studies have used a va¬
riety of immunodeficient mouse lines to study the involvement of
FDCs and PPs in oral scrapie pathogenesis, including TNF-a_/~ X
lymphotoxin (LT)a-/~ mice, alylaly mice, j37_/~ mice, RAG-
mice, and gMT-'" mice (20-22). However, the individual
contributions of the deficiencies in lymphoid tissue, lymphoid tis¬
sue microarchitecture, or FDC development were not distinguished
in the same mouse strains. In the current study, mouse models
were created that lacked specific GALT components (PPs, MLNs,
and ILFs) but had mature FDC networks in the remaining lym¬
phoid tissues. The presence of FDCs in the remaining lymphoid
tissues ensured that TSE agent accumulation could occur within
these tissues if the missing tissues were not critical to disease
pathogenesis. Using these mouse models, experiments were de¬
signed to address the following questions: first, whether TSE sus¬
ceptibility is reduced in the absence lymphoid tissue within the
intestine itself (e.g., PPs)? Second, whether neuroinvasion occurs
from multiple sites such that the lack of one compartment (e.g.,
PPs) can be compensated for by the presence of another (e.g.,
MLNs)? Third, whether neuroninvasion can occur via other lym¬
phoid tissues (e.g., spleen) in the absence of the GALT?
Materials and Methods
Mice
LTa-'- mice (23) and LT|8-'- mice (24) were obtained from B&K Uni¬
versal and were maintained on a C57BL/6 background. Age- and sex-
matched C57BL/6 mice were used as immunocompetent wild-type (WT)
controls in studies using LTa-'- mice and LT/3-'- mice.
Gamma irradiation and bone marrow reconstitution
Bone marrow from the femurs and tibias of immunocompetent C57BL/6
WT mice was prepared as a single-cell suspension (3 X 107—4 X 107
viable cells/ml) in HBSS (Invitrogen Life Technologies). Recipient adult
(6-8 wk old) LTa-'- mice, LT/3-'- mice, and C57BL/6 mice were
gamma irradiated (950 rad) and 24 h later reconstituted with 0.1 ml of bone
marrow by injection into the tail vein.
PP-deficient mice
To create progeny mice deficient in PPs, timed pregnant C57BL/Dk mice
were given a single i.v. injection of 100 fig of a fusion protein containing
the soluble LT/3R domain linked to the Fc portion of human IgGl (LT/3R-
Ig; Ref 25) on day 11.5 of gestation (26).
Scrapie agent inoculation
For oral inoculation mice were fed individual food pellets doused with 50
ju.1 of a 1.0% (w/v) scrapie brain homogenate prepared from mice termi¬
nally affected with ME7 scrapie. Where indicated, separate groups of mice
were inoculated by intracranial injection with 20 /x 1 of a 1.0% (w/v) scrapie
mouse brain homogenate (containing —1 X 104 5 ID50 units). Following
challenge, animals were coded and assessed weekly for signs of clinical
disease and killed at a standard clinical end point (27). Scrapie diagnosis
was confirmed by histopathological assessment of vacuolation in the brain.
Where indicated, some mice were sacrificed 70 days postchallenge, and
small intestines, MLNs, and spleens taken for further analysis. For the
construction of lesion profiles, vacuolar changes were scored in nine gray-
matter areas of brain as described previously (28).
Immunohistochemical and immunofluorescent analysis
Spleens and MLNs were removed and snap-frozen at the temperature of
liquid nitrogen. Small intestines from each mouse were divided into three
roughly equal parts, gently squeezed to remove gut contents, coiled, em¬
bedded in Tissue-Tek OCT Compound (Bayer), and snap-frozen at the
temperature of liquid nitrogen. Serial frozen sections (10 /am in thickness)
were cut on a cryostat. FDCs were visualized by staining with mAb 8C12
to detect CR1 (CD35) or mAb 7G6 to detect CR2/CR1 (CD21/CD35; BD
Biosciences Pharmingen). Complement components C3 and C4 were de¬
tected using mAb RMC7H8 (Connex) and mAb FDC-M2 (AMS Biotech¬
nology), respectively. Cellular PrPc was detected using PrP-specilic poly¬
clonal Ab (pAb) 1B3 (29). B lymphocytes were detected using mAb B220
to detect CD45R (Caltag Laboratories). M cells were detected using biotin-
conjugated Ulex europaeus agglutinin I (UEA-1; Vector Laboratories).
Lymphatic vessels were detected using lymphatic vessel endothelial
hyaluronic acid receptor (LYVE-1 )-specific antiserum (Upstate Bio¬
technology). Nerve fibers and supportive cells were detected using
S 100-specific antiserum (DakoCytomation).
For the detection of disease-specific PrP (TrF!) in brain tissue and small
intestines, tissues were fixed in periodate-lysine-paraformaldehyde and em¬
bedded in paraffin wax. Sections (thickness, 6 /urn) were deparaffinized and
pretreated to enhance PrP immunostaining by hydrated autoclaving (15
min, 121°C, hydration), and subsequent immersion in formic acid (98%)
for 5 min (7). This pretreatment enhances the detection of PrPd. Sections
were then stained with the PrP-specific pAb 1B3 (29). Glial fibrillary acid
protein (GFAP) was detected on adjacent brain sections using rabbit
GFAP-specific antiserum (DakoCytoniation). To detect FDCs and B lym¬
phocytes in paraffin-embedded small intestines, sections were deparaf¬
finized and pretreated with Target Retrieval Solution (DakoCytomation)
and immunostained with mAb 7G6 and mAb B220, respectively, as de¬
scribed above.
For light microscopy, following the addition of primary Abs, biotin-
conjugated species-specific secondary Abs (Stratech) were applied fol¬
lowed by alkaline phosphatase or HRP coupled to the avidin/biotin
complex (Vector Laboratories). Vector Red (Vector Laboratories) and
diaminobenzidine were used as substrates, respectively, and sections were
counterstained with hematoxylin to distinguish cell nuclei. For fluorescent
microscopy, following the addition of primary Ab, species-specific sec¬
ondary Abs coupled to Alexa Fluor 488 (green) or Alexa Fluor 594 (red)
dyes (Invitrogen Life Technologies) were used. Sections were mounted in
fluorescent mounting medium (DakoCytomalion) and examined using a
Zeiss LSM5 confocal microscope (Zeiss).
ILP enumeration and analysis
Entire small intestines from each mouse were divided into three equal
parts, coiled, fixed in paraformaldehyde, and embedded in paraffin wax.
Serial sections (10 ;um in thickness) were deparaffinized and immuno¬
stained with antisera specific for CD45R or CR2/CR1 as described above
and examined using a confocal microscope. The total number of B lym¬
phocyte-containing ILFs in the entire small intestine of each mouse ana¬
lyzed was counted microscopically using CD45R expression for identifi¬
cation. The maturity of each ILF was determined according to size and the
location and density of component cells as described previously (30). The
presence or absence of FDCs (CR2/CR1 +CD45R~ cells) within each ILF
was recorded.
Immunoblot detection of PrPs'
Spleen fragments (—20 mg) or MLNs (approximately half the total from
each mouse assayed) were prepared as 10% (w/v) tissue homogenates, and
PrpSc was enriched by sodium phosphotungstic acid precipitation (31) and
treated in the presence or absence of proteinase K (40 ng/ml, 60 min, 37°C;
VWR). Following enrichment, pellets were resuspended and diluted to 0.5
mg protein/ml, and 10 ftl was electrophoresed through SDS-PAGE gels
(12%) polyacrylamide gels (Invitrogen Life Technologies). Proteins were
transferred to polyvinylidene difluoride membranes (Bio-Rad) by semidry
blotting. PrP was detected with the PrP-specific mouse mAb 8H4 (32),
followed by HRP-conjugated goat anti-mouse antiserum. Bound HRP ac¬
tivity was detected with Supersignal West Dura Extended Duration Sub¬
strate (Pierce).
Statistical analysis
Data are presented as mean ± SE. Significant differences between samples
in different groups were sought by one-way ANOVA. Values of p < 0.05
were accepted as significant.
Results
Effect of lymphotoxin deficiency on scrapie accumulation in
lymphoid tissues
The intestines of LTa-'- mice and LT/3-'- mice lack PPs as
LT/3R signaling during embryonic development is required for
their formation (30, 33, 34). In addition LTa-'- mice also lack the
MLNs as LTa deficiency blocks their formation (34). However,
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FIGURE 1. Immunohistochemical detection of FDCs within the MLNs
(A) and spleens (B) of WT mice, LTa-'- mice, and LT/3-'- mice. CD21/
CD35-expressing (red) FDCs and organized B lymphocyte follicles
(CD45R-positive cells; green) were detected in the tissues of WT mice. No
FDCs were detected in tissues from LTa-'- mice and LT/3-'- mice. Orig¬
inal magnification: X200.
postnatal stimulation via lymphocyte-derived LTa,j32 is criti¬
cally required to maintain FDCs in their differentiated state
(35). As a consequence, the remaining MLNs and spleens of
LTj3-/- mice (Fig. 1, A and B, respectively) and the spleens of
LTa-'- mice (Fig. IB) are deficient in FDCs. Because FDCs
are critical for the efficient neuroinvasion of the ME7 scrapie
agent from the intestine (13), we first investigated scrapie
pathogenesis in the combined absence of GALT (MLNs and/or
PPs) and FDCs in the remaining lymphoid tissues in LTa-'-
mice and LT/3-'- mice.
In this study, the normal cellular form of the PrP is referred to
as PrPc, and two terms (PrPSc or PrPd) are used to describe the
disease-specific, abnormal accumulations of PrP that are charac¬
teristically found only in TSE-affected tissues and considered to
represent the presence of the TSE agent (2). Disease-specific PrP
accumulations are relatively resistant to proteinase digestion,
whereas cellular PrPc is destroyed by this treatment. Where we
were able to confirm this resistance by proteinase K treatment of
samples and analysis by immunoblot, PrPSc is used as a biochem¬
ical marker for the presence of the TSE agent. Unfortunately, treat¬
ment of tissue sections with proteinase K destroys the microarchi¬
tecture. Therefore, tissue sections were fixed and pretreated to
enhance the detection of the disease-specific abnormal accumula¬
tions of PrP (PrPd), whereas cellular PrP° is denatured by these
treatments (7). We have shown in a series of studies that these PrPd
accumulations occur only in the tissues of TSE-affected animals
and correlate closely with the presence of the TSE agent (7, 8, 11,
13, 19). Expression levels of cellular PrPc in tissues from unin¬
fected mice were analyzed on acetone-fixed frozen sections. Im¬
munocompetent C57BL/6 WT mice, LTa-'- mice, and LT/3-'-
mice were inoculated orally with the ME7 scrapie strain. Within 70
days of oral inoculation of WT mice with the ME7 scrapie agent,
strong accumulations of PrPd and agent infectivity are found
within PPs (Ref. 13; N. A. Mabbott, unpublished observations).
High levels of proteinase K-resistant PrPSc and agent infectivity
are also found within MLNs (Fig. 2A, lanes 2 and 4\ Ref. 13;
N. A. Mabbott, unpublished observations) and are sustained
until the terminal stage of disease (Fig. 2C, lanes 2 and 4).
However, in the MLNs of LT/3-'- mice or the mesenteric mem¬
branes taken from MLN-deficient LTa-'- mice, PrPSc was un¬
detectable both 70 days (Fig. 2A) and 545 days (Fig. 2C) after
inoculation. No PrPSc was detected in any of the spleens from
WT mice, LTa-'- mice, and LT/3-'- mice assayed 70 days
after inoculation (Fig. 2B). However, strong accumulations of
PrPSc were found in the spleens of WT mice taken at the ter¬
minal stage of disease (Fig. 2D), but the subsequent accumu¬
lation in the spleens of LTa-'- mice and LT/3-'- mice was
blocked (Fig. 2D). Thus, in the absence of PPs and FDCs in
remaining lymphoid tissues, PrPSc accumulation in MLNs and
the spleen is blocked.
Effect of lymphotoxin deficiency on scrapie susceptibility
We next determined the effect of the combined GALT and FDC
deficiency in LTa-'- mice and LT/3-'- mice on scrapie suscep¬
tibility. All orally inoculated WT mice succumbed to clinical TSE
disease with a mean incubation period of 311 ± 3 days (n = 20;
Table I). In contrast, LT deficiency dramatically affected scrapie-
susceptibility as all LTa-'- mice (n = 13) and LT/3-'- mice (n =
18) remained free of the signs of scrapie up to at least 545 days
after oral inoculation (Table I). Characteristic PrPd accumulation,
reactive astrocytes, and spongiform pathology were detected in
the brains of all clinically affected WT mice (Fig. 3A). The
severity and distribution of the pathological vacuolation within
the brains of WT mice was typical for oral infection with the
ME7 scrapie strain (Fig. 36). However, none of the pathological
FIGURE 2. PrP c accumulation in the MLNs and
spleens of LTa-'- mice and LT/3-'- mice is
blocked following oral inoculation with scrapie. A
and C, MLNs (or the mesenteric membrane contain¬
ing the region where MLNs would have been in
LTa-'- mice) and spleens (B and D) were collected
70 days after oral inoculation with the scrapie agent
(4 and B) or at the terminal stage of disease (C and
D). Samples were treated in the presence (+) or ab¬
sence (—) of proteinase K (PK) before electrophore¬
sis. After PK treatment, a typical three-band pattern
was observed between molecular mass values of
20-30 kDa, representing unglycosylated, monogly-
cosylated, and diglycosylated isomers of PrP (in or¬
der of increasing molecular mass), dpi, day postin-
oculation on which the tissues were analyzed; pos,
mice that developed clinical signs of scrapie; neg,
mice that were free of the signs of scrapie. dpi
PK - + - + - +
dpi 70 70 70 70 70
PK ~ + - +- + - + - + - +
dpi 70 70 70 70 70 70
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Table I. Effect of lymphotoxin deficiency on scrapie agent susceptibility




Mouse Strain PPs mlLFs" MLNs SPL FDCs Incidence* period (days) ± SE Incidence period (days) ± SE
WT +c 5 + + + 20/20 311 ± 3 6/6 173 ± 4
LTa~/_ - 0 - + - 0/13 13X >545 5/5 175 ± 4
LT/3-/~ - 0 + + - 0/18 18X >545 6/6 172 ± 3
a Number of mILFs present in the small intestine at the time of inoculation.
b Incidence = number of animals affected/number of animals tested. The notation "NX > 545" means that mice were free of the clinical and
pathological signs of scrapie up to at least this time after inoculation.
: +
, present; —, absent.
characteristics of TSE disease were detected within the brains
of any of the surviving LTa~/_ mice and LT/3~/_ mice (Fig. 3,
A and B).
When inoculated with the scrapie agent directly into the CNS
(by intracranial injection) WT mice, LTa~'~ mice, and LTj3-/_
mice developed clinical scrapie with similar incubation periods
of 172-175 days (Table 1). These data confirm that the apparent
resistance of LTc*_/~~ mice and LT/3~/_ mice to orally inocu¬
lated scrapie agent could not be attributed to a role for LT/3R
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FIGURE 3. Immunohistochemical and pathological analysis of brain tissue from terminally scrapie-alfected mice and mice that remained free of the
signs of disease at the end of the experiment. A and B, Brains from WT mice, LTa~/_ mice, and LT/3_/~ mice inoculated orally with the scrapie agent.
C and D, Brains from WT^WT mice, WT—»LTa:~/- mice, and WT—»LT/3_/_ mice inoculated orally with the scrapie agent. Large PrPd accumulations
(brown; upper rows), reactive astrocytes expressing high levels of GFAP (red; middle rows), and spongiform pathology (lower rows) were detected in the
hippocampi of all clinically scrapie-affected WT mice (A) and WT—>WT mice (C), but not in the brains clinically negative LTa_/~ mice and LTj3_/~ mice
(A), and WT—»LTo:-/- mice and WT—>LT/3-/_ mice (C). All sections were counterstained with hematoxylin (blue). Original magnification: X200. dpi,
day postinoculation on which the tissues were analyzed; pos, mice that developed clinical signs of scrapie; neg, mice that were free of the signs of
scrapie. B and D, Pathological assessment of the spongiform change (vacuolation) in brains from terminally scrapie-afFected mice and mice that
remained free of the signs of disease at the end of the experiment. Vacuolation was scored on a scale of 0-5 in the following gray matter (G1-G9)
areas: Gl, dorsal medulla; G2, cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6, hippocampus; G7, septum; G8,
retrosplenial and adjacent motor cortex; G9, cingulate and adjacent motor cortex. Each point represents mean vacuolation score ± SE for groups
of 6-20 mice.
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FIGURE 4. Immunohistochemical analysis of the microarchitecture of
the MLNs and spleen at the time of scrapie challenge. A, CD21/CD35-
expressing (red) FDCs and organized B lymphocyte follicles (CD45R-pos-
itive cells; green) were detected in the MLNs of WT—»WT mice and
WT—»LT/3_/_ mice (upper row) and spleens of WT—»WT mice,
WT—»LTa_/_ mice, and WT—>LTj3_/_ mice (lower row). B, The levels
of PrPc expressed upon FDCs (red) were similar in the MLNs ofWT-»WT
mice and WT—>LT/3~'~ mice (upper row) and spleens ofWT-»WT mice,
WT—>LTa_/_ mice, and WT—>LT/3-/_ mice (lower row). Original mag¬
nification: X200.
Reconstitution of LT-deficient mice with WT bone marrow
induces FDC development in remaining lymphoid tissues but not
the development ofmissing lymphoid tissues
Next, the effects of GALT deficiency, but not FDC deficiency, on
scrapie pathogenesis were investigated. Adult WT mice, LTa_/_
mice, and LTf3~'~ mice were reconstituted with LT-expressing
WT bone marrow (termed WT—»WT mice, WT—»LTa-/_ mice,
and WT—>LTj8_/_ mice, respectively). Within 35 days of WT
bone marrow transfer, FDC networks were induced in the remain¬
ing lymphoid tissues of LTa_/_ mice and LT|3~/- mice (Fig. 4A),
but such treatment did not induce the development of missing lym¬
phoid tissues (Table II). Expression of the cellular form of the PrP,
PrPc, upon FDCs within the MLNs (where present) and spleens of
WT—»LTo:~/- mice and WT—»LT£P/_ mice appeared similar to
that in tissues from WT->WT mice (Fig. 4B).
Scrapie pathogenesis in the absence ofMLNs and/or PPs
Groups ofWT^WT mice, WT—>LTa_/_ mice, and WT—>LTj3_/_
mice were inoculated orally with scrapie 35 days after reconstitu¬
tion with WT bone marrow. Strong accumulations of PrPd were
observed within the PPs of WT^WT mice within 70 days of
inoculation (Fig. 5A) and were maintained until the terminal stage
of disease (Fig. 5B). The distribution of the PrPd within PPs was
consistent with accumulation upon FDCs (8, 13). However, PrPd
accumulation within the intestines of WT—»LTo:_/- mice and
WT—»LT/3~/_ mice was blocked (Fig. 5).
In the MLNs, PrPSc was undetectable in tissues from WT—>WT
mice, WT—>LTa-/_ mice, and WT^LT/3~/_ mice assayed 70
days after inoculation (Fig. 6A), although PrPSc was detected in
one of the spleens from a WT^WT mice taken at this time (Fig.
6B, lane 2). At the terminal stage of disease strong accumulations
of PrPSc were found in the MLNs and spleens of WT—>WT mice
(Fig. 6, C and D). However, the accumulation of PrPSc in the
MLNs (where present) and spleens of WT^LTa_/_ mice and
WT—»LTj3_/_ mice remained undetectable (Fig. 6, C and D).
We next determined the effect of MLN and/or PP deficiency on
disease susceptibility. All orally inoculated WT—»WT mice suc¬
cumbed to clinical TSE disease with a mean incubation period of
337 ± 4 days (n = 8, Table II). In contrast, in the absence of both
PPs and MLNs, scrapie susceptibility was dramatically affected as
all orally inoculated WT—»LTa_/_ mice (n = 8) remained free of
the signs of scrapie up to at least 503 days after inoculation (Table
II). Furthermore, in the absence of PPs alone, scrapie susceptibility
was also dramatically affected as all WT—>LT0w_ mice (n = 7)
remained free of clinical scrapie (Table II). Typical neuropatho-
logical characteristics of TSE infection were detected within the
brains of all WT—>WT animals that developed clinical signs of
scrapie (Fig. 3, C and D). None of these characteristics were de¬
tected within the brains of any of the surviving WT^LTa
mice and WT—>LTj3_/~ mice (Fig. 3, C and D).
In this study, a highly sensitive immunoblot method was used to
detect PrPSc in our tissue samples (31). Therefore, we are confident
that in this study the combined absence of 1) PrPSc in the GALT
and spleen, 2) PrPd and neuropathological signs within the CNS,
and 3) clinical signs of TSE disease, is convincing evidence that
transmission was blocked in scrapie-inoculated LTa~/_ mice,
LTj3~/_ mice, WT—>LTa_/~ mice, and WT—>LT/3~/_ mice.
Table II. Reconstitution of LT-deficient mice with WT bone marrow induces FDC maturation in remaining
lymphoid tissues but does not restore susceptibility to orally inoculated scrapie agent
Presence at Time of Inoculation Oral Scrapie Inoculation
Mean incubation
Mouse Strain11 PPs mlLFs* MLNs SPL FDCs Incidence period (days) ± SE
WT—>WT +c 0 + + + 8/8 337 ± 4
WT->LTa"/_ - 0 - + + 0/8 5X > 503d
WT—>LT/3-/~ - 0 + + + 0/7 4X > 503*
a Mice were inoculated orally with the scrapie agent 35 days after gamma irradiation and reconstitution with WT bone
marrow.
b Number of mILFs present in the small intestine at the time of inoculation.
c +, present; —, absent.
d Three mice were killed 406, 450, and 467 days after inoculation. These mice were free of the clinical signs of scrapie at
the time of cull. No histopathological signs of scrapie were detected in the brain (data not shown).
' Three mice were killed 413, 455, and 455 days after inoculation. These mice were free of the clinical signs of scrapie at
the time of cull. No histopathological signs of scrapie were detected in the brain (data not shown).
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FIGURE S. Detection of PrPd in the intestines of
WT—»WT mice, WT—>LTa-/_ mice, and WT—*
LT/3~'~ mice following oral inoculation with the
scrapie agent. Small intestines were collected (A) 70
days after oral inoculation or (B) at the terminal stage of
disease. Adjacent sections were stained with CD45R-
specific antiserum B220 to detect B lymphocytes (red),
CD21/35-specific antiserum to detect CR2/CRl-ex-
pressing FDCs (red), and PrP-specific antiserum 1B3
(red). Strong PrPd staining colocalized with CD21/35
expressing FDCs in the PPs and the few mILFs of
WT—»WT mice 70 days after oral inoculation (A) and at
the terminal stage of disease (B). PrPd was not detected
in the mILFs of scrapie-inoculated WT—>LTa-/~ mice
or WT—>LTjS mice, dpi, day postinoculation on
which the tissues were analyzed; pos, mice that devel¬
oped clinical signs of scrapie; neg, mice that were free
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Mature ILFs contain FDCs
Novel lymphoid clusters termed ILFs have been identified along
the antimesenteric wall of the mucosa of the intestine (36). The
maturity of ILFs has previously been defined according size and
the location and density of component cells (30). Whereas imma¬
ture ILFs (ilLFs) comprise loosely clustered CD45R+ (B220) cells
located at the base of villi (Fig. 7A), mature ILFs (mILFs) are
organized nodular structures, of width greater than one villus and
comprise a single B lymphocyte follicle (Fig. 1A) with an overly¬
ing M cell-containing epithelium similar to the follicle associated
epithelium of PPs (Fig. ~1D). Using these criteria, double immu-
nostaining for B lymphocytes (CD45R+ cells) and FDCs (CR2/
CR1 ' CD45R- cells) on the same tissue section revealed that the
presence of FDCs could also be reliably used to distinguish ILF
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FIGURE 6. PrPSc accumulation in
the MLNs and spleens of WT-*
LTa-/~ mice and WT—>LT/3-/~ mice
is blocked following oral inoculation
with the scrapie agent. A and C,
MLNs (or the mesenteric membrane
containing the region where MLNs
would have been in WT-^LTa~/-
mice) and spleens (B and D) were col¬
lected 70 days after oral inoculation
with the scrapie agent (A and B) or at
the terminal stage of disease (C and
D). Samples were treated in the pres¬
ence (+) or absence (—) of proteinase
K (PK) before electrophoresis, dpi,
day postinoculation on which the tis¬
sues were analyzed; pos, mice that
developed clinical signs of scrapie;
neg, mice that were free of the signs
of scrapie.
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FIGURE 7. Immunohistochemical characterization of mILFs. A, ilLFs
typically comprise a loose aggregation of B lymphocytes at the base of a
villus (CD45R-positive cells; green), whereas mILFs contain both B lym¬
phocytes and CR2/CR1-expressing FDCs (CD21/CD35-positive cells;
red). B, Complement components C4 (red; middle) and C3 (red; right) in
association with CR1-expressing FDCs (CD35-positive cells; red; left)
were detected within mILFs indicating the presence of functional FDCs.
(C) In ilLFs, CR1-expressing FDCs (CD35-positive cells; red; middle) and
associated C4 (red; right) are absent. D, M cells (UEA-1-positive cells; red;
arrowheads) were detected within the epithelium overlying mILFs. Right
panel shows an enlargement of the boxed area. E, Lymphatic vessels
(LYVE-1-expressing cells; brown) were detected within the cores of villi
{left panel) and within and around mILFs {right panel). F, PrP (green) and
S-100 (red)-expressing nerve fibers, and supportive cells were delected
within the gut wall and in close association with mILFs. In B-E, sections
were counterstained with hematoxylin (blue). Each image is orientated
such that the intestinal lumen is uppermost. Original magnification: X200.
maturation status. In this study, >1000 ILFs were analyzed, and our
data showed that all mILFs consistently possessed large networks of
immune complex-trapping FDCs (Fig. 7, A and B). FDCs were never
detected in ilLFs (Fig. 7, A and C). Like PPs, ILFs lack afferent lym¬
phatics, but LYVE-1-expressing cells were observed in close associ¬















FIGURE 8. Detection of PrPd in the intestines of control mice and PP-
deficient mice following oral inoculation with the scrapie agent. Small
intestines were collected (A) 70 days after oral inoculation or {B) at the
terminal stage of disease. Adjacent sections were stained with CD45R-
specific antiserum B220 to detect B lymphocytes (red), CD21/35-specific
antiserum to detect CR2/CR1-expressing FDCs (red), and PrP-specific an¬
tiserum 1B3 (red). At each time point after scrapie inoculation, strong PrPd
staining was found to colocalize with CD21/35-expressing FDCs in the PPs
and the mILFs of control mice and also in the mILFs of PP-deficient mice,
dpi, day postinoculation on which the tissues were analyzed; pos, mice that
developed clinical signs of scrapie; neg, mice that were free of the signs of
scrapie. Original magnification: X100.
IE). S-100-expressing nerve fibers and supportive cells were detected
within the gut wall and in close association with mILFs (Fig. IF).
Involvement ofmILFs in scrapie agent neuroinvasion from the
intestine
Having demonstrated that mILFs contain large FDC networks we
next determined whether scrapie agent neuroinvasion from the in¬
testine could also occur from mILFs. Stimulation via LT/3R is also
important for the development of ILFs as these structures are ab¬
sent in LT-deficient mice (30, 36). However, unlike PPs, ILF for¬
mation occurs postnatally, and their development in LT-deficient
Table III. Effect of PP deficiency on susceptibility to orally inoculated scrapie
Presence at Time of Inoculation Oral Scrapie Inoculation
Mean incubation
Mice PPs mILFsa MLNs SPL FDCs Incidence period (days) ± SE
C57BL/Dk (control) +b 2 + + + 16/16 319 ± 3
PP deficient0 - 20 + + + 10/10 313 ± 6
° Number of mILFs present in the small intestine at the time of inoculation.
b +, present; —, absent.
c Mice treated in utero with LT/3R-Ig on day 11.5 of gestation to ablate PP formation.
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FIGURE 9. PrPSc accumulation in the MLNs and spleens of control
mice and PP-deficient mice following oral inoculation with scrapie. MLNs
(4 and C) and spleens (B and D) were collected 70 days after oral inocu¬
lation with the scrapie agent (A and B) or at the terminal stage of disease
(C and D). Samples were treated in the presence (+) or absence (—) of
proteinase K (PK) before electrophoresis. Lane M contained molecular
mass markers, dpi, day postinoculation on which the tissues were analyzed;
pos, mice that developed clinical signs of scrapie; neg, mice that were free
of the signs of scrapie.
mice can be restored by reconstitution with WT bone marrow (30,
36). In the experiments described above (Table II), no FDC-con-
taining mILFs were present within the intestines of WT->WT
mice, WT—»LTa_/_ mice, and WT—»LT/3_/_ mice at the time of
scrapie inoculation, as these structures take much longer than 35
days to develop after WT bone marrow transfer (—8-12 wk; Refs.
30 and 37). The numbers of mILFs in the intestines of immuno¬
competent control mice in our specific pathogen-free colony are ex¬
tremely low or absent (typically 0-6 mILFs/mouse). However, in the
absence of PPs, LT/3R stimulation substantially increases the number
of mILFs in the intestine (30). We therefore created mice that lacked
PPs but contained numerous mILFs in their intestines through treat¬
ment of pregnant C57BL/Dk mice with LT/3R-Ig (26, 30). As ex¬
pected, PP formation in the progeny mice was blocked (termed PP-
deficient mice), but the development of a significantly greater number
of FDC-containing mILFs was induced when compared with un¬
treated C57BL/Dk (control) mice (p £ 0.001; Table III).
Control and PP-deficient mice (81-110 days old) were inoculated
orally with the scrapie agent. Strong accumulations of PrP*1 were ob¬
served upon FDCs within each of the numerous mILFs of PP-defi¬
cient mice (—20 mILFs per PP-deficient mouse, n — 14) and the PPs
and occasional mILFs in control mice within 70 days of oral inocu¬
lation (Fig. 8A) and at the terminal stage of disease (Fig. SB). PrP11 ac¬
cumulations were never observed within ilLFs from each mouse group.
In the MLNs, PrPSc was detected in all tissues from control mice
70 days after inoculation, but the levels detected in tissues from
PP-deficient mice were variable (Fig. 94). However, high levels of
PrPSc levels were detected in MLNs from each mouse group at the
terminal stage of disease (Fig. 9C). No PrPSc was detected in any
of the spleens taken from control mice and PP-deficient mice 70
days after inoculation (Fig. 96), but strong accumulations were
observed at the terminal stage of disease (Fig. 9D).
Additional experiments demonstrated that the susceptibility of PP-
delicienl mice to orally inoculated scrapie agent was not significantly
affected, as all control mice and PP-deficient mice succumbed to clin¬
ical TSE disease with similar incubation periods (Table III) and dis¬
played similar neuropathological characteristics within the brain (data
not shown). Together, these data imply that FDCs within mILFs are
also important sites of TSE agent neuroinvasion from the intestine.
Discussion
In this study, we show that in the combined absence of the GALT and
FDCs at the time of inoculation, scrapie agent transmission from the
gastrointestinal tract is blocked. Furthermore, when FDC maturation
is induced in remaining lymphoid tissues, mice that lack PPs remain
refractory to oral scrapie challenge. Although the scrapie agent also
accumulates upon FDCs within the MLNs shortly after inoculation,
our data show that MLNs are dispensable for TSE agent neuroinva¬
sion from the intestine. We show that mILFs along the antimesenteric
wall of the small intestine contain large FDC networks, and like PPs,
are important sites of TSE agent neuroinvasion. Together, these data
demonstrate that TSE agent accumulation upon FDCs within GALT
in the intestine itself (e.g., PPs and mILFs) is critically required for
efficient neuroinvasion following oral exposure.
When considered in the context of recent studies, our data sug¬
gest that TSE agent neuroinvasion from the intestine occurs via the
following pathway. Following oral inoculation, FDCs are critical
initial sites of TSE agent accumulation within the GALT (13). In
the absence of FDCs at the time of inoculation, TSE agent accu¬
mulation in the PP and subsequent neuroinvasion are blocked (13).
In the current study, we show that in the absence of PPs, but not
FDCs within other lymphoid tissues, neuroinvasion is likewise
blocked indicating a critical role for PPs and the FDCs within them
in TSE agent neuroinvasion from the intestine. We also show that
mILFs, like PPs, are novel and important sites of TSE agent neu¬
roinvasion from the intestine. Because the number and maturation
status of ILFs is dramatically influenced by luminal stimuli (30,
38, 39), our data suggest that the presence of mILFs will signifi¬
cantly affect TSE susceptibility. Although early TSE agent accu¬
mulation also occurs within the MLNs following oral inoculation,
we demonstrate that their presence does not influence disease
pathogenesis. Likewise, FDCs within the spleen were also unable
to compensate for the absence of the PPs. Together these data
imply that neuroinvasion most likely occurs directly from lym¬
phoid tissue within the intestine following accumulation upon
FDCs. This conclusion is congruent with data from an epidemio¬
logical, mathematical, and pathological study, which suggested
that for sheep, cattle, and humans, there was an association be¬
tween development of lymphoid tissues in the gastrointestinal tract
and susceptibility to natural TSE infection (40). The precise role
that FDCs play in TSE pathogenesis awaits definitive demonstra¬
tion, but they appear to amplify the levels of the TSE agent above
the threshold required to achieve neuroinvasion (11-14). When
and how the TSE agent spreads from the FDCs within PPs to the
peripheral nervous system is likewise unknown. FDC depletion 14
days after oral inoculation does not affect pathogenesis, implying
that neuroinvasion occurs from a very early stage postexposure
and before the agent has disseminated to other lymphoid tissues
(13). We show that within mILFs, like PPs (19), FDC networks are
situated in close association with the nerve fibers that run along the
gut wall. As the distance between FDCs and peripheral nerves
appears to modulate the rate of TSE agent neuroinvasion (16), it is
likely that the close association of FDCs with the nerve fibers that
run along the gut wall facilitates the rapid spread of the TSE agent
from PPs and mILFs to neighboring enteric nerves. Indeed, studies
have demonstrated that PrP'1 accumulates within enteric ganglia
soon after oral inoculation (19).
How TSE agents are initially acquired from the gut lumen and
cross the intestinal epithelium is not known, but several mecha¬
nisms have been implicated including transcytosis by M cells (41)
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and possibly also capture and transport by migratory bone marrow-
derived dendritic cells (42). In the current study, any potential
effects on dendritic cell migration to the spleen, due to a lack of
LTa,j32 expressing B lymphocytes (43), were restored by WT
bone marrow reconstitution. However, our data cannot exclude the
possibility that the lack of M cells within the follicle associated
epithelia of LTa_/_ mice, LTj3_/~ mice, WT—»LTa~/_ mice,
and WT^»LT/3-/_ mice at the time of inoculation also contributes
to their resistance to orally inoculated scrapie agent.
The inability of the MLNs or spleen to compensate for the ab¬
sence of the PPs is unlikely to be due to fundamental differences
in the nature of the FDCs at each of these sites as no significant
differences between the function of FDCs from these tissues has
been described, and each population appears to express similar
levels of PrPc and CR1/CR2. Following oral inoculation, the TSE
agent accumulates first in PPs and is subsequently distributed via
the lymph and/or blood-stream to the MLNs and spleen (Ref. 13
and current study). In the absence of the PPs, our data show that
this down-stream distribution is blocked.
Diet (e.g., consumption of TSE agent-contaminated food) and
PrP genotype (44, 45) are important risk factors that affect TSE
susceptibility, but others remain to be determined. Recent studies
suggest that inflammation may be another factor, either enhancing
agent uptake from mucosal sites (46), or expanding the tissue dis¬
tribution of these agents (47-49). For example, the induction of
FDC networks within the ectopic germinal centers of chronically
inflamed kidneys enables the accumulation of high levels of PrPSc
in this tissue and excretion of low levels of infectivity in urine (47,
48). Likewise, natural chronic inflammatory conditions can expand
the deposition of PrPSc in TSE-affected animals, such as to in¬
flamed mammary glands of scrapie-affected sheep (49).
ILFs are recently identilied lymphoid structures distributed
throughout the intestines of rodents (36, 50-52) and humans (53)
with features similar to PPs. Although the small intestine of an
adult mouse may contain as many as 100 ILFs, data from the
current study and others (30, 37) show that mILFs are highly in¬
frequent (typically <5 per mouse) in tissues from unmanipulated
immunocompetent control mice in a specific pathogen-free colony.
Stimulation via LT/3R is also important for the development of
ILFs, but unlike PPs, their formation occurs postnatally (30, 37). In
response to exogenous stimuli, LT-expressing B lymphocytes trig¬
ger the progression of ilLFs into mILFs resembling lymphoid nod¬
ules containing a single B lymphocyte follicle of predominantly
B2-B lymphocytes with a germinal center and a follicle associated
epithelium containing M cells (30, 37, 54). Our analysis also dem¬
onstrates that mILFs consistently contain large FDC networks,
which are not present in ilLFs. Because the inducible nature of
mILFs (30, 38) shares features with the ectopically induced ger¬
minal centers described above (47-49) we reasoned that mILFs
might represent an important novel site of TSE agent accumulation
and neuroinvasion in the small intestine.
To specifically determine the potential involvement of mILFs in
scrapie agent transmission from the gastrointestinal tract, tempo¬
rary in utero blockade of the LT/3R signaling pathway was used to
create mice that lacked PPs (termed PP-deficient mice), but con¬
tained numerous mILFs (26, 30). Our experiments demonstrate
that FDCs within mILFs are novel and important sites of TSE
agent accumulation within the small intestine. Furthermore, due to
the presence of a significantly larger number of FDC-containing
mILFs in PP-deficient mice, disease susceptibility was unaffected
by the absence of PPs. The formation and maturation status of ILFs
can be modulated by both lumenal bacterial flora (30, 38) and
pathogenic microorganisms (39), implying that the microbiologi¬
cal status of the intestine at the time of TSE agent exposure might
dramatically enhance disease susceptibility.
In the current study, our animals eat the scrapie agent to model
oral pathogenesis as closely as possible. Following ingestion of the
scrapie agent many factors will act on the inoculum to aid its
elimination from the host. Indeed, much of the inoculum will be
eliminated from the host by factors including digestion (by en¬
zymes secreted in the stomach or small intestine) and excretion. As
a consequence, following oral inoculation very little of the original
inoculum will be available to be translocated across the gut epi¬
thelium by M cells or other potential mechanisms (41, 42). In WT
mice it is likely that once the remaining fraction of the inoculum
enters the lamina propria a competitive state exists whereby cells
such as macrophages aid the clearance of the TSE agent (55, 56),
whereas FDCs act to expand the levels of the TSE agent above the
threshold required to achieve neuroinvasion. Thus, in the absence
of FDCs (and lymphoid tissue within the intestine) in LT-deficient
mice, the residual fraction of the inoculum will be gradually de¬
stroyed by phagocytic cells (55, 56). We have previously shown
that the temporary depletion of FDCs for ~21—28 days blocks TSE
agent transmission from the intestine (13), suggesting this time
interval is sufficient to allow clearance of the remaining inoculum.
In the current study, no mILFs were detected in the small intestines
of WT—»LTa-/~ mice and WT^>LT|3_/_ mice at the time the
mice were inoculated with the scrapie agent (5 wk after bone mar¬
row reconstitution) as their formation occurs between 8 and 12 wk
after WT bone marrow reconstitution (30, 37). Therefore, by the
time the mILFs had eventually developed in the intestines of
WT—»LTa~/_ mice and WT—»LTj3_/_ mice, sufficient time will
have elapsed to allow clearance of the remaining inoculum, pre¬
venting PrPd accumulation upon the FDCs within them and sub¬
sequent neuroinvasion.
In conclusion, our data demonstrate the crucial importance of
TSE agent accumulation upon FDCs within the GALT for efficient
neuroinvasion following oral exposure. Current evidence suggests
vCJD shares a similar requirement for accumulation upon FDCs
before neuroinvasion (5). Thus, our data imply that neuroinvasion
of the vCJD agent might also occur soon after accumulation within
the GALT before the agent has disseminated to other lymphoid
tissues. Our data also identify mILFs as a novel and important site
of TSE agent accumulation within the small intestine. As the for¬
mation and maturation status of ILFs is strongly influenced by
commensal and pathogenic microorganisms (30, 38, 39), factors
that stimulate mILF development are likely to dramatically en¬
hance susceptibility to orally acquired TSE agents.
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Abstract
Transmissible spongiform encephalopathies (TSEs) are neurodegenerative diseases that affect humans and animals. Diseases include scrapie
in sheep and Creutzfeldt-Jakob disease in humans. Following peripheral exposure, TSE agents usually accumulate on follicular dendritic cells
(FDCs) in lymphoid tissues before neuroinvasion. Studies in mice have shown that TSE exposure through scarified skin is an effective means of
transmission. Following inoculation by this route TSE agent accumulation upon FDCs is likewise essential for the subsequent transmission of
disease to the brain. However, which lymphoid tissues are crucial for TSE pathogenesis following inoculation via the skin was not known. Mice
were therefore created that lacked the draining inguinal lymph node (ILN), but had functional FDCs in remaining lymphoid tissues such as the
spleen. These mice were inoculated with the scrapie agent by skin scarification to allow the role of draining ILN in scrapie pathogenesis to be
determined. We show that following inoculation with the scrapie agent by skin scarification, disease susceptibility was dramatically reduced in
mice lacking the draining ILN. These data demonstrate that following inoculation by skin scarification, scrapie agent accumulation upon FDCs in
the draining lymph node is critical for the efficient transmission of disease to the brain.
© 2007 Elsevier B.V. All rights reserved.
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1. Introduction
Transmissible spongiform encephalopathies (TSEs), or
'prion diseases', are sub-acute neurodegenerative diseases that
affect humans and both domestic and free-ranging animals. The
neuropathological features within the central nervous system
(CNS) characteristically include spongiform pathology, neu¬
ronal loss, glial activation and amyloidal aggregations of an
abnormally folded host protein. There is little evidence ofpathol¬
ogy in other tissues. The nature of the TSE agent is unknown, but
an abnormal, relatively proteinase-resistant isoform (PrPSc) of
the host cellular prion protein (PrPc), co-purifies with infectivity
in diseased tissues and is a useful biochemical marker [1], The
'prion hypothesis' argues that PrPSc constitutes a major, or the
sole component of infectious agent and facilitates conversion of
PrPc to PrPSc [2],
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Many TSE agents, including natural sheep scrapie, bovine
spongiform encephalopathy (BSE), chronic wasting dis¬
ease (CWD) in mule deer and elk, and kuru and variant
Creutzfeldt-Jakob disease (vCJD) in humans, are acquired by
peripheral exposure. Although the main route of transmission of
BSE to cattle and other species (e.g.: humans) is considered to
be oral (ingestion), other routes of TSE transmission have been
identified. In humans accidental iatrogenic transmissions have
occurred through transplantation of sporadic CJD contaminated
tissues or tissue products, or transfusion of vCJD-contaminated
blood [3,4]. Neurosurgical instruments contaminated with TSE
agents also have the potential to transmit disease [5]. Therefore
the wide tissue tropism of the vCJD agent [6], and potential for
large numbers of sub-clinical vCJD cases [7] implies that a seri¬
ous risk of iatrogenic transmission exists. Studies in mice have
also highlighted that skin scarification is an effective means of
TSE transmission [8]. Thus, it is possible that some natural TSE
cases might be transmitted through skin lesions during close
contact, such as from an infected mother to offspring through
skin lesions at birth or via the unhealed umbilical cord. Like¬
wise, consumption of coarse feed contaminated with TSE agents
0165-2478/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
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might also scarify the mucosa of the mouth or oesophagus aiding
transmission.
Within the lymphoid tissues of patients with vCJD [6], mule
deer fawns with CWD [9], some sheep with natural scrapie [10]
and rodents inoculated with scrapie [11] early PrPSc accumula¬
tion takes place in the germinal centres upon follicular dendritic
cells (FDCs). In the absence of FDCs, TSE agent accumula¬
tion in lymphoid tissues and the subsequent spread of disease
to the CNS (termed neuroinvasion) are both impaired [12-16],
Neuroinvasion from lymphoid tissues proceeds along both sym¬
pathetic nerves and fibres of the vagus nerve [17,18].
Following inoculation via skin scarification, the scrapie agent
accumulates first in the draining lymph node, and subsequently
spreads to non-draining lymph nodes and the spleen [16,19].
TSE agent accumulation upon FDCs in lymphoid tissues is
likewise critical for efficient transmission of disease from the
skin to the CNS [8,16,20], but which lymphoid tissues are
crucial for neuroinvasion is not known. Therefore, in the cur¬
rent study mice deficient in the draining lymph node were
utilized to address the following questions: First, whether TSE-
susceptibility is reduced in the absence the draining lymph node?
Second, whether neuroinvasion occurs from multiple sites such
that the lack of the draining lymph node can be compensated for
by the presence of another such as the spleen?
2. Materials and methods
2.1. Mice and bone-marrow grafting
Lymphotoxin (LT)a_/_ mice [21] and LT[3_/_ mice [22]
were obtained from B & K Universal Ltd. (Hull, UK) and were
maintained on a C57BL/6 background. Age- and sex-matched
C57BL/6 mice were used as immunocompetent wild-type (WT)
controls. Bone-marrow from the femurs and tibias of WT
mice was prepared as a single-cell suspension (3 x 107-4 x 107
viable cells/ml) in HBSS (Invitrogen, Paisley, UK). Recipient
adult (6-8 weeks old) LTa~/_ mice, LT(3-/_ mice and WT
mice were y-irradiated (950 rad) and 24 h later reconstitutedwith
0.1 ml bone-marrow by injection into the tail vein. Recipient
mice were used in subsequent experiments 35 days after bone-
marrow grafting. All protocols using experimental rodents were
approved by the Institute's Protocols and Ethics Committee and
carried out according to the strict regulations of the UK Home
Office 'Animals (scientific procedures) Act 1986'.
2.2. Scrapie agent inoculation
Mice were inoculated with the ME7 scrapie agent strain by
skin scarification of the medial surface of the left thigh. Briefly,
prior to scarification approximately 1 cm2 area of hair cover¬
ing the site of scarification was trimmed using curved scissors
and then removed completely with an electric razor. Twenty-
four hours later a 23-gauge needle was used to create a 5 mm
long abrasion in the epidermal layers of the skin at the scarifi¬
cation site. Then using a 26-gauge needle one droplet (~6 pi)
of ME7 scrapie agent inoculum from a 1.0% (w/v) terminal
scrapie mouse brain homogenate in physiological saline was
applied to the abrasion and worked into the site using sweep¬
ing strokes. The scarification site was then sealed with OpSite
(Smith & Nephew Medical Ltd., Hull, UK) and allowed to dry
before the animals were returned to their final holding cages.
Where indicated, separate groups of WT mice, LTa_/_ mice
and LTP~/_ mice were inoculated by intracranial injection with
20 p.1 of a 1.0% (w/v) scrapie mouse brain homogenate (contain¬
ing approximately 1 x 104 5 ID50 units). Following inoculation,
all animals were coded, assessed weekly for signs of clinical
disease and killed at a standard clinical end-point [23], Scrapie
diagnosis was confirmed by histopathological assessment of
TSE vacuolation in the brain.
2.3. Immunohistochemical and immunofluorescent analysis
Spleens were removed and snap-frozen at the temperature
of liquid nitrogen. Serial frozen sections (10 pm in thickness)
were cut on a cryostat. Follicular dendritic cells were visualized
by staining with mAb 7G6 to detect CD21/CD35 or mAb 8C12
to detect CD35 (BD Biosciences PharMingen, Oxford, UK). B
lymphocytes were detected using mAb B220 to detect CD45R
(Caltag, Towcester, UK). Complement component (C) C4 was
detected using mAb FDC-M2 (AMS Biotechnology, Oxon,
UK). For fluorescent microscopy, following the addition of pri¬
mary antibodies, species-specific secondary antibodies coupled
to Alexa Fluor® 488 (green) or Alexa Fluor® 594 (red) dyes
(Invitrogen) were used. Sections were mounted in fluorescent
mounting medium (Dako, Ely, UK) and examined using a Zeiss
LSM5 confocal microscope (Zeiss, Welwyn Garden City, UK).
For light microscopy, following the addition of primary anti¬
body, biotin-conjugated secondary antibodies (Stratech, Soham,
UK) were applied followed by alkaline phosphatase coupled
to the avidin-biotin complex using Vector Red as a substrate
(Vector Laboratories, Peterborough, UK). Sections were sub¬
sequently counterstained with hematoxylin to distinguish cell
nuclei.
For the detection of PrP in the brain, tissues were fixed in
periodate-lysine-paraformaldehyde and embedded in paral'lin-
wax. Sections (thickness, 6 pm) were deparaffinized, and
pretreated to enhance PrP immunostaining by hydrated auto-
claving (15 min, 121 °C, hydration), and subsequent immersion
in formic acid (98%) for 5 min [24]. Sections were then stained
with the PrP-specific pAb 1B3 [25]. Glial fibrillary acid pro¬
tein (GFAP) was detected on adjacent brain sections using
rabbit GFAP-specific antiserum (Dako). Immunolabelling was
detected using either horse radish peroxidase coupled to the
avidin-biotin complex (Vector Laboratories) with diaminoben-
zidine (DAB) as a substrate, or alkaline phosphatase coupled
to the avidin-biotin complex using Vector Red as a substrate.
Sections were subsequently counterstained with hematoxylin to
distinguish cell nuclei.
2.4. Immunoblot detection ofPrPSc
Spleen fragments (approximately 20 mg) or inguinal lymph
nodes (ILNs) were prepared as 10% (w/v) tissue homogenates
and PrPSc enriched by sodium phosphotungstic acid (NaPTA)
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precipitation [26] and treated in the presence or absence of
proteinase K (40p.g/ml, 60min, 37 °C; VWR, Lutterworth,
UK). Following enrichment, pellets were re-suspended and
diluted to an approximate protein concentration of 0.5 mg pro¬
tein/ml and 10p,l electrophoresed through SDS/PAGE (12%)
polyacrylamide gels (Invitrogen). Proteins were transferred to
polyvinylidene difluoride (PVDF) membranes (Bio-Rad Labo¬
ratories, Hemel Hemstead, UK) by semidry blotting. PrP was
detected with the PrP-specific mouse mAb 8H4 [27], followed
by horse radish peroxidase-conjugated goat anti-mouse anti¬
serum. Bound horse radish peroxidase activity was detectedwith
Supersignal® West Dura Extended Duration Substrate (Pierce
Biotechnology, Rockford, IL, USA).
2.5. Statistical analysis
Data are presented as mean ± S.E.M. Significant differences
between samples in different groups were sought by one-way
ANOVA.
3. Results
3.1. Creation ofmice that lack inguinal lymph nodes
In mice the lymph nodes that drain the skin region of the thigh
are the inguinal lymph nodes (ILNs), and our previous studies
have shown that the TSE agent accumulates first in these lymph
nodes following inoculation via scarification of the skin of the
thigh [ 16,19]. To test the hypothesis that the draining lymph node
plays an important role in TSE agent transmission from the skin
to the CNS, mice were created that lacked the draining ILNs,
but had mature FDCs in remaining lymphoid tissues such as the
spleen. Stimulation through the LT(3-receptor (LT[3R) during
embryonic development is important for the formation of most
lymph nodes but not the spleen [28], As a consequence the ILNs
are lacking in LTa-/~ mice and LT(3_/_ mice (Fig. 1A). How¬
ever, post-natal LTpR-stimulation is also critically required to
induce the maturation of FDCs and maintain them in their dif¬
ferentiated state [29]. As a consequence, the remaining spleens
of LToC/_ mice (Fig. 1B) and spleens (Fig. 1B) and mesenteric
lymph nodes (data not shown) of LT[3-/~ mice are deficient in
FDCs. Since FDCs are critical for the efficient neuroinvasion of
theME7 scrapie agent following inoculation via the skin [ 16,20],
it was important therefore to induce the development of FDCs
in the remaining lymphoid tissues in LTa~'~ mice and LTp~/_
mice.
Adult WT mice, LTa-'~ mice and LT(3~'~ mice were y-
irradiated and 24 h later reconstituted with LT-expressing WT
bone marrow (termed WT -» WT mice, WT —> LTa-/~ mice
and WT —*■ LT(3_/_ mice, respectively). Within 35 days ofWT
bone marrow transfer, the development of FDC networks in the
remaining lymphoid tissues of LTa_/_ mice and LTP~/_ mice
was induced (Fig. IB), but the development of missing lym¬
phoid tissues was not induced (Table 1; [30]). Expression of
complement receptors (CR) 1 and CR2 (CD35 and CD21, respec¬
tively) by FDCs within the spleens ofWT -» LTa_/~ mice and
WT —» LTp-/_ mice appeared similar to that observed in tis¬
sues from immunocompetent control WT —> WTmice (Fig. IB).
The close association of complement component C4 with the
CR1-expressing cells indicated that the spleens of WT -* WT
mice, WT -> LTa_/~ mice and WT -> LTp~/_ mice contained
functional, immune complex-trapping FDCs (Fig. 1C).
3.2. Effect of ILN-deficiency on scrapie pathogenesis
Groups of WT —> WT mice, WT —> LTa_/_ mice and
WT —> LT(3^/_ mice were inoculated with the scrapie agent via
skin scarification 35 days after reconstitution with WT bone
marrow. All immunocompetent WT —>■ WT mice succumbed to
clinical TSE disease with a mean incubation period of 322 ± 9
days (n = 9, Table 1). In contrast, in the absence of the drain¬
ing ILNs, scrapie-susceptibility was dramatically reduced. Six
of seven WT —> LTot-'- mice remained free of the signs of
scrapie up to 503 days after inoculation (Table 1). However,
one WT —> LToC mouse did succumb to clinical scrapie
with an incubation period of 343 days. Likewise, six of eight
WT —> LT[}-/~ mice remained free of the signs of scrapie up
to 503 days after inoculation (Table 1). Characteristic spongi¬
form pathology, disease-specific abnormal accumulations of
PrP (PrPd) and reactive astrocytes expressing high levels of
GFAP were detected within the brains of all WT —» WT mice,
and the few WT —>■ LTa~'~ mice (n= 1) and WT —> LT[3_/_
mice (n = 2) that developed clinical signs of scrapie (Fig. 2). In
contrast, spongiform pathology, PrPd accumulation and reac-
Table 1
Scrapie agent transmission following inoculation via skin scarification is dramatically reduced in mice lacking the draining inguinal lymph node
Mouse strain2 Presence at time of inoculation Disease incidence Mean incubation period (days) ± S.E.M.
ILNs MLNs SPL FDCs
WT —► WT + + + + 9/9 322 ± 9
WT ->■ LTa-'- + + 1/7 343,5X>503b
WT —»■LTp~'~ + + + 2/8 334,350 6X neg. 403-503c
ILNs, inguinal lymph nodes; MLNs, mesenteric lymph nodes; SPL, spleen; FDCs, follicular dendritic cells.
(+) present;(—) absent; neg., mice free of the clinical and histopathological signs of scrapie at the time of analysis.
a Mice were inoculated with the scrapie agent 35 days after y-irradiation and reconstitution with WT bone marrow.
b Two additional mice were killed 336 and 432 days after inoculation. These mice were free of the clinical signs of scrapie at the time of cull. No histopathological
signs of scrapie were detected in the brain (data not shown).
c Six mice were killed 403, 406, 406, 476, 490 and 503 days after inoculation. These mice were free of the clinical signs of scrapie at the time of cull. No
histopathological signs of scrapie were detected in the brain (data not shown).
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Fig. 1. LTa~'~ mice and LT(3~'~ mice lack ILNs and FDCs in remaining lymphoid tissues. (A) In contrast toWTmice (left, arrow), LTa-/" mice (middle) and LTp~'_
mice (right) lack ILNs. (B and C) Immunohistochemical analysis of spleen microarchitecture. (B) Spleens from WT mice and WT -» WT mice showed presence of
CRl/CR2-expressing (red) FDCs and organised B lymphocyte follicles (B220-positive cells; green). FDCs and distinct B lymphocyte follicles were undetectable
in the spleens of unreconstituted LTa~'~ mice and LT|3 ' mice. After reconstitution of LTa ~f mice and LTp mice with WT bone marrow (WT —> LTa-'-
mice and WT —> LT(3_/~ mice, respectively), FDC maturation and follicular organisation were induced. (C) Spleens from WT —» WT mice, WT —* LTa / mice
and WT —>■ LTp '' mice contain functional FDCs. Complement component C4 (red; lower row) was detected in close association with CR1-expressing FDCs (red;
upper row). Original magnification in panels B and C, x200.
five astrocytes were not detected in the brains of any of the
WT —>■ LTa~/_ mice and WT —> LTp~'~ mice that were free of
the clinical signs of scrapie (Fig. 2).
When inoculated with the scrapie agent directly into the
CNS (by intracranial injection) all WT mice, LTot-/_ mice and
Lxp-'- mice developed clinical signs of scrapie with similar
incubation periods of 172-175 days (n = 6; data not shown).
Thus, the dramatically reduced susceptibility ofWT -» LTa_/_
mice and WT -a- LTP_/~ mice to the scrapie agent when
inoculated via the skin could not be attributed to a role for LTPR-
signalling in disease pathogenesis directly within the CNS.
3.3. PrPSc accumulation in remaining lymphoid tissues
Strong accumulations of relatively proteinase K-resistant
PrPSc were found in both the ILNs and spleens ofWT —> WT
mice (Fig. 3A and B). Although WT —> LTot~/_ mice and
WT —> LTp~'~ mice lack ILNs, the area of subcutaneous tissue
where this lymph node would have been located in WT mice
was removed and PrPSc levels within it determined. Congruent
with the absence of the ILNs, PrPSc was likewise undetectable
in subcutaneous tissue taken from WT —> LTa-/~ mice and
WT —> LTp~/_ mice that remained free of clinical disease up to
















Fig. 2. Immunohistochemical analysis of brain tissue from terminally scrapie affected mice and mice that remained free of the signs of disease at the end of the
experiment. Large PrP*1 accumulations (brown; upper row), reactive astrocytes expressing high levels of GFAP (red; middle row) and spongiform pathology (H
and E; lower row) were detected in the hippocampi of all clinically scrapie-affected WT —> WT mice, and the few WT —► LTa_/~ mice (n = 1) and WT -> LTp~~/_
mice (n = 2) that developed clinical disease. None of these pathological signs of scrapie were detected in any of the brains from scrapie-inoculated WT -> LTa-/~
mice (n = 6) and WT —> LTp~/_ mice (n = 6) that remained free of the clinical signs of disease at the end of the experiment. All sections were counterstained with
haematoxylin (blue). Original magnification x200. dpi, day post inoculation on which the tissues were analyzed; pos, mice that developed clinical signs of scrapie;
neg, mice that were free of the signs of scrapie.
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Fig. 3. PrPSc accumulation in the ILNs (A) and spleens (B) of WT— WT mice, WT— LTa-/~ mice and WT— LT(3_/~ mice inoculated with the scrapie agent by
skin scarification. Samples were treated in the presence (+) or absence (—) of proteinase K (PK) prior to electrophoresis. After PK treatment, a typical three-band
pattern was observed between molecular mass values of 20 and 40 kDa, representing unglycosylated, monoglycosylated and diglycosylated isomers of PrP (in order
of increasing molecular mass). Lane U, spleen from an uninoculated control WT mouse; dpi, day post inoculation on which the tissues were analyzed; pos, mice that
developed clinical signs of scrapie; neg, mice that were free of the signs of scrapie.
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503 days after inoculation (Fig. 3A). Similarly, PrPSc was also
undetectable in the spleens ofclinically negativeWT —> LTa_/_
mice and WT —> LT[3-/~ mice (Fig. 3B). In contrast, in the few
WT —» LTa-/_ mice (n = \ ) and WT —> LT(3_/_ mice (« = 2)
that developed clinical signs of scrapie, strong accumulations of
PrPSc were detected in their spleens (Fig. 3B; lanes 6, 14 and
16, respectively).
4. Discussion
We show here that the draining lymph node plays a crucial
role in TSE agent neuroinvasion following inoculation via the
skin. Our data show that in the absence of the draining lymph
node at the time of inoculation, transmission of the scrapie
agent from the skin is dramatically reduced, despite the pres¬
ence of mature FDCs within the spleen and other remaining
lymphoid tissues. Thus following inoculation via the skin TSE
agent accumulation upon FDCs in the draining lymph node is
critical for efficient neuroinvasion. We have previously shown
that following inoculation via scarification of skin of the thigh,
the TSE agent accumulates first within the draining ILN and
subsequently accumulates within the spleen [16,19]. However,
data here show that the spleen is not an important site of neu¬
roinvasion as mature FDCs were present within the spleens of
WT —> LTa_/_ mice and WT —*■ LT(3_/_ mice that remained
refractory to clinical disease. Together, these data demonstrate
that TSE agent accumulation within the draining lymph node is
critically required for efficient neuroinvasion following inocu¬
lation via scarification of the skin.
Stimulation through the LTai(32-LT(3R signalling pathway
during embryonic development is important for the formation
of most lymph nodes but not the spleen [28], As a consequence
the ILNs and most other lymph nodes do not form in LTa_/~
mice or LTP~'~ mice [28]. In adult mice, LTfiR-stimulation is
also critically required to induce the maturation of FDCs and
maintain them in their differentiated state [29]. Thus, LTa~'~
mice and LTP~/_ mice lackmost lymph nodes and FDCs in their
remaining lymphoid tissues. Reconstitution of LTa_/_ mice and
LTp—/— mice with WT bone marrow induces the development
of FDC networks in the remaining lymphoid tissues, but does
not restore the development of the missing lymphoid tissues
(Table 1; [30]). FDCs are critical for the efficient neuroinvasion
of the ME7 scrapie agent following inoculation via the skin as
disease susceptibility is reduced in their absence [16,20], There¬
fore in the current study through reconstitution of LTa_/_ mice
or LT(3-/_ mice with WT bone marrow we created mouse mod¬
els that lacked the draining ILNs but had mature FDC networks
in the remaining lymphoid tissues. In these models, the presence
of FDCs in the remaining tissues would enable TSE agent accu¬
mulation to occur within them if the ILNs were not required for
efficient neuroinvasion.
FDCs are a distinct lineage from the migratory bone marrow-
derived dendritic cells (DCs). FDCs are considered to derive
from stromal precursor cells, are tissue fixed and do not phago-
cyotose antigens. Instead, FDCs characteristically trap and retain
immune-complexes composed of antigen, antibody and/or com¬
plement components, storing them on their surfaces in native
form for long durations [31]. Immune complex retention on
FDCs is highly dependent on complement components and the
expression of CR1 and CR2 [32]. The expression of CR1 and
CR2 by FDCs within the spleens of WT —>• LTa~/_ mice and
WT -> LT(}_/~ mice was similar to that observed in tissues
from immunocompetent control WT —*■ WT mice. Furthermore,
the close association of complement component C4 with the
CR1-expressing cells implied that 35 days after bone marrow
transfer the remaining lymphoid tissues of WT -» WT mice,
WT —> LTct-/~ mice and WT —> LT(3~~/_ mice contained func¬
tional immune complex trapping FDCs. Indeed, previous studies
have demonstrated that reconstitution of LTa_/_ mice with WT
bone marrow or lymphocytes induces the development of FDC
networks in the spleen which support immunoglobulin (Ig) class
switching and maintain an effective IgG response [33,34]. Cur¬
rent hypotheses suggest that complement plays an important role
in the localisation of TSE agents to FDCs [35,36]. Thus these
data indicate that the FDCs within the remaining lymphoid tis¬
sues of WT bone marrow-reconstituted mice had the potential
to acquire the scrapie agent.
Despite the presence of mature FDC networks within the
remaining lymphoid tissues of WT —> LTa~'~ mice (spleen
and nasal associated lymphoid tissue) and WT -»LT(3_/~
mice (spleen, cervical lymph nodes, mesenteric lymph nodes
and nasal associated lymphoid tissue), scrapie susceptibility
following inoculation by skin scarification was dramatically
reduced. Similarly, in the spleens of WT -» LTa_/_ mice and
WT —> LT(3_/_ mice that remained free of the signs of clini¬
cal disease the accumulation of PrPSc was blocked. Although
we have previously demonstrated that TSE agent accumulation
upon FDCs is critical for the efficient transmission of disease
from the skin to the brain the precise tissue within which neu¬
roinvasion occurs was not known [16]. Data in the current study
imply that the initial neuroinvasion occurs following accumula¬
tion upon FDCs within the draining lymph node.
We cannot entirely exclude the possibility that the ILNs serve
as the initial site of scrapie agent accumulation, with neuroin¬
vasion occurring following subsequent dissemination to other
lymphoid tissues. However, data from other studies also implies
that the major route of neuroinvasion following inoculation via
the skin is not via the spleen. Removal of the spleen before sub¬
cutaneous inoculation with the scrapie agent has no effect on
disease pathogenesis [37]. The temporary depletion of FDCs
prior to inoculation with the scrapie agent via the skin signifi¬
cantly reduces disease susceptibility [16]. However, the lack of
any observable effect of such treatment at a time when heavy
accumulations of PrPSc are detectable in the draining ILNs but
not the spleen or non-draining ILNs [16] indicates that neuroin¬
vasion most likely occurs at a very early stage post exposure
and before the agent has had sufficient time to disseminate to
multiple lymphoid tissues.
In the current study, every effort was taken at the time of
skin scarification to avoid drawing blood to prevent the leakage
of infectivity directly into the bloodstream during inocula¬
tion. If the scrapie agent had leached into the bloodstream a
need for the draining ILNs in neuroinvasion would obviously
have been by-passed. As a consequence, all WT —»■ LTa~'~
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mice and WT —> LTp""/_ mice would be fully susceptible to
disease as scrapie agent neuroinvasion could have occurred
via the spleen which filters antigen and microorganisms from
the blood-stream. However, most WT -> LTa_/~ mice and
WT —> LT(i^/_ mice remained free of clinical disease and PrPSc
was undetectable within the spleens of these animals. These
data clearly demonstrate that the major route of scrapie trans¬
mission from the skin to lymphoid tissues does not occur via
the bloodstream. We have previously demonstrated that PrPSc
accumulates first upon FDC networks within the draining ILN
and subsequently spreads to non-draining lymph nodes and
the spleen [16]. Therefore, taken together these data indicate
that following inoculation via the skin the scrapie agent is first
propagated to the draining lymph node via the lymphatics, and
subsequently distributed to the spleen and other lymphoid tissues
via the bloodstream. However, one WT —> LTa_/_ mouse and
twoWT —> LTp ~ mice did develop clinical scrapie despite the
absence of the draining ILN. Although the precise route of neu¬
roinvasion in these rare instances is uncertain, we can not exclude
the possibility that neuroinvasion occurred following contami¬
nation of the blood-stream or via direct infection of peripheral
nerves at the site of skin scarification, by-passing the need for
accumulation within the draining ILN.
The levels of infectivity responsible for natural TSE trans¬
missions are unknown but are likely to be much lower than the
moderate dose used in this study. The lack of detection of PrPSc
within the spleens and brains of surviving WT —> LTa~'~ mice
and WT -> LTp-/~ mice provides strong evidence that scrapie
transmission was blocked in the absence of the draining ILN.
However, these data do not exclude the possibility that follow¬
ing inoculation with a much higher dose of scrapie than the one
used here neuroinvasion might occur via an alternate route, such
as direct uptake by peripheral nerves.
Data presented here show that draining lymphoid tissue local
to the site of inoculation (ILNs in the current study) is critically
required for the efficient transmission of the ME7 scrapie agent
following inoculation via skin scarification. Together, our data
suggest that following inoculation through this route neuroin¬
vasion occurs via the following pathway. Following inoculation
into the skin, the TSE agent disseminates first to the draining
lymph node via the lymph. The precise mechanism by which
the TSE agent is transported within the draining afferent lymph
remains to be identified [19]. Neuroinvasion does not occur fol¬
lowing direct uptake by peripheral nerves in the skin or following
widespread dissemination via the blood-stream [8,20]. Within
the draining lymph node, TSE agent accumulation occurs upon
PrPc-expressing FDCs [20], Accumulation upon FDCs is critical
for efficient neuroinvasion [16]. Following accumulation within
the draining lymph node the TSE agent is subsequently dissem¬
inated to non-draining lymph nodes and the spleen most likely
via the blood-stream [16,19]. Data in the current study demon¬
strate that neuroinvasion is dramatically impaired in the absence
of the draining lymph node implying that the TSE agent most
likely spreads to the peripheral nervous system directly from this
tissue.
Current evidence suggests that the vCJD [6,38,39], CWD [9]
and sheep scrapie [10] agents share a similar requirement for
accumulation upon FDCs prior to neuroinvasion Thus the ini¬
tial neuroinvasion of naturally-acquired TSE agents might also
occur following accumulation within the draining lymphoid tis¬
sue and before the agent has disseminated to other lymphoid
tissues. TSE agents cause considerable neurodegeneration once
they infect CNS. Understanding the early events in TSE agent
neuroinvasion from peripheral tissues will be important for the
development of therapeutic strategies to combat these fatal neu¬
rodegenerative diseases.
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